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Physical inactivity is a global health problem. Despite a good understanding of 
the benefits of completing regular exercise, adherence rates at a population level are 
extremely low. An experimental medicine approach to health behaviour change was 
recently proposed, which prioritises an understanding of how, not just whether 
interventions are effective. The present study serves as the first application of this model 
to develop a physical activity behaviour change intervention. This thesis is comprised of 
eight studies in 6 experimental chapters, which are presented in two parts. 
Part I is focussed on understanding whether changes in perceptual responses to 
exercise, caused by caffeine, are sufficient to elicit a change in physical activity 
behaviour. Chapter 4 utilised a single-subject experimental design as a preliminary trial. 
We provided the first experimental evidence that pharmacological intervention can 
influence physical activity choice behaviour by manipulating feelings during and around 
exercise. In chapter 5, a group trial corroborated many of the psychological and perceptual 
effects of caffeine observed in chapter 4, whilst a qualitative exploratory analysis of the 
factors underlying exercise choice revealed that perception of effort was the primary 
determinant of exercise preference. chapter 6 investigated the metabolic effects of 
caffeine during high-intensity interval training (HIIT). Providing evidence to suggest that 
caffeine can elicit a dual function of increasing non-exercise thermogenic activity, as well 
as increasing metabolic activity during HIIT, without an increase in perceptions of effort 
and discomfort. 
The aim of Part II was to develop a preclinical model to measure the effects of 
pharmacological interventions on physical activity behaviour. In chapter 10 we 
determined an appropriate running wheel access paradigm. In chapter 11 we proved for 
the first time that caffeine does not elicit a significant increase in voluntary wheel-running 
ii 
 
activity during the active phase in mice. Whilst chapter 12 validated a method of 
pharmacologically inducing human sedentary-like behaviours in mice, and demonstrated 
the ability to completely reverse wheel-running suppression with caffeine administration.  
In sum, this thesis offers translational models, able to detect psychological and 
behavioural effects of pharmacological intervention, providing a platform from which to 
test the effects of alternative drugs, for trials at a pre-clinical and human level, on physical 
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Figure 11.4. Shows the initiation time for experimental procedures in study iii, in relation to 
the light-dark cycle. Treatment administration is marked by an illustrated syringe. 
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Figure 11.5. Enclosed free wheel-running activity, during a 2-hour observation period, at 
baseline and following multiple treatment occasions. The time of day was ZT6 (middle of the 
inactive phase). Mice received injections (administered IP) of either saline (n = 5), 20 mgÂkg 
caffeine (n = 5), or 40 mgÂkg caffeine (n = 5). A) total distance covered B) percentage of 
sedentary time. C) average running speed. D) maximum running speed. All values are 
presented as means ± SEM. Indications of significance derive from ANOVAs completed on 
within-VXEMHFWFKDQJHVFRUHYDOXHV6LJQLILFDQWPDLQHIIHFWRIWLPH36LJQLILFDQW
PDLQHIIHFWRIFRQGLWLRQ36LJQLILFDQWFRQGLWLRQ[WLPHLQWHUDFWLRQ3:KHUH
a significant interaction is present, [a] and [b] represent significant differences from saline for 
40 mgÂkg and 20 mgÂkg JURXSVUHVSHFWLYHO\3IURP%RQIHUURQLSRVW-hoc tests. 
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Figure 11.6. Enclosed free wheel-running activity, during a 2-hour observation period, at 
baseline and following multiple treatment occasions. The time of day was ZT12 (start of the 
active phase). Mice received injections (administered IP) of either saline (n = 5), or 20 mgÂkg. 
caffeine (n = 6). A) total distance covered B) percentage of sedentary time. C) average running 
speed. D) maximum running speed. All values are presented as means ± SEM. Indications of 







Figure 11.7. Enclosed free wheel-running activity, during a 2-hour observation period, at 
baseline and following multiple treatment occasions. The time of day was ZT12 (start of the 
active phase). Mice received injections (administered IP) of either saline (n = 5), or 40 mgÂkg. 
caffeine (n = 6). A) total distance covered B) percentage of sedentary time. C) average running 
speed. D) maximum running speed. All values are presented as means ± SEM. Indications of 




Figure 11.8. Enclosed free wheel-running activity, during a 2-hour observation period, at 
baseline and following multiple treatment occasions. The time of day was ZT18 (middle of the 
active phase). Mice received injections (administered IP) of either saline (n = 7), or 20 mgÂkg. 
caffeine (n = 8). A) total distance covered B) percentage of sedentary time. C) average running 
speed. D) maximum running speed. All values are presented as means ± SEM. Indications of 
significance derive from ANOVAs completed on within-VXEMHFW FKDQJH VFRUH YDOXHV 
6LJQLILFDQWPDLQHIIHFWRIWLPH36LJQLILFDQWPDLQHIIHFWRIFRQGLWLRQ3 
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Figure 11.9. Enclosed free wheel-running activity, during a 2-hour observation period, at 
baseline and following multiple treatment occasions. The time of day was ZT6 (middle of the 
active phase). Mice received injections (administered IP) of either saline (n = 7), or 40 mgÂkg 
caffeine (n = 8). A) total distance covered B) percentage of sedentary time. C) average running 
speed. D) maximum running speed. All values are presented as means ± SEM. Indications of 




from Bonferroni post-hoc tests. 
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Figure 12.1. Effect of different doses of haloperidol (0.0, 0.05, 0.1, and 0.2 mgÂkg) on time 
spent in a running wheel or consuming sucrose. Data are presented as mean (± SEM) seconds 
in 15 minutes. Black bars represent sucrose consumption; grey bars represent wheel-running. 
* p  .05, ** p  .01 significantly different from 0.0 mgÂkg haloperidol for the same reinforcer. 
Taken from Correa and colleagues (2016). 
218 
Figure 12.2. Enclosed free wheel-running activity, during a 2-hour observation period, at 
baseline and following 3 treatment conditions. Treatments (received in a randomised order and 
administered via IP injection) were: haloperidol vehicle followed by saline (control); 
haloperidol, followed by saline; and haloperidol, followed by 40 mgÂkg caffeine. The time of 
day was ZT12 (start of the active phase). A) total distance covered B) percentage of sedentary 
time. C) average running speed. D) maximum running speed. All values are presented as means 
± SEM. * Indicates a significant difference between conditions at P < 0.05, ** at P < 0.01, and 
*** at P < 0.001. 
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Figure 12.3. SPA measured via infrared motion detection, in a home-cage environment, after 
completing 2-h enclosed free wheel-running, at baseline and following 3 treatment conditions. 
Treatments (received in a randomised order and administered via IP injection) were: 
haloperidol vehicle followed by saline (control); haloperidol, followed by saline; and 
haloperidol, followed by 40 mgÂkg caffeine. Drugs were administered at ZT12 (start of the 
active phase). A) during the remaining active phase (ZT15 ± ZT00); B) during the following 
inactive phase (ZT00 ± ZT12). All values are presented as means ± SEM. * Indicates a 
significant difference between conditions at P < 0.05; *** at P < 0.001. 
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Figure 12.S. Enclosed free wheel-running activity, during the first 1-hour of a (total) 2-hour 
observation period, at baseline and following 3 treatment conditions. Treatments (received in 
a randomised order and administered via IP injection) were: haloperidol vehicle followed by 
saline (control); haloperidol, followed by saline; and haloperidol, followed by 40 mgÂkg 
caffeine. The time of day was ZT12 (start of the active phase). A) total distance covered B) 
percentage of sedentary time. C) average running speed. D) maximum running speed. All 
values are presented as means ± SEM. * Indicates a significant difference between conditions 




1. General Introduction 
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1.1. Benefits of physical activity 
Evidence indicates a U-shaped curve whereby low and moderate doses of physical 
activity significantly reduce long-term risks for both total mortality and cardiovascular 
mortality, whilst at very high doses of chronic strenuous exercise (>4-5 hours vigorous 
exercise per week) much of the protection against early mortality and cardiovascular 
disease is lost, especially for those over 45 years of age 2¶.HHIH2¶.HHIH	/DYLH
2018). Indeed, this is consistent with animal work suggesting that extreme levels of 
exercise have deleterious effects, including chronically elevated corticosterone levels 
(Girard & Garland, 2002), and impaired learning (J. S. Rhodes, Gammie, & Garland, 
2005a). In appropriate doses, at least, physical activity is a force for good.  
A systematic review of longitudinal studies investigating the effect of physical 
activity on weight gain and obesity, coronary heart disease, type 2 diabetes mellitus and 
dementia and $O]KHLPHU¶VGLVHDVHIRXQGWKDWLQDOODYDLODEOHOLWHUDWXUHSK\VLFDODFWLYLW\
is associated with positive health outcomes (Reiner, Niermann, Jekauc, & Woll, 2013). It 
can prevent some cancers and facilitate the treatment of others (Newton & Galvão, 2008), 
provide treatment for sleep-related disorders (Reid et al., 2010) and depression (Cooney 
et al., 2013), as well as attenuating the negative effects of high levels of sedentary time 
(Ekelund et al., 2016) that are commonplace in modern society (Cardinal, 2016). In fact, 
regular physical activity has so many health benefits that the Academy of Royal Medical 
&ROOHJHVKDVGHILQHGH[HUFLVHDVWKHµµPLUDFOHFXUH¶¶(The Academy of Medical Royal 
Colleges, 2015). Despite ubiquitous understanding of the benefits of physical activity, 
public health exercise guidelines are (almost) entirely ignored (Ekkekakis, Vazou, Bixby, 
& Georgiadis, 2016) and combatting physical inactivity has been characterised as "the 




Physical activity is a very complex behaviour, and only a combination of different 
interventions that target behaviour at all levels is likely to succeed (Biddle, Mutrie, & 
Gorley, 2015; E. Kahn et al., 2002). Accordingly, current research seeking to tackle the 
physical inactivity pandemic (Kohl et al., 2012) has adopted several strategies. 
Approaches recommended in a review by Heath et al. (2012) are: informational 
approaches of community-wide and mass media campaigns, and short physical activity 
messages targeting key community sites, which often utilise high-visibility programming 
such as television, radio, newspapers etc. (e.g., D. R. Young, Haskell, Taylor, & 
Fortmann, 1996); Behavioural and social approaches, introducing social support for 
physical activity within communities and worksites, and school-based strategies that 
encompass physical education, classroom activities, after-school sports, and active 
transport (e.g., Kriska et al., 1986); and environmental and policy approaches include 
creation and improvement of access to places for physical activity with informational 
outreach activities, community-scale and street-scale urban design and land use, active 
transport policy and practices, and community-wide policies and planning (e.g., Heath et 
al., 2006). These types of interventions are necessary to promote physical activity and 
should be widely implemented. However, adherence to physical activity remains a major 
issue (Hallal et al., 2012). 
Many consider physical activity to be a determinant of obesity and view obesity 
as the primary health-related issue. However, in several longitudinal studies (Ekelund, 
Brage, Besson, Sharp, & Wareham, 2008; Metcalf et al., 2011) baseline physical activity 
did not predict follow-up fat mass, whilst baseline fat mass did predict follow-up physical 
activity. Further, in a study investigating a 22-week remotely supervised walking 
programme, stepwise regression analysis revealed baseline body mass index (BMI) to be 
the major determinant of adherence rate (Masuki et al., 2015). Together, these findings 
suggest that fat mass could instead be a determinant of physical activity. Considering 
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recent epidemiological data suggesting that physical inactivity predicts twice as many 
deaths as BMI alone (Ekelund et al., 2015), There should be no disputing what the 
primary objective is. The relevance of introducing the obesity/physical inactivity 
relationship here is that it may shed light on the important relationship between perceptual 
responses to exercise and physical activity behaviour. A study investigation perceptual 
responses to exercise revealed that exercise does not feel the same for participants who 
were overweight as it did for participants who were not overweight (Ekkekakis & Lind, 
2006). Specifically, affect and perceived exertion were lower and higher, respectively, 
which is indicative of a less desirable psychological experience in overweight individuals. 
Perhaps the way that high levels of fat mass affect the way one feels during exercise, at 
least in part, explains the relationship between BMI and adherence? If so, it is likely that 
variance in perceptual responses to physical activity, independent of BMI, may also 
impact adherence. 
A recent editorial suggested that not enough attention has been paid to the core 
psychobiological reason for why most people do not regularly engage in physical activity, 
which, according to Marcora (2016), is that humans do not like to exert effort. Marcora 
(2016) is not alone in this view, however, the Principle of Least Effort was first presented 
by Ferrero (1894), and later developed and supported by 25 years of empirical data 
(Florence & Zipf, 1950; Zipf, 1949)=LSIFRQFOXGHGWKDW³(DFKLQGLYLGXDOZLOO
adopt a course of action that will involve the expenditure of the probably least average of 
KLVZRUN´,QRWKHUZRUGVKXPDQVDUHefficient. The principle of least effort still stands 
and perceived exertion, which is measured as a proxy to perception of effort, is currently 
established as a negative correlate of physical activity behaviour (Bauman et al., 2012; R. 
E. Rhodes & Smith, 2006; Trost, Owen, Bauman, Sallis, & Brown, 2002; van Stralen, De 
Vries, Mudde, Bolman, & Lechner, 2009). There is a call for further development in this 
area as brain mechanisms of physical activity have been dubbed as new and innovative 
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categories of physical activity correlates (Bauman et al., 2012). Therefore, perceptual 
responses to physical activity which are underpinned by neurophysiological processing, 
such as perception of effort (de Morree, Klein, & Marcora, 2012), exercise-induced pain 
and discomfort 2¶&RQQRU	&RRN, as well as affect and enjoyment (Dishman & 
2¶&RQQRU, are prime areas for further investigation.  
 
1.2. Experimental medicine approach to behaviour change 
A recent review article (Sheeran et al., 2017) proposed adRSWLQJDQµ([SHULPHQWDO
0HGLFLQH (0¶ DSSURDFK WR JXLGH WKH GHYHORSPHQW RI KHDOWK EHKDYLRXU FKDQJH
interventions. The EM approach (visually represented in Figure 1.1.) was developed by 
the Science of Behaviour Change (SOBC) working group, with support from the National 
Institutes of Health (NIH) Common Fund (Riddle, 2015). This approach can be contrasted 
with traditional efficacy trials (Figure 1.1. Path X), which are principally concerned with 
whether, not how, interventions promote health behaviour change and often fail to 
identify mechanisms by which interventions have elicited their effect on the primary 
behavioural outcome, which in this case would be physical activity behaviour. The EM 
model offers a vantage point on what programs of research need to be undertaken, why 
research questions need to be tackled experimentally, and how different research 
programs can be integrated to forge a more cumulative science of physical activity 
behaviour change (Sheeran et al., 2017).  
The EM approach involves four steps: 1) the identification of factors that relate to 
behaviour and are potentially modifiable and that thus qualify as targets for interventions 
to change health behaviours (Figure 1.1., Path A); 2) validate targets by developing 
measures of the targets and assessing when, how, and to what extent those targets elicit 
behaviour change (Figure 1.1., Path B); 3) test different intervention strategies to 
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determine how target engagement, the desired change in targets, can be maximised 
(Figure 1.1., Path C); 4) Findings from studies following Paths B and C provide 
researchers with a firm foundation from which to pursue the final step, full tests or 
randomised controlled trials (RCTs) to determine whether an intervention strategy or a 
set of strategies changes physical activity behaviour via their effects on specified targets 
(Figure 1.1., Path D). Whilst the standard efficacy trial measures the direct effect of 
interventions on behaviour (Figure 1.1, Path X). 
The EM approach has been adopted here to guide the development of this 
investigation. The paths, which were introduced in the previous paragraph and displayed 
in Figure 1.1., are subsequently referred to (where appropriate) throughout the thesis. 
 
Figure 1.1. Illustrates the experimental medicine approach, and its implications for intervention 
development. Taken from Sheeran et al., (2017). 
 
1.3. Target Identification ± Path A 
Putative targets are modifiable factors that may cause, or mediate, behaviour (i.e., 
physical activity/exercise) (path A). There is extensive literature on barriers and 
determinants of physical activity behaviour, for example the Lancet Physical activity 
series in 2012 (e.g., Bauman et al., 2012; Hallal et al., 2012; Heath et al., 2012; Kohl et 
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al., 2012) and subsequent update in 2016 (e.g., Das & Horton, 2016; Ding et al., 2016; 
Ekelund et al., 2016). As eluded to in the previous section, the psychobiological reasons 
for physical inactivity are still poorly understood (Bauman et al., 2012; Marcora, 2016).  
There are currently two available theories, which together predict the relationship 
between psychological and perceptual responses during and around exercise and future 
physical activity behaviour. These are Hedonic Theory (HT; Ekkekakis et al., 2011; 
Kahneman, 1999; P. T. Young, 1952) and Motivational Intensity Theory (MIT: Brehm & 
Self, 1989; Richter, Gendolla, & Wright, 2016; Wright, 2008). Of these two theories, HT 
has thus far received considerably more research interest, in the context of physical 
activity, and is used frequently to explain physical activity behaviour from the perspective 
of acute perceptual responses to exercise. HT suggests that positive/negative valence of 
affective responses to a stimulus serve as reward (positive valence) and punishment 
(negative valence), which will influence DQLQGLYLGXDO¶VGHFLVLRQWRHQJDJHVHHNUHZDUG
or disengage (avoid punishment) with similar behaviours in the future (Kahneman, 1999; 
P. T. Young, 1952). In the context of physical activity behaviour, the HT predicts that, 
among previously sedentary individuals, the acute affective response to exercise would 
either reinforce or punish the behaviour, making it more or less likely for that individual 
to engage with similar activities (exercise) in the future.  
In short, MIT (Brehm & Self, 1989; Richter et al., 2016; Wright, 2008) suggests 
that task disengagement (i.e., exhaustion in the case of exercise tasks) occurs when either 
the effort required by a task exceeds potential motivation (i.e., maximum effort the 
participant is willing to exert to succeed in the exercise task) or, when an individual 
perceives the exercise to be impossible (i.e., said individual feels as though they have 
already exerted a true maximal effort and therefore can no longer continue). Within the 
limit of what an individual perceives to be possible, an increase in potential motivation 
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will improve exercise tolerance (Marcora, Bosio, & de Morree, 2008). Despite MIT 
receiving relatively less interest from a physical activity behaviour perspective thus far, 
it is the primary theory which underpins the psychobiological model, which provides an 
explanation for intensity regulation and (in)tolerance in endurance exercise and has stood 
up to considerable experimental testing (e.g., Blanchfield, Hardy, & Marcora, 2014; 
Blanchfield, Hardy, De Morree, Staiano, & Marcora, 2014; de Morree & Marcora, 2010, 
2013; Marcora & Bosio, 2007; Marcora, Bosio, & de Morree, 2008a, 2008b; Marcora, 
Staiano, & Manning, 2009; Marcora & Staiano, 2010; Pageaux, Marcora, & Lepers, 
2013). 
Together, HT and MIT propose an explanation for the mediating role of perceptual 
responses to exercise in determining physical activity behaviour. These theories are 
primarily related to affect and perception of effort but can also be extended to related 
constructs such as enjoyment, mood responses such as fatigue, tiredness, and vigour as 
well as discomfort, and exercise-induced muscle pain. Together, these individual 
perceptual/psychological constructs can be considered broadly to form an overall putative 
target of how one feels during (and around) exercise. Utilising the experimental medicine 
approach, this thesis will investigate the role of this overall putative target in explaining 
physical activity behaviour.  
 
1.4. Target measurement 
An essential requisite for establishing promising targets for interventions to 
promote behaviour change is having reliable and valid target measurements (Riddle, 
2015; Sheeran et al., 2017). Often, researchers seeking to test new innovative targets are 
forced to create a unique measurement that has not been previously validated. 
Consequently, these studies, no matter how innovative, they lack measurement validity. 
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As such, the SOBC working group also provided guidance on measure development when 
they introduced the EM approach. Figure 1.2. shows the assay types that can be developed 
to ensure valid putative target measurement (Riddle, 2015), and ultimately determine 
whether an intervention has engaged its intended targets. 
 As the proposed overall putative target is how one feels during (and around) 
exercise we are primarily concerned with perceptual and psychological measurements. 
The construct of perceived exertion was introduced in the early 1960s by Gunnar Borg, 
who also developed the two most common instruments used to measure perception of 
effort; the rating of perceived exertion scale (RPE) scale (Borg, 1970) and the category-
ratio (CR-10) scale (Borg, 1982). The RPE scale uses a 15-point scale with verbal 
anchors. Whilst the CR-10 can not only be used to measure perception of effort, but also 
the intensity of other sensations, such as exercise-induced muscle pain (Borg, 1998), the 
rating of dyspnoea (Zamunér et al., 2011), and thermal sensation (Versey, Halson, & 
Dawson, 2012). Both scales have good reliability and validity when appropriate 
familiarisation and standardised instructions are provided (M. J. Chen, Fan, & Moe, 
2002). For the measurement of basic affect responses, particularly during exercise, the 
feeling scale (FS) (Hardy & Rejeski, 1989) is recommended (Ekkekakis, Hall, & 
Petruzzello, 2005) and demonstrates strong concurrent and discriminant validity 
(Ekkekakis, Hall, & Petruzzello, 2004; Svebak & Murgatroyd, 1985). With this scale, 
individuals can provide a positive, neutral or negative response on an 11-point scale. 
Other associated targets, such as enjoyment, and mood state also have valid and reliable 
self-report measures. Here, we are ultimately interested in feelings and perceptions, these 
perceptual scales provide a highly appropriate tool for putative target measurement. 
However, there is a developing body of literature which corroborates these perceptual 
response scales with objective measurements. Behavioural models of effort are used in 
animals, where collecting perceptual responses is not possible. For example, T-maze 
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paradigms, with barriers which require substantial effort to climb separate animals. By 
manipulating brain function, through drug administration, or by creating lesions in brain 
areas associated with calculating decision costs (i.e., effort), subsequent behavioural 
observation (i.e., are they willing to climb the barrier?) is used to quantify effort 
perception (Salamone, Correa, Nunes, Randall, & Pardo, 2012). Similar experiments are 
also now being conducted with humans (Treadway et al., 2012). There are also a few 
studies which have used neuroimaging techniques to identify areas of the brain that are 
associated with the perception of effort during physical tasks (Staiano & Marcora, 2014). 
Whilst EEG, which is a biological technique, has been used to establish neural correlates 
of the perception of effort (de Morree et al., 2012). 
 
 
Figure 1.2. Illustrates the experimental medicine approach, and its implications for measures 




1.5. Target Validation ± Path B 
This section will review the currently available literature validating the 
relationship between physical activity behaviour the broad putative target of feelings 
during exercise. Including affect, perception of effort, and related constructs.  
 Dishman, Ickes, and Morgan, (1980) originally proposed the association between 
perceptual responses to exercise and physical activity behaviour, suggesting that 
³ELRORJLFDOIDFWors may influence behaviour by interacting with psychological or setting 
factors to affect behaviour by interacting with psychological factors to effect behavioural 
VWDWHV WKDW DUH UHLQIRUFLQJ RU DYHUVLYH VXFK DV H[HUFLVH VHQVDWLRQV´ $ IHZ \HDUV ODWHU
Dishman, Sallis, and Orenstein, (1985) stated, more generally, that physical activity 
produces results that can encourage or discourage subsequent participation, which is 
echoed by Kendzierski and Johnson (1993), who suggested that the thoughts people have 
when contemplating actual performance of a behaviour affect whether the behaviour is 
subsequently performed. The following two section will review evidence relating to the 
broad putative target of feelings during exercise, a focus will be given to affect and 
perception of effort (and related constructs) responses and their association with physical 
activity behaviour.  
 
1.5.1. Affect and related constructs 
Although a clear theoretical application of this theory can be made, in relation to 
HT (as discussed previously in section 1.1.) it was Pollock that first suggested a causal 
OLQNEHWZHHQDIIHFWDQGH[HUFLVHDGKHUHQFHLQWKHODWHVHYHQWLHV³SHRSOHSDUWLFLSDWHLQ
SURJUDPV WKH\ HQMR\´ (Pollock, 1978). Despite this relatively early proposition, most 
research has been concerned with changes in affect states associated with acute bouts of 
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exercise (Berger & Motl, 2000; Ekkekakis et al., 2005; Gauvin & Rejeski, 1993; 
McAuley, Courneya, Rudolph, & Lox, 1994), consequently, there are relatively few 
studies investigating the link between affect responses to exercise and positive changes 
in long-term physical activity behaviour (i.e., exercise adherence). 
Annesi (2002a, 2002b, 2006) conducted three studies examining affective states 
pre- and post-exercise and subsequent attendance at an exercise facility. The authors 
measured affect using the Exercise-induced Feeling Inventory (EFI; Gauvin & Rejeski, 
1993), which measures four distinct affective states - these are engagement, revitalisation, 
tranquillity, and physical exhaustion. Although observing no main effects for the first two 
studies, it is interesting to note that there was an interaction with engagement, 
revitalisation, and tranquillity with scores positively relating to attendance for participants 
with low self-motivation, but the reverse was seen for those with high self-motivation. 
This suggests that facilitating affect related feelings in physical activity settings may be 
particularly important for individuals who are not highly motivated. In the third study 
revitalisation related positively, and exhaustion negatively to exercise attendance and the 
other two subscales were not used.  
Berger and Owen (1992), assessed state-trait anxiety and the mood state (using 
the Profile of Mood States (POMS); McNair, Lorr, & Droppleman, 1971) for students 
enrolled in exercise classes. The authors established an association between mood and 
physical activity behaviour, reporting that the exercisers who reported greater mood 
benefits had fewer absences. Unfortunately, in this study, the participants were not 
previously sedentary, and previous physical activity was not controlled for, thus, the 
changes in mood states could have been influenced by differences in baseline physical 
activity. A more recent study (Carels, Berger, & Darby, 2006) also used the POMS to 
assess mood states pre- and post-exercise among obese, previously sedentary women. 
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Although no relationships were found for changes in POMS scores and subsequent 
exercise behaviour, it should be noted that when post- baseline exercise scores are 
considered in isolation, the subscales of vigour-activity, depression-dejection, anger-
hostility related positively to measures of subsequent physical activity, and negative 
relationships were found for fatigue-inertia and confusion-bewilderment. Although 
interesting, the authors did not control for baseline scores in this secondary analysis. It is 
possible that baseline affect may have influenced both the post-baseline exercise affect 
and the subsequent physical activity behaviours, therefore, these results should be 
interpreted with caution.  
Taking a slightly different approach in scaling affect, Klonoff, Annechild and 
Landrine (1994) used single item Likert scales to measure both happiness and euphoria 
pre- and post-exercise (an aerobics session). Changes in scores were not related to the 
number of sessions that were subsequently completed. Similarly, another study found that 
although mood, specifically measures of happiness, euphoria, and overall mood, did 
improve with exercise, stepwise multiple regression analysis revealed that mood was un-
related to exercise adherence in a free 10-week supervised aerobics programme (Klonoff 
et al., 1994). 
All of the studies discussed thus far used measures of µdistinct affect¶, where 
DFWXDOO\WKHUHDUHVHYHUDOUHDVRQVZK\XVLQJWKHDOWHUQDWLYHµEDVLFaffect¶LVSUHIHUDEOH
Multi-item inventories required for measuring distinct affect, for example, can only be 
completed pre- and post-exercise, not during. Ekkekakis and Petruzzello (2000) reviewed 
WKLV ³DQDO\VLV RI affect PHDVXUHPHQW FRQXQGUXP´ KLJKOLJKWLQJ LVVXHV ZLWK PHDVXULQJ
acute affective responses to exercise. Ekkekakis and Petruzzello (2000) suggest single 
item scale for basic affect such as the feeling scale (FS; Hardy & Rejeski, 1989) would 
be preferable as affective responses to exercise can be recorded before, during and after 
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exercise. Subsequently, several more recent studies have followed Ekkekakis and 
Petruzzello's (2000) recommendations and adopted this approach, either exclusively 
using, or at least including, a measure of basic affect. 
Williams and colleagues (2008), examined affective responses to a moderate 
intensity exercise stimulus and then recorded subsequent physical activity participation 
6-months and 12-months later. They found that individuals who reported more positive 
affective responses to a single bout of exercise at baseline also reported more physical 
activity at both 6-months and 12-months later. What is interesting is that although these 
findings are concurrent with HT in that positive valence seems to predict future activity - 
in this study they also recorded ratings of perceived exertion (RPE). The perception of 
effort (RPE) and affect (FS) are distinct constructs, but negatively related to one another 
(Hardy & Rejeski, 1989) VR LW¶V QRW VXUSULVLQJ WKDW 53( ZDV QHJDWLYHO\ UHODWHG WR
subsequent physical activity too (i.e., the higher the perception of effort experienced 
during the baseline exercise bout, the less physical activity was completed 6- and 12-
months later). Based on their primary objective of understanding the role of affect 
UHVSRQVHVDXWKRUVVHHPWRGLVPLVVWKLVVWDWLQJWKDWIXWXUHUHVHDUFKVKRXOG³VHHNWRFODULI\
the relationship between affective responses to exercise and subsequent physical activity 
EHKDYLRXULQGHSHQGHQWRIWKHSHUFHSWLRQRIHIIRUW´(Williams et al., 2008).  
A later investigation by Williams, Dunsinger, Jennings, and Marcus (2012) sought 
to determine whether affect during and following a 10-min walk predict future physical 
activity behaviour. Affect, measured using the feeling scale, during walking and cool 
down was associated with physical activity 6- and 12-months post. Interestingly, 
however, RPE, which was the strongest predictor of physical activity in their previous 
study (Williams et al., 2008), was not associated with subsequent physical activity at 6 or 
12 months post. This is not surprising, as it was their intention to clarify the relationship 
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between affect exercise behaviour independently of RPE. It appears this has, in part, been 
achieved by more accurately standardising relative exercise intensity, indicated by lower 
variability in RPE during exercise, which was lower in 2012 (M ± SD; 11.7 ± 1.6) than it 
was in 2008 (M ± SD; 11.4 ± 2.27). With more homogenous RPE responses it is less like 
to explain considerable variance in subsequent physical activity behaviour. 
Whilst the majority of these previous studies focused on physical activity or 
participation in exercise programs. With technological advancements, a relatively new 
area of physical activity assessment is utilising accelerometry to capture bodily 
movement as exhibited in everyday life. The analysis of links between affective states 
and free-living physical activity, especially whether and how affective and physical 
feeling states might act as a predictor for daily physical activity, has subsequently been 
enhanced by the addition of this objective measure of behaviour. For an overview of 
studies investigating this relationship (i.e., with daily physical activity rather than with 
exercise adherence), see Liao, Shonkoff, and Dunton, (2015). One particular study using 
accelerometry to explore the affect/physical activity behaviour relationship was by 
Schwerdtfeger and colleagues (Schwerdtfeger, Eberhardt, Chmitorz, & Schaller, 2010). 
Where various positive and negative affect states (e.g., exhausted, tired, lively, happy 
etc.,) were monitored throughout the day on tablets (handheld computers). Whilst 
Physical activity was sampled in 1-minute blocks throughout. Positive changes in affect 
ZHUHDVVRFLDWHGZLWKDUHGXFWLRQLQµVHGHQWDU\¶WLPH7KHUHZDVQRDVVRFLDWLRQEHWZHHQ
affect DQG WKH SHUFHQWDJH RI WLPH VSHQW LQ D µORZ¶ intensity domain, whereas positive 
changes in affect ZHUHDVVRFLDWHGZLWKLQFUHDVHGWLPHLQERWKµPRGHUDWH¶DQGµYLJRURXV¶
intensity domains. Similarly, another study (Niermann, Herrmann, Von Haaren, Van 
Kann, & Woll, 2016), using the same accelerometer devices and periods of activity data 
extraction, measured distinct affect YLD WKH ³YLJRXU´ SRVLWLYH affect DQG ³IDWLJXH´
(negative affect) subscales of the POMS  (McNair et al., 1971). Multilevel modelling 
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revealed that afternoon affect scores predicted after-work physical activity, so the greater 
affect, the more physical activity was completed. Inconsistent with these findings, in a 
very recent study (Maher et al., 2018), accelerometer data were used to measure free-
living physical activity as well as sedentary time over a 4-7 day period. Taking it one step 
further, the authors calculated total time in respective intensity domains and compared to 
WKHFXUUHQWSXEOLFKHDOWKJXLGHOLQHVLHPLQXWHVRIPRGHUDWHYROXQWDU\ physical 
DFWLYLW\SHUGD\IRUFKLOGUHQDQGPLQXWHVIRUDGXOWV:LWKLQ-subject variability in 
³HQHUJ\´ZDVDVLJQLILFDQWSUHGLFWRURIPHHWLQJDFWLYLW\JXLGHOLQHVVRWKRVHZLWKPRUH
variability in self-reported energy were less likely to meet activity guidelines, whilst 
energy in itself was not a predictor of behaviour. Neither positive affect nor variability in 
SRVLWLYH DIIHFW PHDVXUHG XVLQJ GLVWLQFW VFDOHV RI ³KDSS\´ ³MR\IXO´ ³FKHHUIXO´ DQG
³FDOP´SUHGLFWHGVXEVHTXHQWSK\VLFDODFWLYLW\$XWKRUs of this study recognised that their 
exclusive use of distinct measures of affect may have resulted in them not capturing the 
complete picture. The inclusion of a measure of basic affect (as was suggested by 
Ekkekakis and colleagues (2005 and discussed previously) such as the FS (Hardy & 
Rejeski, 1989) in future work seems a logical recommendation. This measurement issue 
seems to be recurrent in the literature examining the relationship between affect and 
physical activity behaviour. Affect is conceptually broad and there is a fundamental lack 
of consistency in its measurement. Therefore, interpretation of previous research findings 
should be conservative. There is a need for consistency, particularly in relation to the EM 
approach, when measuring the effect of an intervention on a putative target, such as affect, 
it necessary to determine if an intervention produces a behavioural outcome by engaging 





1.5.2. Effort and related constructs 
Perception of effort/perceived exertion is well accepted as a consistent negative 
correlate of physical activity behaviour (Bauman et al., 2012). Which is certainly an 
association that is supported by intuition, as well as theory (Brehm & Self, 1989; Zipf, 
1949). Perception of effort is also reciprocally related to self-efficacy (Rudolph & 
McAuley, 1996) which is considered to be the main correlate of physical activity 
behaviour in adults (Bauman et al., 2012; Courneya & McAuley, 1994). The following 
section reviews the substantive body of evidence that was cited in the development of a 
series of reviews on the correlates and determinants of physical activity behaviour, 
published between 1985 and 2012 (Bauman et al., 2012; Dishman, 1990; Dishman & 
Pender, 1988; Dishman & Sallis, 1994; Dishman et al., 1985; Sallis & Owen, 1998; Trost 
et al., 2002). This is the literature which underpins the well-HVWDEOLVKHG µQHJDWLYH
FRUUHODWH¶VWDWXV(Bauman et al., 2012) of the relationship between perceived exertion and 
physical activity behaviour.  
It is worth noting that spanning half a century there is some conceptual/semantic 
ambiguity. For example, in a review by Dishman and colleagues (1985), the literature is 
discussed in relation to exertion, but the main review summary table of results refers 
instead to perceived discomfort. Which was, in a subsequently updated review (Dishman, 
1990) changed to perceived effort, as it has remained since (Bauman et al., 2012). Another 
source of ambiguity is in terms of measurement. For example, in a study which reports 
µIDWLJXH¶LQSDWLHQWV(Hughes, Crow, Jacobs, Mittelmark, & Leon, 1984), closer inspection 
reveals that they used a standard RPE scale which, of course, actually measures perceived 
exertion, which is an analogue of perception of effort. Therefore, when reviewing these 
studies, it is necessary to accept a broad conceptual definition of perception of effort to 
include: exercise-related fatigue, exhaustion, discomfort, and exertion etc. Finally, it is 
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also important to note that although the following literature serves to validate the 
theoretically important relationship between perception of effort and physical activity 
behaviour, this includes physical activity behaviours such as preference, exercise 
initiation, as well as factors directly influencing exercise adherence.  
When investigating why individuals found the transition in to exercise so difficult, 
participants in the fitness Ontario study (White, 1983) UHSRUWHGWKDW³IDWLJXH´DVVRFLDWHG
with exercise is the reason for their sedentary behaviours. Similarly, a later study, using 
interviews to develop barrier scales, presented qualitative data from individuals who were 
FRQVLGHULQJH[HUFLVHSURJUDPV UHSRUWLQJ WKDW³H[HUFLVHZRXOGEH WLULQJ´:KLOVWRWKHU
VWXGLHV KDYH DOVR UHSRUWHG WKDW SK\VLFDO ³GLVFRPIRUW´ GXUing exercise is a perceived 
barrier to their participation (Garcia & King, 1991; Marcus, Selby, Nlaura, & Rossi, 
1992). Other negative factors/costs associated with exercise have been indicated by items 
VXFK DV EHLQJ ³WRR WLUHG´ WR H[HUFLVH IHHOLQJ ³RXW RI EUHDWK´ (Marcus et al., 1992). 
$GGLWLRQDOµEDUULHUV¶WRH[HUFLVHUHIHUWRH[HUFLVHEHLQJ³WRRPXFKZRUN´RU³WRRERULQJ´
DQGWKHLQGLYLGXDOLGHQWLI\LQJDV³WRRWLUHG´RU³WRROD]\´(Myers & Roth, 1997; Salmon, 
Owen, Crawford, Bauman, & Sallis, 2003)DVZHOODVSK\VLFDOEDUULHUVVXFKDV³JHWWLQJ
KRWDQGVZHDW\´WKHSUHFRQFHSWLRQWKDWH[HUFLVH³FDXVHVVRUHPXVFOHV´7KLVLVVXSSRUWHG
by other findings that individuals are more likely to adopt moderate compared to vigorous 
activity (Rizk et al., 2015; Sallis et al., 1986). Clearly, the perception of effort and related 
constructs are an important consideration for those planning to initiate exercise as they 
present perceived psychological barriers. 
Among individuals who have initiated regular exercise, those who report greater 
levels of perceived discomfort are more likely to drop out (Ingjer & Dahl, 1979; Mann, 
Garrett, Farhi, Murray, & Billings, 1969; Oldridge et al., 1983) which is supported by a 
finding that there was a lower dropout rate for a walking programme in contrast to a more 
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vigorous regime (Ballantyne et al., 1978). Although no specific measure of either 
affective responses or the perception of effort were provided in these studies so this does 
not provide any direct support for a causal link between perceptual responses and 
behaviour, although it can be, cautiously, inferred.  
During a 6-month supervised training programme, approximately 50% of 
dropouts were attributed to the muscle and joint soreness which appeared during or were 
aggravated by exercise (Mann et al., 1969). Later, in a cohort of participants completing 
a cardiac rehabilitation program, a questionnaire regarding the reasons for drop-out was 
completed, and the item most consistently relating to drop-RXWZDV³IDWLJXHGE\H[HUFLVH´
(Andrew & Oldridge, 1981). In another study where participants completed 7-9 weeks of 
an aerobic exercise program eight out of the 15 previously sedentary participants dropped 
out (Ingjer & Dahl, 1979). The authors stated that the participants who dropped out had 
frequently reported excessive stress and discomfort associated with the exercise program. 
Although there was no difference in the aerobic capacity of those that completed the study 
vs. those who dropped out, and all training was completed at the same relative intensity 
for all participants. Interesting, a muscle biopsy revealed that those who dropped out had 
a lower percentage of slow twitch muscle fibres than those continued for the duration of 
the study (57.9% and 46.6% respectively). As the training program consisted of 
exclusively aerobic exercise it could be speculated that the participant who adhered were 
naturally predisposed to the type of training. If so, perhaps a combined resistance and 
aerobic training program could have seen different results.  
Several studies have revealed that if individuals have physically demanding jobs 
LHLWHP³ZRUNRIKHDY\QDWXUH´WKH\DUHOHVVOLNHO\WRDGKHUHWRH[HUFLVH7KLVKDVEHHQ
supported by a negative association with self-report spontaneous physically activity 
(White, 1983), as well as with the initiation of, and adherence to supervised exercise 
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training (Cox, 1984; Fielding, 1982; Oldridge, 1982; Oldridge et al., 1983). Whilst 
previously sedentary individuals and smokers (regardless of previous physical activity) 
ZHUHIRXQG WRKDYHH[SHULHQFHGKLJKHU OHYHOVRI µIDWLJXH¶GXULQJH[HUFLVHZKLFKZDV
measured using an RPE scale), that was not associated with risk factors of age, blood 
pressure, serum cholesterol, serum high-density lipoprotein, and obesity. It was 
concluded that the increased fatigue experienced by inactive persons and smokers may 
account for their decreased compliance to exercise programs (Hughes et al., 1984). 
Together, these findings implicate fatigue and perceived exertion as important factors in 
exercise adherence. 
The 2012 review (Bauman et al., 2012) did not update the 2002 review (Trost et 
al., 2002) with any new literature supporting the association between perception of effort 
and physical activity behaviour. However, there is some additional evidence. A few 
studies reviewed in the previous section reported a negative association between physical 
activity behaviour DQGFRQVWUXFWVVXFKDVµSK\VLFDOH[KDXVWLRQ¶(Annesi, 2006) µIDWLJXH-
LQHUWLD¶ (Carels et al., 2006) and rating of perceived exertion (Williams et al., 2008). 
Though not the objective of their research, the strongest link was provided by Williams 
and colleagues (2008), who demonstrated that RPE during an acute bout of exercise-
related negatively to exercise adherence at 6-months and 12-months post. Further, when 
RPE was controlled for, the relationship between affective responses and adherence was 
lost.  
There is certainly evidence to support the association between effort and related 
constructs which justify its status as a negative correlate of physical activity behaviour, 
however, there is a clear lack of quantitative data and a general over-reliance on the 
qualitative explanation of dropout and the generation of barriers questionnaires through 
the use of interviews. It may be that the association is accepted at large, and therefore is 
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not provoking further interest. Alternatively, this stagnation may be the result of 
disciplinary level complacency where researchers have lost touch with the original 
sources that inform review articles, perhaps especially those published in highly respected 
DQGµKLJKLPSDFW¶MRXUQDOV(Seglen, 1997). Either way, the appropriate course of action is 
the same. In the mid-eighties, Dishman and colleagues (1985) stated that it should be 
determined how perceived exertion during and after exercise influences future activity. 
This statement is still valid. We need to develop a clearer understanding of how negative 
perceptual responses to exercise, including effort and affect and related constructs, relate 
to physical activity behaviour if we are to affect change. By taking an EM approach, 
ultimately conducting full trials (Figure 1.1. Path D), revealing a causal relationship 
between the putative targets and behaviour, would provide evidence to classify perception 
of effort and other perceptual responses as a determinant, rather than as negative correlate 
of physical activity behaviour. 
 
1.6. Intervention to Elicit Target Engagement - Path C 
This section will cover target engagement ± which (in this thesis) is the process of 
establishing interventions that manipulate effort and/or other perceptual responses to 
exercise. 
There is a multitude of interventions that have been used to manipulate perceptual 
responses during exercise. These include psychological interventions, for example 
imagery (Razon, Mandler, Arsal, Tokac, & Tenenbaum, 2014) and self-talk (Blanchfield, 
Hardy, De Morree, et al., 2014; McCormick, Meijen, & Marcora, 2018) interventions, 
which have both elicited a reduction in perception of effort and improved exercise 
performance. Pharmacological intervention via psychoactive drugs such as caffeine 
(Doherty & Smith, 2005; Schubert et al., 2014), or modafinil (Jacobs & Bell, 2004), for 
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example, have been shown to increase affect, reduce perception of effort, and improve 
exercise performance. There is even literature on the use of hypnotism (Williamson et al., 
2001), subliminal cues (Blanchfield, Hardy, & Marcora, 2014), and afternoon naps  
(Blanchfield, Lewis-Jones, Wignall, Roberts, & Oliver, 2018) being used to increase 
exercise tolerance by modifying perceptual responses during exercise, predominantly the 
perception of effort. 
Establishing target engagement is not limited to perceptual responses from 
humans, however. Effort-based decision-making paradigms are frequently used in animal 
models to test target engagement (Salamone et al., 2012). An example of this would be a 
barrier climbing task that required physical effort to ascend. When factors affecting effort-
related decision making are manipulated, for example, via brain lesions in areas 
associated with effort-related processing, or with pharmacological intervention targeting 
pathways responsible for calculating effort-related decision cost. In these experiments, 
observations of subsequent effort-based behaviour (i.e., do they climb the barrier to 
receive a reward) can be used as an indication of target engagement (Salamone, Yohn, 
López-Cruz, San Miguel, & Correa, 2016), just as, for example, lower RPE in humans 
can be. In fact, effort-related functions engage a distributed neural circuitry that includes 
multiple neurotransmitters across the brain, including the basal ganglia, limbic and 
cortical areas. Moreover, there is a striking similarity between the brain areas involved in 
behavioural activation and effort-related processes in rodents and in humans (Salamone 
et al., 2016), making it possible to use rodents in preclinical studies which are translatable 
to concurrent human-based research. Target engagement from interventions in animal 
models will be discussed in more detail in the Animal Introduction (chapter 8).  
Clearly, there are several interventions that would be suitable candidates for 
testing path C and subsequently path D of the EM approach. However, there is a particular 
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form of intervention that was recently suggested by an NIH Working Group Report on 
innovative research to improve maintenance of weight loss (MacLean et al., 2015). The 
DXWKRUVSURSRVHWKH³SRWHQWLDOWRSDLUGUXJVZLWKVSHFLILFEHKDYLRXUDOWKHUDSLHV´³WRWDNH
DGYDQWDJH RI V\QHUJLVWLF HIIHFWV´ DQG ³FRXQWHU D EURDG UDQJH RI WKH KRPHRVWDWLF DQG
KHGRQLFDGDSWDWLRQV´7KH\DOVRVWDWHWKDWWKHZRUNLQJJURXS³HQYLVLRQHGQRYHOWDUJHWV
for pharmacotherapy which include the motivation to EHSK\VLFDOO\DFWLYH´7KRXJKWKH\
do not make direct reference to HT or MIT their proposal is consistent with predictions 
from these theories. For example, drugs may be paired with physical activity to counter 
hedonic and effort related adaptation, such as pain, discomfort, exertion, fatigue. This 
echoes the suggestion from a recent editorial (Marcora, 2016) that psychoactive drugs 
may be appropriate for the facilitation of exercise by reducing perception of effort and 
discomfort associated with exercise. See Figure 1.3. for MaUFRUD¶VLOOXVWUDWLRQRI
theory-based psychological mediators of the hypothesised positive effect of psychoactive 
drugs on physical activity behaviour. 
 
Figure 1.3. Theory-based psychological mediators of the hypothesised positive effect of psychoactive drugs 




Caffeine is a psychoactive drug, and also a proven ergogenic aid for exercise 
performance, which has been demonstrated by a meta-analysis of forty double-blind 
studies, eliciting an improvement in exercise test outcomes by an average of 12.3% 
(Doherty, 2004)7KHSULPDU\PHFKDQLVPRIDFWLRQVHHPLQJO\UHVSRQVLEOHIRUFDIIHLQH¶V
ergogenic effect may be due to its antagonism of receptors for the neurotransmitter 
adenosine (this mechanism will be elaborated upon in the next section of this chapter). 
Caffeine can affect exercise performance while decreasing perceived exertion (Doherty, 
2004; Doherty & Smith, 2005). In addition, blocking adenosine receptors can decrease 
the activation of nociceptors, resulting in a blunted pain response to exercise, which is 
supported by multiple studies reporting lower exercise-induced muscle pain following 
caffeine ingestion *OLRWWRQL	0RWO0RWO2¶&RQQRU	'LVKPDQ, an effect 
that is persistent even with low doses (Spriet, 2014), and among high habitual caffeine 
users (Gliottoni, Meyers, Broglio, & Motl, 2009). Caffeine has also been shown to 
increase affect related constructs such as pleasure (Backhouse, Biddle, Bishop, & 
Williams, 2011), and enjoyment (Schubert et al., 2014) during exercise. All of these 
responses to caffeine ingestion can not only improve exercise performance but, according 
to MIT and HT may also facilitate physical activity behaviour and adherence. In 
accordance with suggestions from Marcora (2016) and MacLean and colleagues (2015), 
and considering the potential for caffeine to elicit effects on so many constructs relating 
to our broad putative target ³IHHOLQJVGXULQJH[HUFLVH´DVUHIHUUHGWRLQWKHEULHIreview 
above, it presents the ideal intervention to apply to this EM approach. 
 
1.7. General introduction to caffeine 
Caffeine (1,3,7-trimethylxanthine) is the most commonly consumed stimulant 
worldwide (Fredholm, Bättig, Holmén, Nehlig, & Zvartau, 1999).  In pure form, it is a 
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bitter white powder. Following ingestion, caffeine is rapidly absorbed by the body and 
appears in the blood within 5±15 min, with serum concentration peaking between 40 and 
80 min (Spriet, 2014). In humans, the principal metabolic pathway for caffeine is 
catalysed by the cytochrome P450 (CYP) enzyme CYP1A2 in the liver and accounts for 
approximately 95% of its initial breakdown. The process begins with removal of a methyl 
group to form the primary metabolite paraxanthine; theobromine and theophylline are 
also formed in smaller concentrations (Doepker et al., 2016). The half-life of caffeine in 
healthy adults is approximately 4±5 hours (Carvey, Thompson, Mahoney, & Lieberman, 
2012); however, half-life may range between 1.5 and 9.5 hours (Brachtel & Richter, 1992; 
Busto, Bendayan, & Sellers, 1989). In mice, the half-life is considerably shorter between, 
40 and 60 minutes, and is eliminated from serum and tissues (i.e., liver, kidney, brain, 
muscle) after 4 to 5 hours (Hartmann & Czok, 1980). 
Caffeine binds reversibly to plasma proteins, and protein-bound caffeine accounts 
for about 10% to 30% of the total plasma pool. Caffeine is hydrophilic and distributes 
freely into the intracellular tissue water (Abd, Benson, Roberts, & Grice, 2018). However, 
caffeine is also sufficiently lipophilic to pass through all biological membranes and 
readily crosses the blood-brain barrier (Fong, 2015; McCall, Millington, & Wurtman, 
1982). 
Plasma caffeine levels rise to ~15±20 µmol/L with a low caffeine dose (3 mgÂkg), 
~40 µmol/L with a moderate dose (6 mgÂkg), and ~60±70 µmol/L with a high dose of 9 
mgÂkg (Graham & Spriet, 1995). Since caffeine interacts with many tissues, it is difficult 
to independently study its effects on the CNS, the peripheral nervous system, and the 
many metabolic tissues in the body (skeletal muscle, liver, heart, and adipose tissue) at 
rest and during exercise. However, it has been shown that the plasma caffeine levels 
needed to effect changes in the metabolic tissues are substantially higher than required to 
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affect the adenosine receptors in the brain and peripheral nervous system (Fredholm, 
1995; Nehlig, Daval, & Debry, 1992; Spriet, 2014).   
Desirable effects of low or moderate intake levels include changes in mood, 
energy, alertness, and vigour (Garrett & Griffiths, 1997; Nehlig et al., 1992) as well as 
alteration in the perceptual responses to exercise, resulting in a more desirable exercise 
experience, have been shown to increase tolerance and improve performance on physical 
tasks (Doherty & Smith, 2005). There is also literature demonstrating that caffeine may 
be used to create an energy deficit that facilitates weight regulation, by concurrently 
increasing metabolic rate and reducing appetite for fatty foods (Schubert et al., 2014). 
In relatively low doses, caffeine mediates many of its physiological actions 
through the antagonism of central adenosine receptors (ARs) (Nehlig et al., 1992). 
Adenosine is an inhibitory neuromodulator in the central nervous system, with sedative-
like properties. Four subtypes (A1, A2A, A2B, and A3) of G protein-coupled ARs have 
been identified. Although the contribution of each is uncertain, A1 and A2A receptors in 
the brain are responsible for the behavioural effects of caffeine (Doepker et al., 2016). 
Adenosine A1 receptors are present in almost all brain areas, but particularly in the 
hippocampus, cerebral cortex, cerebellar cortex and thalamus. The stimulatory effects of 
caffeine appear to result primarily from the blockade of A2A receptors, which, in turn, 
functionally increases dopamine (Josselyn & Beninger, 1991). Therefore, the behavioural 
effects of intrastriatal caffeine are ultimately mediated by dopamine (Josselyn & 
Beninger, 1991; Nehlig et al., 1992).  
Desirable effects of caffeine, such as changes in mood, energy, alertness, and 
vigour, are associated with low or moderate intake levels (Nehlig et al., 1992), In the case 
of depression, moderate caffeine intake has been associated with fewer symptoms and a 
lower risk of suicide. This antidepressant effect of caffeine may have implications for 
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other aspects of health due to the strong association of depression with 
immunosuppression (A. P. Smith, 2011). Caffeine consumption is also considered to be 
safe for the heart (Wilson & Bloom, 2016) with little evidence to suggest that chronic 
ingestion increases blood pressure. 
However, high levels of caffeine are reported to produce negative effects, such as 
anxiety, jitters, and nervousness (Benowitz, 1990; Fredholm et al., 1999; Garrett & 
Griffiths, 1997; Lorist & Tops, 2003). Extreme side effects were observed in humans at 
caffeine intakes of 1,000 mg (15 mgÂkg), including restlessness, irritability, and 
progressing to delirium, emesis, neuromuscular tremors, and convulsions (Gilman, Rall, 
Nies, & Taylor, 1990). Other symptoms included tachycardia and increased respiration. 
&DIIHLQLVPLVRQHRI WKHPRUHH[WUHPHH[DPSOHVRIFDIIHLQH¶VDGYHUVHHIIHFWVDQGKDV
been discussed as a potential psychiatric disorder (Victor, Lubetsky, & Greden, 1981). 
Caffeinism is usually associated with daily intake of 1,000±1,500 mg caffeine. This term 
refers to a constellation of symptoms associated with very high caffeine intake that are 
virtually indistinguishable from severe chronic anxiety; however, caffeinism appears to 
be a specific condition, and there is little evidence for correlations between caffeine intake 
and anxiety in either nonclinical volunteers or psychiatric outpatients (Lara, 2010). The 
fatal acute oral dose of caffeine in humans is estimated to be 10±14 g (150±200 mgÂkg) 
(Hodgman, 1998) whilst the toxic dose for mice is between 125 and 500 mgÂkg (Seale, 
Johnson, Carney, & Rennert, 1984). 
For the effect of caffeine on physical activity in mice, see the Animal Introduction 
(chapter 8). For the effect of caffeine on perception of effort, pain, affect, mood, and 




1.8. Full tests - Path D 
The purpose of path D is to answer the fundamental question that underlies the 
experimental medicine approach: How much change in behaviour accrues from 
interventions that successfully engage key targets specified by health behaviour theories? 
MIT and HT have been introduced and predictions they make about how engaging the 
SXWDWLYHWDUJHW³IHHOLQJVGXULQJH[HUFLVH´VKRXOGDOVRIDFLOLWDWHSK\VLFDODFWLYLW\EHKDYLRXU
among sedentary populations have been discussed. Correlational designs cannot rule out 
the impact of unmeasured (third) variables and are therefore not fit for determining 
whether engaging a target changes health behaviours (Weinstein, 2007). To satisfy (i.e., 
test) this path (D), only experimental studies able to permit causal inferences are 
acceptable (Sheeran et al., 2017). Experiments have three defining features: 1) 
Participants are randomised to a treatment versus a control or comparison condition; 2) 
the treatment engages the target (i.e., engenders a difference between the treatment versus 
control condition on the target measurement); and 3) behaviour change or some other 
related outcome is measured in the wake of the intervention (Sheeran et al., 2017; West, 
Biesanz, & Pitts, 2000). 
To date, there have been very few experimental studies testing interventions in 
sedentary populations, where feelings during exercise have been included as putative 
targets and physical activity behaviour, or a related outcome measure, have been reported. 
A review of the literature has identified only two such studies (Ivanova, Jensen, Cassoff, 
Gu, & Knäuper, 2015; Schrader, Panek, & Temple, 2013).  
The first of these studies (Schrader et al., 2013) used low-dose caffeine (3 mgÂkg) 
as an intervention to facilitate repeated (6 sessions over a two-week period) moderate 
intensity treadmill walking in previously sedentary adults. Their targets were RPE and 
H[HUFLVH µOLNLQJ¶ ZKLFK LV DQ affect related construct). As a behavioural outcome 
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measure, they included a self-determined exercise trial (in an additional visit following 
the final training session) where exercise duration was determined by the participant (i.e., 
participants chose when to stop walking). Individuals who received caffeine on the final 
test day exercised for significantly longer in the self-determined exercise trial than those 
who received placebo. However, surprisingly, RPE was not significantly different 
between conditions. There are two potential explanations for this null finding that are not 
fully identified by the authors. Firstly, there is no reference to standardised instructions 
on how to use the RPE scale, nor was there an opportunity for participants to gain 
familiarity with its use. Secondly, exercise intensity was set based on age-predicted 
maximum heart rate rather than 9%cO2max, for example, to standardise intensity, which 
would have been preferable. Thirdly, relating the second point about standardising 
exercise intensity, the workload was not fixed or monitored in any way, instead, it was 
regulated by the participant continuously throughout each session against a target heart 
rate range. This is problematic because in order to identify perceptual differences between 
conditions the physical demand (i.e., workload) needs to be standardised. Another reason 
this method is problematic is that the heart rate may have also been directly affected by 
the caffeine (Nehlig et al., 1992) making it an unsuitable reference for setting intensity. 
The second study (Ivanova et al., 2015) used acceptance and commitment therapy 
(ACT; a form of psychotherapy) as an intervention to improve exercise tolerance in 
sedentary women. Their a priori target was affect, measured using the FS, and RPE based 
on theoretical predictions of MIT and HT. However, the intervention was specifically 
designed to develop cognitive diffusion and acceptance techniques for coping with 
aversive physical discomfort (e.g., leg discomfort) and negative affect (e.g., boredom). 
Exercise tolerance time during a high-intensity cycle exercise test was used as a 
behavioural outcome measure. In line with MIT, they found that psychological techniques 
derived from ACT help low-active women to perform the high-intensity exercise for 
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longer while also feeling less perceived effort. However, contrary to expectations, there 
was not a group-time interaction for affect during or immediately post cool-down. This 
result suggests that affective responses during exercise cannot predict exercise tolerance. 
Together, these studies suggest that interventions engaging targets related to 
feelings during exercise, such as perception of effort and affect are able to elicit positive 
changes in outcomes related to physical activity behaviour. However, clearly more 
experimental studies are needed.  
 
1.9. Standard efficacy trials ± Path X 
Standard efficacy trials (Figure 1.1. Path X), are principally concerned with 
whether, not how, interventions promote health behaviour change and often fail to 
identify mechanisms by which interventions have elicited their effect on the primary 
behavioural outcome. There is one relevant human study (Júdice et al., 2013), which 
demonstrated that caffeine (5 mgÂkg administered in two equal doses of 2.5 mgÂkg in a 
single day) did not elicit a change in daily free-living physical activity energy 
expenditure, which was measured using accelerometry. The issue here is not that caffeine 
did not elicit an effect, it is that no putative targets were measured. Thus, it could not be 
concluded whether the intervention was not sufficient to engage a target, or whether target 
engagement was not sufficient to produce a change in the behavioural outcome measure. 
Although this type of design does not offer the same explanatory power as an experiment 
testing path D, it is suitable for use in preclinical models, for example, where it is not 
possible to collect self-report perceptual data. Instead, behavioural paradigms such as T-
maze experiments (which were briefly introduced earlier, in section 1.6.), and exercise 
tasks, use the primary behavioural outcome (i.e., exercise completed, or barrier climbed) 
to determine whether the putative target has been engaged. Target engagement from 
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interventions in animal models will be discussed in more detail in the Animal Introduction 
(chapter 8).  
 
1.10. Thesis aim 
The EM approach has been adopted to guide the development of this investigation. 
This approach provides a framework to examine not just whether, but also how an 
intervention elicits its effect on behaviour change. Specifically, the work conducted in 
this study is focussed on understanding whether changes in perceptual responses to 
exercise, caused by psychoactive drugs such as caffeine, are sufficient to elicit a change 
in physical activity behaviour. It is also an aim to facilitate the further development of 
pharmacological interventions, in a form of pharmacotherapy, by providing a basis to 
investigate the effects of other drug compounds at a pre-clinical level. To achieve both 
aims two independent research pathways were followed, which are presented in two parts. 
 
1.11. Thesis structure 
This thesis is split into two parts. Part I utilises human participants to test path D 
of the EM model. Part II uses an animal model (mice) to test path X, directly observing 
the effects of interventions on physical activity behaviour. However, each part follows 
the same structure. Chapters 2 and 8 provide separate introductions to the human and 
animal work respectively. The investigations then unfold in series, with general methods 
in chapters 3 and 9. In each part of the thesis, there are 3 experimental chapters. Human 
studies are presented in chapters 4, 5, and 6, animal studies are detailed in chapters 10, 
11, and 12. Chapter 7 and 13 are general discussions specific to each part. Finally, the 







A Full Test (Path D): Pharmacological intervention to facilitate exercise in 









There is some evidence that ³feelings during exercise´ LQFOXGLQJ DIIHFW DQG
perception of effort, are considered important correlates of physical activity behaviour, 
as was discussed in the general introduction (sections 1.5.1., and 1.5.2.). However, 
extraordinarily little has been done to look at the effect of factors that manipulate these 
feelings on physical activity behaviour (as identified in section 1.8.). Caffeine has been 
chosen as an intervention to elicit changes in physical activity behaviour via its effect on 
(engagement of) the putative target (i.e., ³IHHOLQJV GXULQJ H[HUFLVH´). Caffeine was 
introduced in the general introduction (section 1.6. and 1.7.) but the literature on 
performance effects and perceptual responses to exercise will be discussed here (section 
2.3.) in more detail. Literature also relating to exercise training modalities suitable for 
sedentary populations (section 2.2.), as well as the identification and measurement of 
outcomes relating to physical activity behaviour (section 2.4.). 
 
2.2. High vs moderate intensity exercise for previously sedentary humans 
The American College of Sports Medicine (ACSM) recommends that most adults 
engage in moderate-intensity cardiorespiratory exercise training for 30 minÂday-1 on 5 
GD\ÂZHHN-1 for a total of 150 PLQÂZHHN-1, vigorous-intensity cardiorespiratory exercise 
training for 20 PLQÂday-1 on 3 GD\ÂZHHN-1 (75 PLQÂZHHN-1), or a combination of 
moderate- and vigorous-intensity exercise (Garber et al., 2011). Whilst exercise 
recommendations related to weight management call for 200 to 300 PLQÂZHHN-1 of 
moderate intensity exercise (Jensen et al., 2014). Despite the benefits of completing 
regular exercise (as discussed in the general introduction section 1.1.), according to 




The reasons for not engaging in regular physical activity are numerous and 
FRPSOH[EXW³ODFNRIWLPH´ is one of the most commonly cited barriers (Steinhardt & 
Dishman, 1989; Trost et al., 2002). Therefore, developing more time-efficient, yet equally 
effective exercise strategies are urgently needed (Gillen et al., 2016). At least, that is the 
view of some experts. The Journal of Behavioural Nutrition and Physical Activity 
published a debate regarding the intensity and duration of exercise prescription in 
previously sedentary adults, between Biddle and Batterham (Biddle & Batterham, 2015). 
Essentially, some (e.g., Biddle) advocate moderate intensity and long duration, whereas 
others (e.g., Batterham) call for high-intensity and shorter duration. The latter approach 
attributes the inactivity and high dropout to limited time availability and the slow 
development of visible benefits. 
There are some extreme examples of high-intensity µVSULQWLQWHUYDOWUDLQLQJ¶ (SIT), 
which consists of a total exercise duration of 10 minutes (Gillen et al., 2016). This is made 
up of 2-minute warm-up and 3-minute cool-down, either side of 3 x 20-VHFRQGµDOO-out¶
cycle sprints, interspersed with 2-minutes of cycling at a moderate intensity. This protocol 
was found to be equally as effective at improving 9%cO2max as 45-minute sessions of 
moderate-intensity continuous training in previously sedentary men. However, although 
this type of SIT appears to be effective for physiological benefits, it has been heavily 
criticised. SIT has been described a ³LQDSSURSULDWH IRUD ODUJHO\VHGHQWDU\SRSXODWLRQ´
(Hardcastle, Ray, Beale, & Hagger, 2014) because engagement required high levels of 
motivation and confidence. In addition, the supramaximal intensities are considered likely 
to evoke negative affect, which may lead to subsequent avoidance of further exercise 
(Hardcastle et al., 2014). 
Both sides of the debate (Biddle & Batterham, 2015) agree that SIT is not viable. 
Batterham, however, argues that scalable HIIT interventions have evolved which have 
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similar cardio-metabolic responses to those observed with the more extreme protocol. 
These HIIT interventions are often described as Aerobic Interval Training (AIT), 
typically involving 4-6 cycles of exercise at 80-95% of maximal capacity, each lasting 3-
4-minutes (Decker & Ekkekakis, 2017). For example using brisk inclined walking 
(Francois et al., 2014; Lunt et al., 2014), which has been shown to be more effective than 
moderate continuous exercise and is well tolerated in patients with coronary artery disease 
(Rognmo, Hetland, Helgerud, Hoff, & Slordahl, 2004), metabolic syndrome (Tjønna et 
al., 2008), and heart failure (Wisloff et al., 2007). Although a FRPPLWPHQW RI  
minÂday-1 is still required with many of these protocols, the vigorous intervals have a 
higher relative contribution, in terms of meeting health guidelines, so fewer sessions are 
required per week. For example, the protocol developed by Rognmo and colleagues 
(2004) (and adopted in the studies detailed in chapters 4, 5, and 6 of this thesis) requires 
33-minutes of exercise per session, made up of 16-minutes of vigorous intensity exercise 
and 18-minutes of moderate intensity exercise. When the duration of vigorous exercise is 
doubled (i.e., 32-minutes) and combined with the duration of moderate intensity exercise 
(i.e., 18-minutes) the session can be considered equivalent to 50-minutes. Therefore, 
rather than accruing 150-minutes of exercise over five days of 30-minutes, this protocol 
would only need to be completed 3 times per week, reducing the overall time commitment 
by 34%, before considering reduced travel time. 
The second point of contention is underpinned by hedonic theory, which suggests 
that displeasure during exercise will lead to aversion and drop-out. However, Batterham 
identifies that the assertion that high-intensity exercise will be aversive is based on work 
demonstrating that exercise at or above the ventilatory threshold is unpleasant 
(Ekkekakis, Hall, & Petruzzello, 2008). This, of course, does not account for the 
anticipation of impending recovery, and the recovery period per se can result in more 
positive affect than continuous vigorous intensity exercise. For example, in one study 
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recreationally active men found HIIT (6 x 3 minutes at 90% 9%cO2max) more enjoyable than 
continuous moderate, despite higher perception of effort (Bartlett et al., 2011). Whilst the 
authors of another study (Jung, Bourne, & Little, 2014) reported that HIIT intervals were 
conducted at a higher intensity than in the continuous vigorous intensity condition, yet 
affect was more positive. A caveat to this argument may be the potential moderating role 
that obesity plays in the relationship between affect and intensity, which was originally 
identified by a study (Ekkekakis & Lind, 2006) where overweight participants reported 
lower ratings of pleasure during relatively higher intensities, whilst there was not a 
difference for  WKHLUµLGHDOZHLJKW¶FRXQWHUSDUWV. The BMI of the participant in the study 
by Bartlett and colleagues (2011) was (M ± SD) 24.2 ± 2.2 kg/m2 and in Jung and 
colleagues (2014) study it was 23.34 ± 2.78 kg/m2 for men and 24.92 ± 5.54 for women. 
Whereas, in a more recent study (Decker & Ekkekakis, 2017)  where participants had a 
BMI of 34.96 ± 4.46 kg/m2, despite using a similar protocol to Jung and colleagues 
(2014), in 'HFNHUDQG(NNHNDNLV¶VVWXG\ affect was lower and perception of effort 
was higher in the HIIT compared to the moderate intensity continuous exercise group. 
Furthermore, post-exercise enjoyment was lower in the HIIT condition. 
In his rebuttal, Biddle accepts the effectiveness of HIIT, whilst maintaining that 
³IHZZKRneed to exercise the most will choosHWKHµKDUG¶ RSWLRQRI+,,7´7KLVPD\
indeed be the key, as although the relationship between intensity and affect is thus far 
equivocal, an increase in exercise intensity requires higher effort to meet task demands. 
Biddle also states, in relation to the time efficiency of HIITWKDW³LWLVQRWZKHWKHUZH
have time, but how we choose to spend our time´. This links clearly to a study by Vara 
and Epstein (1993) which identify that even when sedentary behaviours are µliked¶
equally to physically active behaviours, in choice paradigm sedentary behaviours are 
chosen significantly more than active (exercise) behaviours (Vara & Epstein, 1993). 
Similar to the effort-based decision-making paradigm used in rodents to study effort 
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dysfunction (which was introduced in the General Introduction and will be discussed 
further in the Animal Introduction), choices to engage in sedentary rather than active 
behaviours, despite no difference in task preference (Vara & Epstein, 1993), suggests that 
the required effort is influencing decisions to engage in these behaviours. This assertion 
is supported by MIT, the principle of least effort (both of which are introduced in the 
general introduction) and also an evolutionary biological perspective. There is apparently 
no innate drive to be substantially physically active (Cordain, Gotshall, Eaton, & Eaton, 
1998; Eaton & Eaton, 2003; Peters, Wyatt, Donahoo, & Hill, 2002). It is thought that in 
the period in which the current human genome was selected physical activity energy 
expenditure was driven by the procurement of food (Eaton et al., 2002). Because of 
human societal evolution, for many at least, physical effort is no longer required to 
procure food. Therefore, for those in high-income industrialised countries, at least, 
engaging in regular and frequent physical activity behaviours requires a conscious 
cognitive effort (Peters et al., 2002). 
Biddle, Batterham, and to a certain extent Vara and Epstein (1993), have a 
commonality. They have each made a single assumption, which is that perceptual 
responses to exercise are not modifiable. This assumption is false. There is a multitude of 
interventions that can manipulate perceptual responses during exercise independent of 
physical demand. These include psychological interventions, for example, imagery 
(Razon et al., 2014) and self-talk (Blanchfield, Hardy, De Morree, et al., 2014; 
McCormick et al., 2018) interventions, which have both elicited a reduction in perception 
of effort and improved exercise performance. Pharmacological intervention via 
psychoactive drugs such as caffeine (Doherty & Smith, 2005; Schubert et al., 2014), or 
modafinil (Jacobs & Bell, 2004), for example, have been shown to increase affect, reduce 
perception, and improve exercise performance. There is even literature on the use of 
hypnotism (Williamson et al., 2001), subliminal cues (Blanchfield, Hardy, & Marcora, 
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2014), and afternoon naps  (Blanchfield et al., 2018) successfully modifying perceptual 
responses during exercise. 
It stands that, in addition to being more time efficient, HIIT has desirable 
physiological outcomes either proving to be as effective (e.g., Gillen et al., 2016; 
Shepherd et al., 2015), or more effective (Helgerud et al., 2007; Karstoft et al., 2013; 
0LODQRYLü6SRULã	:HVWRQ5RJQPRHt al., 2004; Tjønna et al., 2008; Wisloff et 
al., 2007) when compared to continuous moderate intensity/endurance exercise training. 
The issue is that it is not considered to be a feasible modality in the treatment of disease 
or for previously sedentary individuals due to associated negative affect and high 
perception of effort (Biddle & Batterham, 2015; Decker & Ekkekakis, 2017; Hardcastle 
et al., 2014; Holloway & Spriet, 2015). It is therefore logical that if HIIT can be 
facilitated, modifying the psychological experience (i.e., increasing affect and/or 




2.3.1. Caffeine and activity levels 
Benefits associated with caffeine ingestion in athletic populations include delayed 
feelings of fatigue (Anselme, Collomp, Mercier, Ahmadi, & Prefaut, 1992; Jackman, 
Wendling, Friars, & Graham, 1996), reduced exercise-induced muscle pain (D. G. Bell 
& McLellan, 2002) and perception of effort (Backhouse et al., 2011; D. G. Bell & 
McLellan, 2002; Doherty & Smith, 2005), increased time to exhaustion (Graham & 
Spriet, 1991), as well as increasing affect (FS scale scores) (Backhouse et al., 2011) 
alertness, feelings of subjective energy and ability to concentrate (Keisler & Armsey, 
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2006; Lorist, Snel, & Kok, 1994). Which provides a strong rationale for the potentially 
positive effects of caffeine on feelings during exercise. 
The effects of caffeine on exercise tolerance and perceptual physical performance 
have also been assessed to a lesser degree in recreationally active populations. These 
studies reported that caffeine significantly reduces the perception of effort (Schubert et 
al., 2014) and exercise-induced muscle pain during high (Gliottoni & Motl, 2008) and 
moderate (Motl et al., 2003) intensity exercise. Exercise enjoyment has been shown to be 
higher following caffeine ingestion (Schubert et al., 2014) as well as it delaying the 
feelings of fatigue and increasing feelings of vigour around a bout of exercise (Olson, 
Thornton, Adam, & Lieberman, 2010). Despite the huge interest caffeine has received at 
large, there is, however, still relatively little work investigating the effects of caffeine on 
exercise tolerance and feelings during exercise in sedentary populations.  
The first study investigating the effect of caffeine during exercise in sedentary 
participants was conducted by Engels and Haymes (1992). In that study researchers 
reported significantly higher minute ventilation, as well as an increase in pre and post-
exercise free fatty acids associated with a 60-minute walking protocol in sedentary males 
following caffeine ingestions, however, the ability to perform work, tolerance for 
exercise, or any perceptual responses were not measured. Likewise, in a more recent study 
(Leelarungrayub, Sallepan, & Charoenwattana, 2011) found differences in substrate 
mobilisation in sedentary men following coffee equivalent to 5 mgÂkg. However, no 
perceptual responses were recorded. In another study (Wallman, Goh, & Guelfi, 2010). 
Perception of effort was not different during steady-state exercise, at 65% HRpeak, 
following 6 mgÂkg caffeine ingestion compared to placebo in sedentary women. There 
was also not an improvement in performance in a subsequent time trial task, nor were 
there any differences in any other variables, including HR, RPE, 9%cO2, and RER. However, 
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60% of participants correctly identified when they were in the caffeine condition due to 
feelings of restlessness, hyperactivity, and shaky hands and legs. It is possible here that, 
as a relatively high dose of caffeine was used, 6 mgÂkg, some of the negative side effects 
of caffeine were more prevalent than the beneficial effects, which may not be such an 
issue with a lower dose. For example, 3 mgÂkg has been shown to elicit positive responses 
to exercise in active people without eliciting side effects (Spriet, 2014).  
A subsequent study from the same lab investigated the effects of caffeine (6 
mgÂkg) ingestion on time trial performance in sedentary males (Laurence, Wallman, & 
Guelfi, 2012). The authors reported that exercise tolerance improved, with greater work 
done, higher energy expenditure, higher oxygen consumption, and higher HR in the 
caffeine condition despite QRFKDQJH LQ µHIIRUW VHQVH¶7KHDXWKRUV FRQFOXGHG WKDW WKH
ability to do more exercise after caffeine ingestion, without an accompanying increase in 
perception of effort, could motivate sedentary men to participate in exercise more often 
and so reduce adverse effects of inactivity on health (Laurence et al., 2012), which is 
consistent with the theories that have been presented in this thesis (i.e., MIT and HT). 
7KH µOiking¶ of physical activity was higher following caffeine ingestion (3 
mgÂkg), compared to placebo, in previously sedentary women, whilst there was no 
difference between conditions for men. Independent of sex, participants in the caffeine 
group exercised for significantly longer in a µtolerance test¶ (essentially a time to 
exhaustion test), compared to those in the placebo group (Schrader et al., 2013). 
 Despite considerable data on the effects of caffeine during exercise in athletic 
populations, the amount of available data is inversely correlated with the habitual physical 
activity levels among participants, as there are relatively fewer studies on un-trained and 
sedentary participants. The limited data that does exist from sedentary populations is 
inconsistent and largely focussed on the metabolic rather than perceptual effects. This is 
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not surprising as caffeine is widely considered to be an ergogenic aid, with well know 
performance-enhancing effects, whilst the idea of using it as an intervention to improve 
tolerance in sedentary people is relatively new (Schrader et al., 2013) and requires further 
investigation.  
 
2.3.2. Caffeine and intensity of exercise 
There is extensive literature (for a review see Burke, 2008) supporting the 
ingestion of caffeine to increase tolerance and improve endurance performance. Rather 
astonishingly, however, there is currently no published literature on the effects of caffeine 
on exercise tolerance during highintensity interval training (HIIT). Whilst inference can 
be made about tolerance to exercise from studies investigating the effects of caffeine on 
short-term high-intensity exercise performance (for a review see Astorino and Roberson 
(2010), as performance is inextricably linked with exercise tolerance. There are relatively 
few studies, compared to endurance performance, and the finding from these studies are 
equivocal.  
Some studies demonstrate an increase in exercise tolerance, with caffeine (250 
mg) increasing performance in sprints on a cycle ergometer following a dose of 250 mg 
(Anselme et al., 1992) and following 5 mgÂkg (Woolf, Bidwell, & Carlson, 2008). 
Caffeine has also been shown to improve bench press performance in strength-trained 
men following a 2.5 mgÂkg dose (Beck et al., 2006) and after a dose of 5 mgÂkg (Woolf 
et al., 2008). Sprint speed, drive power, and passing accuracy has been shown to improve 
among rugby players following 6 mgÂkg (Stuart, Hopkins, Cook, & Cairns, 2005). 
Swimming velocity increases over 100-m following a dose of 250 mg,  but this effect was 
only true for trained swimmers as there was no difference in performance for untrained 
swimmers (Collomp, Ahmaidi, Chatard, Audran, & Prefaut, 1992). Other research has 
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shown that caffeine has no effect, for example, in one study 6 mg.kg did not elicit an 
increase in maximal strength or muscular endurance (reps to fatigue) in bench press or 
leg press (Astorino, Rohmann, & Firth, 2008). Whilst in another study, 2.5 mg.kg had no 
effect on maximal strength or running performance at 85% 9%cO2peak (Beck, Housh, Malek, 
Mielke, & Hendrix, 2008). There is even research to suggest that caffeine diminishes 
performance, as a study showed that healthy physically active men had lower mean power 
in repeated Wingate tests after receiving 6 mg.kg caffeine (Greer, McLean, & Graham, 
1998).  
Although there is an overwhelming body of literature documenting the positive 
effects of caffeine on endurance performance and continuous intensity exercise activity, 
clearly the evidence in relation to high-intensity exercise is not as substantial, and 
somewhat equivocal. Although performance data can be used to make initial inferences 
about subjective exercise tolerance, this is not ideal. Considering the potential impact that 
caffeine could have in mitigating the negative perceptual responses associated with HIIT 
(Biddle & Batterham, 2015), to access the superior physiological benefits of this (HIIT) 
exercise modality +HOJHUXGHWDO.DUVWRIWHWDO0LODQRYLüHWDO
Rognmo et al., 2004; Tjønna et al., 2008; Wisloff et al., 2007) (as discussed in section 
2.2.) this is an area that is in need of research attention. 
 
2.4. Exercise choice ± choice as a behavioural outcome 
Increasing adherence to exercise is the ultimate long-term goal of the work 
presented in this thesis, as well as many researchers across the globe. Although the end 
goal is shared, approaches vary dramatically. As part of the EM approach that has guided 
all investigation herein, understanding the mechanisms by which an intervention elicits 
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its effect on behaviours is of fundamental importance. Therefore, behavioural outcomes, 
as well as putative target engagement needs to be quantifiable.  
Essentially, completing exercise, or indeed any other instrumental behaviour is 
the result of a decision where a particular action/behaviour is chosen in favour of 
competing alternatives. Therefore, what ultimately determines adherence is a systematic 
bias, resulting in individuals repeatedly choosing to engage in exercise in favour of 
competing alternatives. Although adherence can be measured directly, either by 
monitoring attendance at supervised exercise classes (e.g., Klonoff et al., 1994), or via a 
physical activity recall (e.g., Williams et al., 2008; Williams, Dunsinger, Jennings, & 
Marcus, 2012) this is a big undertaking, requiring relatively long time-frames and an 
extended commitment from participant to engage in the follow-up, or significant 
resourcing to run supervised exercise session for participants to attend. However, 
understanding this decision-making process mechanistically can be achieved in a 
relatively shorter time frame and with few participants than would a large scale RCT 
testing the effect of caffeine on adherence to exercise.  
Traditionally choice as a behavioural outcome, related to exercise behaviours in 
humans has sought to quantify how reinforcing the behaviour is. This has been achieved 
using complex choice paradigms. An example of one of these paradigms was used in a 
study (Williams & Raynor, 2013) to determine preference for exercise. In this study 
participants were asked whether they would prefer to walk for one mile at a self-selected 
intensity or sort paper clips for 2 minutes. Subsequent questions required participants to 
choose between walking for one mile at self-selected intensity versus sorting for 4, 6, 8, 
10, 12, 14, 16, 18, and 20 min. There were various iterations of this question exploring 
differences in preference for self-selected- vs imposed-intensity physical activity, but that 
is not the subject of this discussion. The fact is that the established way to quantify 
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preference for exercise is to equate to sorting paperclips. This is useful when comparing 
two conditions directly, for example, testing path X of the EM approach, where it would 
be possible to determine whether exercise was preferable following caffeine ingestion or 
not. However, it is not possible to attribute the difference in task preference to the 
engagement of a putative target. In other words, even if caffeine (or an alternative 
intervention) did increase preference it would not be possible to determine why. An 
alternative approach is the effort expenditure for rewards task, which is a behavioural 
measure of cost/benefit decision-making in humans. In this decision making paradigm 
participants play a game in which they are given an opportunity on each trial to choose 
between two different task difficulty levels (effortful gripping vs merely holding the 
gripping device) to obtain varying monetary rewards (e.g., Klein-Flügge, Kennerley, 
Saraiva, Penny, & Bestmann, 2015; Kurniawan et al., 2010; Treadway et al., 2012).  
There is also a version of this paradigm which has been used to investigate the 
role of mental effort in decision making. For example, in the first study of its kind (Kool, 
McGuire, Rosen, & Botvinick, 2010), participants were introduced to two decks of cards. 
Participants were told that they were free to choose from either deck on any trial and that 
WKH\VKRXOG³IHHOIUHHWRPRYHIURPRQHGHFNWRWKHRWKHUZKHQHYHU\RXFKRRVH´EXWDOVR
WKDW ³LI RQH GHFN EHJLQV WR VHHP SUHIHUDEOH IHHO IUHH FKRRVH WKDW GHFN PRUH RIWHQ´ 
Unannounced to participants, the decks could be distinguished by their demand, as one 
deck required task switching on 90% of occasions, whilst for the other deck task switching 
only occurred on 10% of occasions. Thus, deck preference was used to determine the role 
of mental effort/demand on decision-making behaviours.  
On a small scale, these effort-based decision-making tasks are not only providing 
a measure of initial task preference but also what is essentially adherence. If you consider 
one hand grip effort decision to be equivalent to each day where a decision is made about 
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whether or not to engage in exercise. In this scenario, selection for the low effort option 
would be equivalent to selecting a sedentary behaviour in favour of exercise. Clearly 
assertions from the findings of these hand-grip studies (e.g., Klein-Flügge, Kennerley, 
Saraiva, Penny, & Bestmann, 2015; Kurniawan et al., 2010; Treadway et al., 2012) cannot 
be made about whole body exercise behaviour as they neither matched in terms of energy 
expenditure or perceived value (i.e., a brief handgrip task will elicit the same health 
benefits as HIIT or moderate intensity continuous exercise). However, conceptually this 
paradigm makes sense. The advantage of using hand-grip is the ability to explore the 
mechanistic relationship between the putative target and the outcome behaviour (i.e., 
preference) on several choice occasions per minute. The issue is that this cannot translate 
to whole-body exercise at a level that is required to, for example, meet public health 
guidelines of   PLQÂweek-1 of moderate- RU  PLQÂZHHN-1 of vigorous intensity 
exercise (Garber et al., 2011). Therefore, an adaptation of this paradigm would be 
required. However, there is an alternative approach that is currently available to help 
establish where there is an initial preference for a particular condition. 
Preference tests are not common in this field, however, they are prominent in 
consumer sensory evaluation, where the preference for cosmetic products, for example, 
helps to predict consumer purchasing behaviour (Cochrane, Dubnicka, & Loughin, 2005). 
In simple terms, if people prefer something they are more likely to choose it in the future. 
This can be applied to physical activity behaviour. For example, if an intervention elicits 
a change in preference for a particular condition, such as an exercise modality, theory 
(i.e., MIT and HT) suggests that the change in preference will predict positive changes in 
subsequent physical activity behaviour (i.e., adherence). Traditionally these preference 
tests are completed without replication, effectively leading to a single 0/1 (binary) 
measurement. Which would equate to participants completing one training session after 
ingesting caffeine, and another after ingesting placebo before choosing which condition 
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they preferred. However, with only a single preference teVWIRUHDFKµFRQsumer panellist¶
LW LV GLIILFXOW WR WHOO ZKHWKHU WKH FRQVXPHU¶V UHVSRQVH LV EDVHG RQ true preference, or 
whether they cannot differentiate between the two products and simply selects a product 
at random (Cochrane et al., 2005). The response to this limitation in consumer research 
has been to adopt a replicated preference test approach, resulting in binomial counts of 
preference for each panellist. This would equate to participants completing several 
training sessions after consuming either caffeine or placebo and comparing each pair of 
sessions to establish a binomial measure of preference. Taking this approach (i.e., 
replicated preference tests), measuring preference for exercise conditions such as between 
a treatment and placebo can be used as a behavioural outcome which is related to ultimate 
behavioural outcome (Sheeran et al., 2017), which is exercise adherence. 
 
2.5. The present study 
It stands that HIIT has desirable physiological outcomes, proving to be as, if not 
more, effective than continuous moderate intensity exercise (Helgerud et al., 2007; 
.DUVWRIWHWDO0LODQRYLüHWDO5RJQPRHWDO7M¡QQDHWDO
Wisloff et al., 2007) as well as addressing one of the most frequently cited barriers to 
engaging in regular physical activity, which is the perceived lack of time (Steinhardt & 
Dishman, 1989; Trost et al., 2002) . The present study will, therefore, adopt HIIT as the 
exercise modality, whilst combining with caffeine as an intervention to mitigate the 
negative perceptual responses associated with HIIT (Biddle & Batterham, 2015). Despite 
limited research investigating the effects of caffeine on exercise tolerance and feelings 
during exercise in sedentary populations, data from athletic as well as recreationally 
active populations clearly identify it as a suitable intervention for putative target 
engagement and therefore warrants further investigation in this population. For this initial 
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stage of inquiry, utilising replicated preference tests (Sheeran et al., 2017) as behavioural 
outcome related to physical activity behaviour rather than adherence itself will allow 
experimental designs to explore the mechanistic relationship between caffeine, feelings 
during exercise and an exercise-related choice, without long follow-up periods required 
to evaluate effects on adherence. 
 
2.6. Aim of thesis Part I 
The aim of Part I of this thesis was to conduct a full test (Path D of the EM approach). 
Full tests determine whether an intervention strategy or a set of strategies changes 
physical activity behaviour, or a related outcome, via their effects on specified targets 
(Figure 1.1., Path D). Therefore, in this case, the aim was to determine whether caffeine 
was able to influence exercise preference via its effects on feelings during exercise. 
Broadly, the hypothesis was that caffeine would elicit positive changes in feelings 
during exercise, which would result in positive changes in physical activity behaviour, as 
determined by an increased preference for exercise following caffeine ingestion. 
Experimental work in this part of the thesis consists of three chapters. Chapter 4 
utilises a single-subject experimental design as a preliminary test of this hypothesis, 
which is built upon by chapter 5, where a group design is employed. Chapter 6 tests an 
alternative hypothesis, related to the physiological rather than psychological/perceptual 








3.1. Caffeine deception in humans 
(Used in chapters 4, 5 and 6) 
The participant was informed that for each one of the 12 experimental visits they 
would be consuming either tyrosine or beta-alanine, in combination with caffeine; 
however, this was a deception. Instead, they consumed a capsule containing either 3 
mgÂkg caffeine (Sigma-Aldrich, Dorset, UK), or a placebo substance (dextrose 
monohydrate). The primary reason for this deception is that caffeine, the most commonly 
used psychoactive substance in the world (Mitchell, Knight, Hockenberry, Teplansky, & 
Hartman, 2014), is perhaps too familiar. Thus, recognising the familiar effects could 
essentially un-blind the participant to the experimental condition. By deceiving the 
participant into believing that they would receive caffeine as a constant, in combination 
with one of two theoretically comparable substances, should remove bias and equate the 
prior expectancy of the two conditions. When participants had completed their final visit, 
WKH\ZHUHGHEULHIHGDERXWWKHVWXG\¶VJHQXLQHUDWLRQDOHDQGWKHGHFHSWLRQZDVUHYHDOHG 
 
3.1. Caffeine and placebo capsules and administration 
(Used in chapters 4, 5 and 6) 
Substances were weighed using high-precision scales and all capsules for each 
participant were filled ahead of their first experimental session. Capsules were size 00, 
holding approximately 1000 milligram (mg), and clear in colour (Capsugel, Lonza Group 
Ltd, Basel, Switzerland). Placebo capsules contained 1000 mg of dextrose monohydrate 
(myprotein.com). The caffeine dose was 3 milligrams per kilogram of body mass (mgÂkg). 
Therefore, for example, an individual weighing 80 kg, would receive a 240 mg dose of 
caffeine (Sigma-Aldrich, Dorset, UK). Continuing with this example, the remaining space 
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in the 1000 mg capsule (~760 mg) would be filled with dextrose monohydrate 
(myprotein.com). Although the dextrose monohydrate was a good colour-matched, the 
caffeine had a slightly finer grain. However, once the caffeine and dextrose monohydrate 
had mixed, caffeine + dextrose monohydrate capsules were indistinguishable from 
dextrose monohydrate only capsules. Participants ingested the capsules between 90- and 
60-minutes before arrival at the lab (Spriet, 2014; Wickham & Spriet, 2018). 
 
3.2. Determination of maximal oxygen uptake (9լ O2max) in humans 
(Used in chapters 4, 5 and 6) 
9%cO2max was assessed using an incremental treadmill test. Initially, participants 
were fitted with a HR monitor (Polar Electro, Kempele, Finland). To familiarise with 
treadmill walking, the test started on a flat treadmill (Expert Fitness UK, Powerjog) until 
the participant was able to walk confidently without needing to grab the handrails. As 
soon as participants were able to walk properly a comfortable walking pace (self-selected) 
was established, whilst the experimenter made adjustments to treadmill inclination for a 
10-min warm-up, with a desired intensity of ~70% age-predicted maximum Heart Rate. 
The final intensity for the warm-up was the starting intensity for the incremental test, 
thus, the intention of these adjustments was to bring the participant to 9%cO2max after 
approximately 8±12 min, as recommended by Buchfuhrer et al., (1983).  
After the warm-up period participants were fitted with a facemask (Cortex 
Biophysik GmbH, Leipzig, Germany) which was connected to a breath by breath gas 
analyser (MetaLyzer 3BR2, Cortex Biophysik GmbH, Leipzig, Germany) that had been 
calibrated with a gas of a known composition prior to use, following the manufacturers¶ 
guidelines. The 9%cO2max test was performed using a ramp protocol where the speed was 
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constant, and the incline was increased by 2% every second minute until volitional 
fatigue. The highest average 30-s measurement determined 9%cO2max. Heart rate was 
continuously recorded using a Polar Sport Tester (Polar Electro OY, Finland), and 
maximum attainable heart rate (HRpeak) was determined. One minute after task failure, 
ODFWDWHFRQFHQWUDWLRQZDVPHDVXUHGE\FROOHFWLQJȝORIZKROHIUHVKEORRGIURPDILQJHU
Blood samples were analysed using a calibrated device (EKF Diagnostic, Biosen C-Line). 
A test was accepted as a µtrue max¶if three of the following four conditions were met: 
achieved 90% age-predicted maximum heart rate; reached plateaux (9%cO2 levelled off 
when workload increased); a respiratory exchange ratio (RER) of >1.05; blood lactate 
>6mmol.l-1. In a previous study (Rognmo et al., 2004), using the same protocol, an 
instructor blinded for the values from an initial test carried out a second 9%cO2max test on 
the same participants, to ensure that learning to walk properly on the treadmill did not 
affect 9%cO2max measured during the initial test. The mean difference from test two to test 
one was only 0.011±0.11l/min, or 0.46% of the two measurements.  
 
3.3. HIIT protocol for humans 
(Used in chapters 4, 5 and 6) 
All HIIT sessions FRQVLVWHGRI³XSKLOO´WUHDGPLOOZDONLQJ, as described previously 
(Rognmo et al., 2004). During each HIIT session, participants carried out a 5-min warm-
up period at an intensity corresponding to 50±60% of 9%cO2max (65±75% of HRpeak) before 
walking four intervals of 4-min at 80±90% of 9%cO2max (85±95% of HRpeak). Between the 
intervals 3-min of walking at 50±60% of 9%cO2max was conducted. The training session was 
terminated by a 3-min cool-down period at 50±60% of 9%cO2max. This gave a total exercise 
time of 33-min. Training was completed on an HP Cosmos (Pulsar) treadmill. Participants 
wore heart rate monitors (Polar Electro, Kempele, Finland) during every training session. 
53 
 
The HR display was visible to the researcher but not to the participant. The researcher 
could thus control the corresponding exercise heart rate relative to 9%cO2max. The speed 
remained constant throughout the entire study after it was selected by the participants 
during their first visit. The average self-selected speed across the studies detailed in 
chapters 4, 5, and 6 was (M ± SD) 3.99 ± 0.51 km/h. The inclination of the treadmill was 
continually adjusted throughout the first WKUHHµIDPLOLDULVDWLRQ¶VHVVLRQVZLWKWKHDLPIRU
participants to reach the top end of the intensity band during their final 4-min bout. The 
average gradient during the (relatively) low intensity periods (i.e., warm-up, recover and 
cool down) was (M ± SD) 3.1 ± 1.59%, whist it was 16 ± 2.15% during the 4-minute 
(relatively) high intensity periods across the studies detailed in chapters 4, 5, and 6. 
 
3.4. Measuring acute perceptual and HR responses to HIIT in humans 
(Used in chapters 4, and 5) 
During each of the HIIT sessions, perception of effort, affective valence, exercise-
induced muscle pain, and HR were recorded. These measurements were taken during the 
final 15-s of every low-intensity block, and the final 15-s of the 2nd and 4th minute of high-
intensity blocks (i.e., half-way through, and at the end). The rating of perceived exertion 
(RPE) 6 - 20 scale (Borg, 1970) was used as a measure of the perception of effort. Low 
(6) and high (20) anchors were established during the incremental ramp test using 
standard procedures (Borg, 1998; Noble & Robertson, 1996). During subsequent visits, 
standardised instructions for memory anchoring of the scale were given to the participant 
before the warm-up. Briefly, the participant was asked to rate the conscious sensation of 
how hard, heavy, and strenuous the physical task was (Marcora & Staiano, 2010). 
Affective valence was measured using the Feeling Scale (FS), which was developed to 




µQHXWUDO¶Participants received standard instructions prior to the warm-up and were 
DVNHG³KRZGR\RXIHHOULJKWQRZ´HDFKWLPHWKHPHDVXUHZDVWDNHQ([HUFLVH-induced 
muscle pain was measured using a categorical scale &RRN2¶&RQQRU(XEDQNV6PLWK
& Lee, 1997). This categorical pain scale (PS) has 12 categories from 0 to 10: 0 = no pain 
at all, 0.5 = very faint pain (just noticeable), 1 = weak pain, 2 = mild pain, 3 = moderate 
pain, 4 = somewhat strong pain, 5 = strong pain, 7 = very strong pain, and 10 = extremely 
intense pain (almost unbearable). These three (i.e., RPE, FS, and PS), scales were used in 
the current study both because of the evidence of their reliability and validity and because 
of their advantages being applied during exercise - unlike visual analogue scales for 
example, where physical marks need to be made on a sheet of paper.  
 
3.5. Mood-state around HIIT 
(Used in chapters 4, and 5) 
Both immediately before and after HIIT, participants completed the fatigue 
(GHILQHGDV³6WDWHRIWLUHGQHVVORZHQHUJ\´ (Brandt et al., 2016). Example item: ³tired´) 
and vigour (GHILQHGDV³VWDWHRIHQHUJ\SK\VLFDOIRUFH´ (Brandt et al., 2016). Example 
item: ³energetic´) subscales of the Brunel Mood Scale (BRUMS) to quantify current 
PRRG³+RZGR\RXIHHOULJKWQRZ"´ This measure of mood has been validated for use 
with adult populations (Terry, Lane, & Fogarty, 2003). The items are answered on a five 
points scale (0 = not at all, 1 = a little, 2 = moderately, 3 = quite a bit, 4 = extremely), and 






3.6. Task (HIIT) motivation 
(Used in chapters 4, and 5) 
Motivation was measured immediately prior to HIIT via the success motivation 
(example item; ³7KHWDVNZLOOEULQJRXWP\FRPSHWLWLYHGULYH´) and intrinsic motivation 
(example item; ³'RLQJ WKH WDVN LVZRUWKZKLOH´) scales, from the Dundee Stress State 
Questionnaire (DSSQ), developed and validated by Matthews and colleagues (2002). 
Each scale consists of seven items responded to on a 5-point Likert-type scale (0 = not at 
all, 1 = a little, 2 = moderately, 3 = quite a bit, 4 = extremely). Additionally, a stand-alone 
item measuring potential motivation (item: ³I am motivated to do the task´), developed 
and validated by Mathews and colleagues (2001), was completed. This item used the same 
5-point scale as described above. 
 
3.7. Exercise Enjoyment 
(Used in chapters 4, and 5) 
The Physical Activity Enjoyment Scale (Kendzierski & DeCarlo, 1991; Motl et 
al., 2001) was completed immediately post-HIIT a measure of self-reported exercise 
enjoyment. The participant was asked to rate "how you feel at the moment about the 
physical activity you have been doing". Each item was rated on a 7-point bipolar scale 
weighted by not at all (1), and extremely (7) with moderately (4) representing a neutral 
point in terms of how much they enjoyed the exercise (example item: I feel good 





3.8. Session RPE 
(Used in chapters 4, 5 and 6) 
Ten minutes post-exercise, whole session RPE was recorded. As with perceptions 
of effort recorded during exercise, the Borg (1970) 6-20 scale was used, but the context 
was somewhat different. Rather, we explained to the participant that we wanted a global 
rating of the entire training bout using whatever cues they felt to be appropriate. 
Therefore, the session RPE represents a single global rating of the intensity for the entire 
training session. This measure is sensitive to the effects of caffeine (Killen et al., 2013), 
and accurate measurements can be determined as early as 10-minutes after exercise 




4. The effects of caffeine on feelings during exercise and choice 





N-of-1/single-subject trials offer an alternative to group RCTs by using intensive 
data collection in small samples while still maintaining the internal validity of traditional 
trials such as experimental design and randomisation to conditions (Craig et al., 2013). In 
single-subject trials, instead of randomising groups of participants to experimental 
conditions (e.g., caffeine or placebo), individual participants are randomised to conditions 
in a pre-determined order and time series fashion whereby each participant is exposed to 
both the intervention and control group on different days of the trial period (Nyman, 
Goodwin, Kwasnicka, & Callaway, 2016). As well as a tool for scientific research, single-
subject trials can inform best practice in patient care (Price & Grimley Evans, 2002). For 
example, single-subject trials have been used to identify optimal treatment for patients 
(Scuffham et al., 2010).  
The single-subject design has a history in pharmaceutical medicine (Barlow, 
Knock, & Hersen, 2008; Gabler, Duan, Vohra, & Kravitz, 2011), but has more recently 
been adopted for the study of exercise behaviour. A single-subject design was used to 
investigate the effect of action related non-conscious visual cues on perception of effort 
and exercise tolerance (Blanchfield, Hardy, & Marcora, 2014), which are parameters 
related to the putative target and behavioural outcome in the present study. Moreover, a 
recent study has demonstrated the utility of single-subject trials for advancing scientific 
HQTXLU\RIEHKDYLRXUFKDQJHIRULQFUHDVLQJROGHUSHRSOH¶VSK\VLFDODFWLYLW\ (Nyman et 
al., 2016).  In Nyman and colleagues¶ (2016) study, self-regulatory techniques of goal 
setting and self-monitoring were employed, and subsequent physical activity behaviour 
was measured using pedometers.  
In the current study, a single-subject design was used as an initial experimental 
test of path D of the EM approach. The primary aim, which was broadly stated in the 
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Human Introduction (section 2.6.), was to determine whether caffeine ingestion prior to 
completing HIIT would engage the overall putative target of ³IHHOLQJGXULQJH[HUFLVH´. 
This putative target is a compound of several perceptual and psychological responses 
identified by their association, either empirical or theoretical (MIT and HT), with physical 
activity behaviour. Specifically, individual putative targets include perception of effort 
and exercise-induced muscle pain, affect (i.e., pleasure/displeasure), exercise enjoyment, 
as well as mood (fatigue and vigour) and motivation. The secondary aim of this study was 
to investigate whether the effect of caffeine on feelings during and around HIIT are 
associated with changes in exercise behaviour, as determined by choice.  
The primary hypothesis was that caffeine would elicit an increase in affect, 
µOLNLQJ¶ HQMR\PHQW DQG YLJRXU; a decrease in perception of effort, exercise-induced 
muscle pain, and fatigue; despite no differences in motivation. The secondary hypothesis 






One female participant (age 32 years; height, 170 cm; mass, 85 kg; BMI, 29.4 
kg/m2; 9%cO2max 25.9 ml·kgí1 ·  miní1) volunteered to take part in the study. The participant 
was previously sedentary (i.e., relatively inactive), defined here as a score of < 4 and with 
 2 on both items of the Occupational and Spare-Time Physical Activity Questionnaire 
(OSTPAQ ± Appendix B) (Saltin & Grimby, 1968). The pDUWLFLSDQW¶V habitual caffeine 
intake was ~170 mg per day, estimated using the Caffeine Consumption Questionnaire 
(CCQ ± Appendix C) (Landrum, 1992) ZKLFK LV FRQVLGHUHG µORZ¶. The study was 
approved by the School of Sport and Exercise Sciences Research Ethics Committee at the 
University of Kent. Prior to taking part, the participant completed an informed consent 
form along with a standard medical questionnaire (Appendix A) to confirm their present 
state of health. The participant was given an overview, detailing all procedures and 
requirements of the study and was informed that the study was testing the effect of two 
different substances (either tyrosine, or beta-alanine), in combination with caffeine, on 
physiological and psychological responses to HIIT ± when in fact they received either 
caffeine alone, or placebo. Consequently, the participant was naive to the true aims and 
hypotheses of the study until the final session was complete, at which point they were 
debriefed about its genuine rationale (see General Human Methods section 3³&DIIHLQH
GHFHSWLRQ´IRUGHWDLOV. 
 
4.2.2. Experimental design 
The experiment was a double-blind blocked randomisation test design (Dugard, 
File, & Todman, 2012) in which the participant visited the laboratory on 18 occasions. 
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Visits 1, 11, and 18 involved a treadmill-based incremental test, visits 2-4 served as a 
familiarisation, with visits 5-10, and 12-17 comprising the 12 experimental visits. These 
12 experimental visits encompassed a crossover design in which the participant was 
allocated to six visits for each of the two experimental treatment conditions (caffeine vs. 
placebo). The treatment received for the first visit of each block was randomised, though 
the treatment for the remaining five visits of each block alternated to maximise the 
number of choice pairs (see section on choice). Blocking the experimental period allowed 
for any necessary adjustments to training intensity, to maintain the training stimulus if 
there are changes in exercise capacity.  
 
4.2.3. Caffeine dose and deception 
For the experimental sessions, the participant received either caffeine (3 mgÂkg) 
or placebo (dextrose monohydrate). A deception was used to minimise the impact of the 
SDUWLFLSDQW¶VIDPLOLDULW\ZLWKFDIIHLQH)RUIXUWKHUGHWDLOVRQGUXJDGPLQLVWUDWLRQDQGWKH
deception see General Human Methods section 3³&DIIHLQHDQGSODFHERFDSVXOHVDQG
DGPLQLVWUDWLRQ´DQGVHFWLon 3³&DIIHLQHGHFHSWLRQ´respectively. 
 
4.2.4. Procedures  
During visit 1, a treadmill-based incremental test was completed to establish 
9%cO2max ± from which subsequent training intensities were determined. See General 
Human Methods section 3.3. ³Determination of maximal oxygen uptake (9%cO2max)´for 
details. This test was repeated during visits 11 and 18. Visits 2 ± 10, and 12 ± 17 
comprised the training portion of the study, which were completed at a frequency of 2 ± 
3 times per week, supervised by an exercise physiologist. The participant was instructed 
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not to add any leisure exercise during the study period. All training consisted of uphill 
treadmill walking. See General Human Methods section 3³+,,7SURWRFRO´ for details. 
 
4.2.5. Acute perceptual and HR responses to HIIT 
During each of the HIIT sessions (visits 2 ± 10, and 12 - 17) perception of effort, 
affect, exercise-induced muscle pain, and HR responses were recorded throughout. See 
General Human Methods section 3.³0HDVXULQJDFXWHSHUFHSWXDODQG+5UHVSRQVHVWR
+,,7´ for details. 
 
4.2.6. Psychological questionnaires before and/or after HIIT 
The participant completed the fatigue and vigour subscales of the Brunel Mood 
Scale (BRUMS) immediately before and after HIIT. Scales for intrinsic motivation (IM), 
and potential motivation (PM) were complete before HIIT only. Whilst self-reported 
exercise enjoyment was measured immediately post HIIT only, using the PACES. See 
General Human Methods sections 3 ³0RRG-VWDWH DURXQG +,,7´ 3 ³7DVN +,,7
PRWLYDWLRQ´DQG3³([HUFLVHHQMR\PHQW´IRUPRUHGHWDLOV. Ten-minutes post-exercise, 
whole session RPE was recorded using the Borg (1970) 6-20 scale, representing a single 
global rating of the intensity for the entire training session. See General Human Methods 
section 3³6HVVLRQ53(´IRUGHWDLOV 
 
4.2.7. Choice measurement 
Our measurement of choice is simple. As described previously, the participant 
received either caffeine or placebo for their first experimental training session, the 
treatment alternated thereafter. After the second experimental training session, ten 
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minutes post-exercise, the participant was asked whether they preferred the session they 
had just completed or the session they completed during their previous visit. This process 
was completed after each subsequent session, so they had the opportunity to choose 
(forced choice) between caffeine and placebo on 11 occasions throughout the course of 
the study.  
 
4.2.8. Statistical analyses  
Randomisation tests (Dugard et al., 2012) were used to assess for mean 
differences between treatments (Caffeine/Placebo) in the following parameters: RPE, FS, 
PS, and HR during training; BRUMS (fatigue and vigour subscales) scores from pre- and 
post-exercise; intrinsic and potential motivation pre-exercise; exercise enjoyment post-
exercise; exercise liking; and session RPE. For the variables measured during exercise 
(i.e., RPE, FS, PS, and HR) an aggregate of the scores reported at the end of each of the 
four high-intensity blocks was used as a single test value (for statistical analysis) from 
each session. For each of the randomisation tests, to test for statistical significance, mean 
values for each treatment condition were first calculated. The difference between these 
means was then obtained. These values provided the true experimental difference 
between treatments for the dependent variable. The randomised order of experimental 
treatments across the 12 visits represented one of many possible ways in which the 
treatment visits could have been arranged. Using a pre-designed macro (Dugard et al., 
2012) the raw data from the 12 experimental treatment visits was randomly rearranged 
2000 times to coincide with alternative visits in the original treatment allocation. For each 
of these 2000 rearrangements, only the raw data from treatment conditions was randomly 
rearranged with the allocated treatment order of the respective 12 experimental visits 
remaining the same. Specifically, this meant that the raw data for each visit was randomly 
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swapped between the allocated treatment visits 2000 times. Rearranging the raw data in 
proximity to the assigned visits in this manner permitted the calculation of a mean 
difference between treatment conditions for each of the 2000 treatment rearrangements. 
In order of magnitude from high to low, the true mean difference was then ranked 
amongst the 2000 mean differences that were obtained from the treatment 
rearrangements. Statistical significance was obtained if the mean difference for the 
experimental data was greater than 95% of the mean differences acquired from the 2000 
treatment rearrangements. Statistical significance was set at p  0.05 (one-tailed) and the 
data analyses were conducted using a specified macro (Dugard et al., 2012) in Microsoft 
Excel 2010. 
 
4.2.9. Choice analysis 
As with the measurement, the analysis is simple, taken from consumer research 
where this choice paradigm is used often ± WHUPHGµSUHIHUHQFHWHVWV¶ (Cochrane et al., 
2005). A score of 1 was given for each choice made in preference for caffeine, and 0 for 
placebo. Using the number of "successes" (i.e., how many times caffeine was preferred), 
and the number of trials per experiment (i.e., the total number of choice opportunities), a 
sign-test was performed (http://graphpad.com/quickcalcs/binomial1/), assuming the 







4.3.1. Effects of caffeine on acute perceptual and HR responses to HIIT 
In a randomisation test of the prediction that caffeine consumption would produce 
lower ratings of RPE during HIIT than placebo consumption, from a random sample of 
2000 rearrangement statistics 1.89% were at least as large as our experimental value. This 
is less than 5% - meaning that caffeine consumption significantly reduced RPE during 
exercise (Figure 4.2.). Furthermore, FS ratings were significantly higher (Figure 4.1.), 
and PS scores were significantly lower (Figure 4.3.) during HIIT in the caffeine condition 
compared to the placebo condition, with only 1.70%, and 1.39% of the samples, 
respectively, from the randomisation tests being as large as our experimental value. 
Furthermore, there was no significant difference in mean heart rate during HIIT between 
conditions with 30.93% of samples being at least as large as our experimental value. With 
the participant obtaining a mean heart rate of 168 ± 2 beats·miní in the placebo condition, 


















Figure 4.1. Effects of caffeine consumption (3 mgÂkg), or placebo, on feeling scale scores during HIIT. 
µHigh¶ 2-minutes at an exercise intensity corresponding to 80±90% of 9%cO2max; µWarm¶µLow¶and µCool¶
= 5- 3- and 3-minutes respectively at an exercise intensity corresponding to 50±60% of 9%cO2max. Data are 
presented as mean (± SD). Statistics were derived from an aggregate of the scores reported at the end of 
each of the four four-minute high-LQWHQVLW\ SHULRGV LH WKH VHFRQG LQ HDFK SDLU RI µ+LJK¶ WLPHSRLQWV
corresponding to minute 9, 16, 23, and 30 (see general methods section 3.3. for full details of the protocol).* 














Figure 4.2. Effects of caffeine consumption (3 mgÂkg), or placebo, on the perception of effort experienced 
during HIIT. µHigh¶ 2-minutes at an exercise intensity corresponding to 80±90% of 9%cO2max; µWarm¶
µLow¶and µCool¶ - 3- and 3-minutes respectively at an exercise intensity corresponding to 50±60% of 
9%cO2max. Data are presented as mean (± SD). Statistics were derived from an aggregate of the scores reported 
at the end of each of the four four-minute high-LQWHQVLW\SHULRGVLH WKHVHFRQG LQHDFKSDLURIµ+LJK¶
timepoints), corresponding to minute 9, 16, 23, and 30 (see general methods section 3.3. for full details of 











Figure 4.3. Effects of caffeine consumption (3 mgÂkg), or placebo, on exercise-induced muscle pain 
experienced during HIIT. µHigh¶ 2-minutes at an exercise intensity corresponding to 80±90% of 9%cO2max; 
µWarm¶µLow¶and µCool¶ - 3- and 3-minutes respectively at an exercise intensity corresponding to 50±
60% of 9%cO2max. Data are presented as mean (± SD). Statistics were derived from an aggregate of the scores 
reported at the end of each of the four four-minute high-intensity periods (i.e., the second in each pair of 
µ+LJK¶WLPHSRLQWVFRUUHVSRQGLQJWRPLQXWH and 30 (see general methods section 3.3. for full 































Figure 4.4. Effects of caffeine consumption (3 mgÂkg), or placebo, on heart rate during HIIT. µ+LJK¶ -
minutes at an exercise intensity corresponding to 80±90% of 9%cO2max; µWarm¶µLow¶and µCool¶ - 3- 
and 3-minutes respectively at an exercise intensity corresponding to 50±60% of 9%cO2max. Data are presented 
as mean (± SD). Statistics were derived from an aggregate of the values recorded at the end of each of the 
four four-minute high-LQWHQVLW\SHULRGVLHWKHVHFRQGLQHDFKSDLURIµ+LJK¶WLPHSRLQWVFRUUHVSRQGLQJ











4.3.2. Effects of caffeine on psychological parameters pre-HIIT 
Randomisation tests between conditions immediately prior to exercise initiation 
revealed no significant differences for either the fatigue or vigour subscales of the 
BRUMS (Figure 4.5. A & B respectively). Similarly, there was no significant difference 
between conditions for potential motivation (Figure 4.6. D); however, caffeine 
consumption resulted in significantly higher ratings of intrinsic motivation (Figure 4.6. 
C), with only 3% of samples from the randomisation tests being as large as our 
experimental value.  
 
Figure 4.5. Effects of caffeine consumption (3 mgÂkg) or placebo on pre- and post-training mood-state. (A) 
displays scores from the fatigue subscale of the Brunel Mood Scale (BRUMS). (B) displays scores from 
the vigour subscale of the BRUMS. Data are presented as mean (± SD). (crucifix symbol) indicates a trend 
for a difference between conditions (p < 0.1) * Indicates a significant difference between conditions (p < 
0.05). 
 
4.3.3. Effects of caffeine on psychological parameters post-HIIT 
Randomisation tests between conditions following the cessation of exercise 
revealed a trend for fatigue scores being lower in the caffeine condition than in the 
placebo condition, with 6.2% of samples from the randomisation tests being as large as 
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our experimental value. Vigour scores were significantly higher in the caffeine condition 
than in the placebo condition - with 4.5% of samples from the randomisation tests being 
at least as large as our experimental value. Similarly, caffeine produced a significant 
positive effect on exercise enjoyment and session RPE (Figure 4.6. A & B respectively). 
Enjoyment scores were higher, and session RPE scores were lower in the caffeine 
condition, with 1.3%, and 1.85% of samples from the randomisation tests being at least 
as large as our experimental value respectively.  
Figure 4.6. Effects of caffeine consumption (3 mgÂkg), or placebo, on psychological responses to HIIT. 
(A) displays post-exercise session RPE scores. (B) displays post-exercise Physical activity Enjoyment Scale 
(PACES) scores. (C) displays scores from the intrinsic motivation subscale of the Dundee Stress-State 
Questionnaire (DSSQ). (D) displays scores from the potential motivation item of the DSSQ. Data are 
presented as mean (± SD). * Indicates significant difference between conditions (p < 0.05). 
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3.3.3. Effects of caffeine on choice behaviour 
Of the 11 preference tests (i.e., the total number of choice opportunities) the 
number of "successes" (i.e., how many times caffeine was preferred), was ten. Which a 
sign-test revealed to be significant (p = 0.006). This suggests there is a significant 









Figure 4.7. Effects of caffeine consumption (3 mgÂkg), or placebo, on physical activity choice. The chart 
segment represents the distribution of preference for caffeine and placebo respectively. * Indicates 














The purpose of this study was to conduct a preliminary test of the hypothesis that 
caffeine administration would facilitate HIIT by reducing the perception of effort and 
discomfort. The primary aim of our study was to investigate whether caffeine engaged 
the putative target during HIIT. The secondary aim was to determine if the effect of 
caffeine on perceptual responses to HIIT are associated with changes in exercise 
behaviour, as determined by our novel exercise choice paradigm. The findings of this 
study largely support our hypotheses. Caffeine consumption reduced the perception of 
effort reported acutely during exercise, as well as session RPE ± which represents the 
perception of effort associated with a training session overall. The participant reported 
more positive affect and enjoyment during exercise, as well as a reduction in exercise-
induced muscle pain when training in the caffeine condition. Further, it seems caffeine 
consumption may also be improving mood state. The participant reported higher pre-
training intrinsic motivation; higher vigour reported post-training, and there was a trend 
for a reduction in self-reported fatigue post-training in the caffeine condition. 
Importantly, in our preference tests, caffeine was chosen significantly more often than 
placebo, providing the first empirical evidence that the acute perceptual effects of caffeine 
consumption are associated with changes in physical activity behaviour. 
The ability of caffeine to manipulate psychological variables is well established 
(A. Smith, 2002). In agreement with prior research in athletic and physically active 
populations (Doherty & Smith, 2005; Schubert et al., 2014), we found caffeine also 
attenuated RPE during exercise in a sedentary participant. This is also consistent with a 
study conducted with sedentary participants, where perception of effort following 3 
PJÂNJFDIIHLQHZDVOower during steady-state exercise only in women (Schrader et al., 
2013). As this study exclusively tested one female participant it is still unclear whether 
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the effect of caffeine on perception of effort is also prevalent in sedentary men. Exercise-
induced muscle pain (PS) was also lower in the caffeine condition, which is consistent 
with previous work (Gliottoni et al., 2009; Gliottoni & Motl, 2008; Motl et al., 2003). 
We also observed improved affect (FS: pleasure/displeasure) which is in 
agreement with a prior study in endurance-trained men (Backhouse et al., 2011) and 
recreationally active participants (Schubert et al., 2014). Schrader and colleagues (2013) 
previously reported, using Likert scales, that caffeine supplementation increased µliking¶ 
of physical activity in sedentary women after two weeks of caffeine paired with 30 min 
RI PRGHUDWH SK\VLFDO DFWLYLW\ ([HUFLVH µOLNLQJ¶ ZDV QRW PHDVXUHG KHUH WKXV GLUHFW
comparisons with Schrader and colleagues' (2013) paper are not possible, however, the 
present study extended these findings by showing that caffeine supplementation improved 
the enjoyment of HIIT in a sedentary female. This is also consistent with the findings 
from a study (Schubert et al., 2014) which utilised the same relative caffeine dose (3 
PJÂNJ but during sub-maximal exercise in recreationally active participants. It has been 
reported that both pleasure and enjoyment are associated with exercise participation and 
compliance (Ekkekakis et al., 2011). Considering that HIIT is associated with eliciting 
high effort and increase discomfort and displeasure (Biddle & Batterham, 2015; 
Hardcastle et al., 2014), together, these findings are very promising indeed.  
Despite the changes to perceptual responses, elicited by caffeine, there is no 
difference in HR, which was the only objective physiological measure included in this 
study. This is not surprising as the metabolic effects of caffeine at this relatively low dose 
is not entirely clear. There are studies demonstrating that a dose of PJÂNJ can produce 
an ergogenic effect, with no changes in exercise heart rate (e.g., Graham & Spriet, 1995) 
but higher doses (PJÂNJ) are associated with increased HR. Whilst there are studies 
demonstrating that despite no changes in HR, energy expenditure at rest and during 
75 
 
moderate intensity exercise are increased IROORZLQJDPJÂNJGRVHRIFDIIHLQH(Schubert 
et al., 2014). Therefore, it is possible that HR is not sensitive enough to capture any 
metabolic effects of caffeine at this dose.  
There were no differences in ratings of fatigue, or vigour (BRUMS) prior to HIIT 
which is not surprising as it has been suggested that mood effects occur after changes in 
performance (Rusted, 1999), or in this case, after HIIT. Whilst it is typical to see 
significant changes in alertness, energy, fatigue at rest only with relatively high doses (A. 
Smith, 2002), which may account for the absence of an effect here. An alternative 
explanation is that positive mood changes may be masked by increases in negative mood 
immediately prior to HIIT, such as anxiety, which can be exacerbated by caffeine (A. 
Smith, 2002), or anticipation of exercise-related effort and discomfort. A similar dose of 
caffeine (200 mg) has been shown to increase vigour and decrease fatigue (POMS) 
following a visual vigilance task (Olson et al., 2010). Which is consistent with the fact 
that vigour scores were significantly higher in the caffeine after HIIT and there was a 
trend for lower ratings of fatigue in the present study.  
The increase in intrinsic motivation here was not necessarily predicted. Rather the 
motivation scales were included, primarily, to quantify potential motivation as it is an 
essential component of MIT. MIT (Brehm & Self, 1989; Richter et al., 2016; Wright, 
2008) suggests that task disengagement occurs when either the effort required by a task 
exceeds potential motivation (i.e., maximum effort the participant is willing to exert to 
succeed in the exercise task) or, when an individual perceives the exercise to be 
impossible (i.e., said individual feels as though they have already exerted a true maximal 
effort and therefore can no longer continue). Within the limit of what an individual 
perceives to be possible, an increase in potential motivation will improve exercise 
tolerance (Marcora et al., 2008). It was assumed that caffeine would elicit its effect on 
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task engagement but reducing the relative perceived effort, rather than by acting directly 
on motivational factors. This is partially true as there is no difference in potential 
motivation scores. However intrinsic motivation is significantly higher after caffeine 
ingestion but prior to HIIT. There is a growing body of evidence implicating dopamine 
in motivational factors which was collated in a recent review on the neuroscience of 
intrinsic motivation (Di Domenico & Ryan, 2017), putting forward the initial working 
hypothesis that dopamine is a key substrate of intrinsic motivation. Briefly, like intrinsic 
motivation, dopamine is associated with increased positive affect, cognitive flexibility, 
creativity (Ashby, Isen, & Turken, 1999), behavioural persistence (Salamone & Correa, 
2012), and exploration in the face of novelty (DeYoung, 2013). There is also some 
evidence of a direct link between intrinsic motivation and dopamine. Using positron 
emission tomography, de Manzano and colleagues (2013) found that people who are 
disposed to experience intrinsically motivated flow states in their daily activities have 
greater dopamine D2-receptor availability in striatal regions, particularly the putamen. 
7KLVILQGLQJVXJJHVWVWKDWSHRSOH¶VFDSDFLWLHVIRU intrinsic motivation are associated with 
the number of targets within the striatum for dopamine to act upon. More recently, 
Gyurkovics and colleagues (2016) found that carriers of a genetic polymorphism that 
affects striatal D2-receptor availability were more prone to experience flow during study- 
and work-related activities. There is considerable evidence of cellular interactions 
between dopamine D2 and adenosine A2A receptors (Ferré, Fredholm, Morelli, Popoli, 
& Fuxe, 1997; Fink et al., 1992; Fuxe et al., 2003; Hillion et al., 2002). Therefore, as 
caffeine acts primarily on A2A receptors it is reasonable to suppose that caffeine, through 
an interaction between A2A and D2 receptors is eliciting an effect on intrinsic motivation. 
This study is the first to observe a relationship between intrinsic motivation and caffeine 
consumption, and as intrinsic motivation is thought to facilitate long-term adherence to 
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physical activities (Ryan, Fredrick, Lepes, Rubio, & Sheldon, 1997), this is an exciting 
finding and certainly warrants further investigation. 
The first study to measure post-exercise session RPE following caffeine ingestion 
was Killen and colleagues (2013), which demonstrated that session RPE, recorded 30-
minutes after completing 40-minutes moderate intensity cycling, was significantly lower 
in the caffeine condition compared to placebo. In the present study, we extend this to 
show that session RPE is also lower following caffeine, compared to placebo, when 
recorded 10-minutes post-exercise. Session RPE has been shown to be consistent whether 
measured 10- or 30-minutes post-exercise in boxing (Uchida et al., 2014), and now 
following HIIT, which is a more practical time-frame to be adopted by future studies.  
Importantly, in our preference tests, caffeine was chosen significantly more often 
than placebo providing the first empirical evidence that the acute perceptual and 
psychological effects of caffeine consumption are associated with changes in physical 
activity behaviour.  
 
4.4.1. Limitations 
Clearly, the present study is limited by the fact that a single-subject design was 
used, which although able to maintain the internal validity of traditional groups trials such 
as experimental design and randomisation to conditions (Craig et al., 2013), does 
inherently lack external validity. This preliminary single-subject study warrants further 
investigation with a group trial. 
We have demonstrated that changes in behaviour are associated with target 
engagement, that is, changes in feelings during exercise. However, with the current data, 
it is not possible to establish which specific putative target, or targets, determine changes 
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in choice behaviour. For example, the perception of effort (RPE) and affect (FS) are 
distinct constructs, but negatively related to one another (Hardy & Rejeski, 1989). It is 
likely that many of the other putative targets, which have been measured in this study, are 
also inter-related. As caffeine appears to elicit significant changes in several of these 
variables it is important to establish which of the variables is the primary determining 
factor. 
An evaluation of the limitations which are shared between this study and those 
presented in the following two experimental chapters will be provided in the Human 
Discussion (chapter 7). 
 
4.4.2. Conclusion 
In this study, we demonstrated for the first time that caffeine is effective at 
facilitating HIIT in a sedentary participant. Further, this is the first experimental evidence 
demonstrating that pharmacological intervention can influence physical activity choice 
behaviour by manipulating feelings during and around exercise training. These 
preliminary findings provide a valuable contribution to the field and warrant further 







5. The effects of caffeine on feelings during exercise and choice 





High-intensity interval training (HIIT) has been suggested as an effective exercise 
strategy for its time efficiency and ability to produce rapid improvements in physical 
fitness (Rognmo et al., 2004; Wisloff et al., 2007). However, although the rewards of 
HIIT can be great, so can the costs, as it requires substantial effort and discomfort 
(Hardcastle, Ray, Beale, & Hagger, 2014; Biddle & Batterham, 2015). In the previous 
chapter (4. Single-subject trial), we demonstrated the use of caffeine to facilitate HIIT by 
reducing the perception of effort and discomfort. In the study detailed in this chapter, a 
group study design was employed to build upon these preliminary findings.  
To test Path D (Figure 1.1.) of the experimental medicine approach to behaviour 
change an investigation needs to be able to determine whether an intervention changes 
physical activity behaviour via their effects on specified ³SXWDWLYH´targets. Therefore, the 
primary aim of this study was to corroborate whether the effect of caffeine on 
psychological responses to HIIT are associated with changes in exercise behaviour, as 
determined by choice. A secondary aim is to understand the mechanisms explaining 
exercise choice behaviour by employing a qualitative explanatory analysis.  
As with the single-subject experiment presented in the previous chapter, the 
SULPDU\ K\SRWKHVLV ZDV WKDW FDIIHLQH ZRXOG HOLFLW DQ LQFUHDVH LQ DIIHFW µOLNLQJ¶
enjoyment, and vigour; a decrease in perception of effort, exercise-induced muscle pain, 
and fatigue; despite no differences in motivation or HR. The secondary hypothesis was 
that there would be a significant preference for HIIT in the caffeine condition. 
Additionally, the question: which putative target is the strongest determinant of behaviour 
change? will be investigated. As there is no current literature that has addressed this 





Ten physically inactive, but otherwise healthy, adults (see tables 5.1., and 5.2.) 
volunteered to take part in the study. Participants were previously sedentary (i.e., 
relatively inactive), defined here as a score of < 4 and with  2 on both items of the 
Occupational and Spare-Time Physical Activity Questionnaire (OSTPAQ ± Appendix B) 
(Saltin & Grimby, 1968), and with low or moderate habitual caffeine intake (<400 
mgÂkgÂday), which was estimated using the Caffeine Consumption Questionnaire (CCQ 
± Appendix C) (Landrum, 1992). The study was approved by the SSES ethics committee, 
at the University of Kent. Participants provided informed consent and completed a 
standard medical health questionnaire (Appendix A) to confirm their present state of 
health. Participants were given an overview, detailing all procedures and requirements of 
the study and were informed that the study was testing the effect of two different 
substances (either tyrosine, or beta-alanine), in combination with caffeine, on 
physiological and psychological responses to HIIT ± when in fact they received either 
caffeine alone, or placebo. Consequently, the participants were naive to the true aims and 
hypotheses of this study until the final session was complete, at which point they were 
debriefed about its genuine rationale (see General Human Methods section 3³&DIIHLQH
GHFHSWLRQ´IRUGHWDLOV 
Table 5.1. Participant demographic information. n = 10. 
Variable: Mean SD 
Age (years) 33 12 
Sex (Males/Females) 2/8 NA 
Height (cm) 168.4 6.59 
Mass (kg) 79.87 23.71 
Recreational Physical Activity (1-4) 1.7 (0.48) 
Occupational Physical Activity (1-4) 1.3 (0.48) 
Habitual Caffeine Consumption (mgÂday) 188 (141.79) 
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5.2.2. Exercise regulation and motivation 
Participant completed the Behavioural Regulation in Exercise Questionnaire 
(BREQ-2) (see Appendix D) during session 1 and session 11 (the first and last sessions). 
The BREQ-2 is a 19-item self-report measure developed by Markland and Tobin, (2004) 
to assess exercise regulations consistent with Self Determination Theory (SDT). The 
questionnaire includes subscales that measure external, introjected, identified, and 
intrinsic regulation of exercise behaviour. It also includes a subscale for amotivation. 
Sample items characterising subscale are: "I don't see the point in exercise (Amotivation; 
4 items); "I exercise because other people say I should" (External Regulation; 4 items); 
"I feel guilty when I don't exercise" (Introjected Regulation; 3 items); "I value the benefits 
of exercise" (Identified Regulation; 4 items); "I enjoy my exercise sessions" (intrinsic 
Regulation; 4 items). In answer to the question "why do you exercise" participants 
respond to each item on a 5-point Likert-type scale anchored by (0) "not true for me" and 
(4) "very true for me.). 
 
5.2.3. Experimental design 
The experiment was a double-blind fully repeated measures cross-over design, in 
which participants visited the laboratory on 11 occasions. Visits 1 and 11 involved a 
treadmill-based incremental test, visits 2-4 served as familiarisation, with visits 5-10 
comprising the six experimental visits. Experimental visits encompassed a crossover 
design in which the participants were allocated to three visits for each of the two 
experimental treatment conditions (caffeine vs. placebo). The treatment received for the 
first visit was randomised, though the treatment for the remaining five visits was 
alternated to maximise the number of choice pairs.  
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5.2.4. Caffeine dose and deception 
For experimental sessions, participants received either caffeine (3 mgÂkg) or 
placebo (dextrose monohydrate) in a single capsule. A deception was used to minimise 
the impact of the participantV¶ familiarity with caffeine. For further details on drug 
administration and the deception see General Human Methods section 3³&DIIHLQHDQG
SODFHERFDSVXOHVDQGDGPLQLVWUDWLRQ´DQGVHFWLRQ3³&DIIHLQHGHFHSWLRQ´respectively. 
 
5.2.5. Procedures  
During visit 1, a treadmill-based incremental test was completed to establish 
9%cO2max ± from which subsequent training intensities were determined. See General 
Human Methods section 3.3. ³Determination of maximal oxygen uptake (9%cO2max)´for 
details. As shown in Figure 5.1. this test was repeated during session 11. During sessions 
2 ± 10 the participants completed HIIT (see General Human Methods section 3³+,,7
SURWRFRO´ for details) 2-3 times per week for 3-4 weeks (until 3 familiarisation and 6 
experimental sessions had been completed). The participants were instructed not to add 
any leisure exercise during the study period. 
 
 




5.2.6. Acute perceptual and HR responses to HIIT 
During each of the HIIT sessions (visits 2 ± 10) perception of effort, affective 
valence, exercise-induced muscle pain, and HR responses were recorded throughout. See 
General Human Methods section 3³0HDVXULQJDFXWHSHUFHSWXDODQG+5UHVSRQVHVWR
+,,7´IRUGHWDLOV 
 
5.2.7. Psychological questionnaires immediately before and/or after HIIT 
Participants completed the fatigue and vigour subscales of the Brunel Mood Scale 
(BRUMS) immediately before and after HIIT. Scales for intrinsic motivation (IM), 
success motivation (SM), and potential motivation (PM) were complete before HIIT only. 
Whilst self-reported exercise enjoyment was measured immediately post HIIT only, using 
the PACES. See General Human Methods sections 3³0RRG-VWDWHDURXQG+,,7´3.7. 
³7DVN+,,7PRWLYDWLRQ´DQG3³([HUFLVHHQMR\PHQW´IRUGHWDLOV  
 
5.2.8. Psychological measures taken 10-minutes post-exercise 
Ten minutes post-exercise, whole session RPE was recorded using the Borg 
(1970) 6-20 scale, representing a single global rating of the intensity for the entire training 
session. See General Human Methods section 3³6HVVLRQ53(´IRUGHWDLOV Liking of 
SK\VLFDODFWLYLW\ZDVWKHILQDOSV\FKRORJLFDOPHDVXUHWDNHQGXULQJWKLVSHULRGµ/LNLQJ¶
was assessed on a 5-SRLQW/LNHUWVFDOHDQFKRUHGE\³QRWDWDOO´DQG³H[WUHPHO\´
This measure has been used previously with the same purpose in a physical activity 




5.2.9. Measuring and understanding exercise-related choice 
Using a sequential explanatory mixed-method approach both quantitative and 
qualitative data are used to measure and understand exercise-related choice. Our 
measurement of choice is simple. As described previously, the participant received either 
caffeine or placebo for their first experimental training session, the treatment alternated 
thereafter. After the second experimental training session, ten minutes post-exercise, 
participants were asked whether they preferred the session they had just completed or the 
session they completed during their previous visit. This process was completed after each 
subsequent session, so they had the opportunity to choose (forced choice) between 
caffeine and placebo on 5 occasions throughout the course of the study. In order to 
XQGHUVWDQGSDUWLFLSDQWV¶FKRLFHEHKDYLRXURnce they had made their decision, on each 
choice occasion, participants were asked: ³ZK\"´7KLVTXHVWLRQZDVSXUSRVHIXOO\µRSHQ¶
WRFDSWXUHWKH³XQGLJHVWHGFRPSOH[LW\RIUHDOLW\´(Patton, 2002 p. 463). 
 
 
5.2.10. Statistical analyses  
Means and standard deviations for descriptive characteristics of participants were 
calculated and paired samples T-tests were performed to determine whether significant 
changes occurred over the course of the study for BMI, 9%cO2max, and each of the five 
exercise motivation sub-scales from the BREQ-2. Subjective responses between 
conditions from pre-trial only (IM, SM, and PM), or post-trial only (µ/LNLQJ¶6HVVLRQ
RPE, and PACES) questionnaires were compared using a paired samples T-test for each 
dependent measure. Separate 2-way (condition/time) repeated measures ANOVAs were 
used for between trial comparisons of pre-post subjective responses to fatigue and vigour 
sub-scales of the BRUMS. Further, separate 2-way Condition (caffeine, or placebo) x 
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Time (9, 16, 23, 30 min) repeated measures ANOVAs were used for between trial 
comparisons of perceptual (RPE, FS, and PS) and HR responses during HIIT. The 
Shapiro-Wilk's test of normality on the studentised residuals was performed for all 
variables. Where sphericity was violated the degrees of freedom were corrected with the 
Greenhouse±*HLVVHUİ (Maxwell & Delaney, 2004). When necessary, a Bonferroni post-
hoc procedure was used for follow-up comparisons. When 2-way repeated measures 
$129$¶V revealed a significant interaction between condition and time, simple main 
effects were run. (IIHFWVL]HVIRUUHOHYDQWFRPSDULVRQVZHUHFDOFXODWHGXVLQJ&RKHQ¶VG
and defined as trivial (< 0.30), small ( 0.3), moderate ( 0.5), and large ( 0.8), 
respectively (Cohen, 1992). Results were considered significant at p  0.05. All tests were 
carried out using IBM SPSS Statistics for Windows, Version 24.0. (Armonk, NY: IBM 
Corp). 
 
5.2.11. Quantitative analysis and qualitative explanation of exercise-related choice 
As with its measurement, the quantitative analysis is simple, taken from consumer 
research where this choice paradigm is often used ± UHIHUUHG WR DV µSUHIHUHQFH WHVWV¶
(Cochrane et al., 2005). A score of 1 was given for each choice made in preference for 
caffeine, and 0 for placebo. A total score, between 0 (0%) (placebo was preferred at every 
choice opportunity) and 5 (100%) (caffeine was preferred at every choice opportunity) 
was determined for each participant. This score repUHVHQWVWKHµWHVWYDULDEOH¶8VLQJDRQH-
sample T-test (IBM SPSS Statistics for Windows, Version 24.0. (Armonk, NY: IBM 
Corp)), the test variable was compared to the test value, which was set at 2.5 (as it is half 
way between 0 and 5), representing a theoretical outcome where caffeine and placebo are 
chosen equally (i.e., in 50% of choice occasions). Preference is determined by whether 
the test variable is significantly different (S) to the test value. Responses to the 
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question "why?" a particular session was preferred were transcribed verbatim, from which 
a content analysis was carried out; which has been used previously, in a similar context, 
in an investigation seeking to explain LQGLYLGXDOV¶DIIHFWLYHUHVSRQVHVWRH[HUFLVH(Rose 
& Parfitt, 2007). Quotes were analysed for patterns and meaning and organised into 
themes. Subsequently, themes were combined into larger higher-order categories. To 
ensure validity and reliability in the data, two researchers independently identified the 
emergent themes and following discussions established a set of common themes (Patton, 
2002). Direct quotes are provided from the participants so that readers can experience for 









5.3.1. Participant characteristics 
Comparing participant characteristic pre and post HIIT (table 5.2.), there was no 
mean change in BMI, with a mean difference of .000 (95% CI, -.311 to .311) kg/m2, 
which was not statistically significant t(9) = .000, p = 1.000, d = .000. Whilst 9%cO2max 
increased, with a mean difference of 1.250 (95% CI, -.0451 to 2.545) ml·kgí1 ·  miní1, 
and a moderate effect size, the change was not statistically significant, t(9) = 2.183, p = 
.057, d = .690. 
Table 5.2. Participant characteristics before and after completing nine HIIT sessions. n = 10. 
 Pre-HIIT Post-HIIT P 
Value 
 M SD M SD  
Body Mass Index (kg/m2) 27.92 (7.12) 27.92 (6.97) 1.000 
9%cO2max (ml·kgí ·  miní) 32.6 (5.23) 33.85 (3.95) .057 
 
5.3.2. Exercise Motivation - Behavioural Regulation in Exercise Questionnaire (BREQ-2) 
There was no change in self-reported amotivation from session 1 to session 11. A 
correlation and t could not be computed because the standard error of the difference was 
0. There was also no change in self-reported external regulation, with a mean difference 
of .000 (95% CI, -.612 to .612), which was not significant, t(7) = .000, p = 1.000, d = 0. 
There was a non-significant increase in identified regulation t(7) = 1.528, p = .170, d = 
.540, and in intrinsic regulation t(7) = .403, p = .699, d = .143, with mean differences of 
.250 (95% CI, -.137 to .637), and .063 (95% CI, -.304 to .429) respectively. Whilst 
introjected regulation was statistically significantly higher in session 11 than it was in 
session 1, with a mean difference of .500 (95% CI, .053 to .947), t(7) = 2.646, p = .033, 




Figure 5.1. Exercise motivation at the start of the study (session 1) and at the end (session 11). Variables 
are derived from the Behavioural Regulation in Exercise Questionnaire (BREQ-2). * represents a 
significant difference between time-points p  .05. n = 8. 
 
5.3.3. Task Motivation - Dundee Stress State Questionnaire (DSSQ) pre-HIIT 
Success Motivation (SM) was .095 (95% CI, -.015 to .205), higher for caffeine 
sessions that it was for placebo sessions. Though there was a moderate effect size, this 
mean difference is not statistically significantly different, t(9) = 1.951, p = .083, d = .617. 
Intrinsic Motivation (IM) was .099 (95% CI, -.120 to .318), higher for caffeine sessions 
than it was for placebo sessions, with a small effect size. This mean difference was also 
not statistically significant, t(9) = 1.024, p = .332, d = .324. Finally, caffeine elicited a 
mean change of .033 (95% CI, -.230 to .296), on Potential Motivation (PM). A difference 





Figure 5.2. Effects of caffeine consumption (3 mgÂkg), or placebo, on task motivation prior to HIIT. IM = 
Intrinsic Motivation; SM = Success Motivation; PM = Potential Motivation. Values are presented as Mean 
(± SD) and are derived from the Dundee Stress State Questionnaire (DSSQ). n = 10. 
 
5.3.4. Heart rate responses during HIIT 
There was no statistically significant main effect of condition, showing that there 
is no difference in HR responses to HIIT between the caffeine and placebo sessions, F(1, 
9) = 0.066, p = .804. With a mean difference of .108 (95% CI, -.850 to 1.066). The main 
effect of time showed that there was a statistically significant increase in HR over 
time, F(1.194, 10.745) = 68.878, p < .00İ  Changes in HR responses over time 
were not dependent on which condition participants were in, as there was no statistically 




Figure 5.3. displays the effect of caffeine consumption (3 mgÂkg) or placebo, on acute heart rate (HR) 
responses to HIIT. µHigh¶   2-minutes at an exercise intensity corresponding to 80±90% of 9%cO2max; 
µWarm¶µLow¶and µCool¶ - 3- and 3-minutes respectively at an exercise intensity corresponding to 50±
60% of 9%cO2max. Data are presented as mean values with error bars representing the SD. Statistics were 
derived from a 2-way Condition (caffeine, or placebo) x Time repeated measures ANOVA. Only the data 
recorded at minutes 9, 16, 23, and 30 were included in the analysis, which correspond to the end of each of 
the four four-minute high-intensity periods (i.e., the second iQHDFKSDLURIµ+LJK¶WLPHSRLQWVVHHJHQHUDO
PHWKRGVVHFWLRQIRUIXOOGHWDLOVRI WKHSURWRFRO,QGLFDWHVDVLJQLILFDQWPDLQHIIHFWRI WLPHS
0.001. n = 10. 
 
5.3.5. Perceptual responses during HIIT ± Rating of perceived exertion 
The main effect of condition showed that RPE responses to HIIT in the caffeine 
condition were statistically significantly lower than those in the placebo condition, F(1, 
9) = 10.743, p = .010. With a mean difference of .763 (95% CI, .236 to 1.289). The main 
effect of time showed that there was a statistically significant change in RPE responses 
over time, F(3, 27) = 8.261, p < .001. Changes in RPE responses over time were not 
dependent on condition, as there was no statistically significant two-way interaction 




Figure 5.4. displays the effect of caffeine consumption (3 mgÂkg) or placebo, on acute rating of perceived 
exertion scale (RPE) responses to HIIT, used here to measure the perception of effort. µHigh¶ 2-minutes 
at an exercise intensity corresponding to 80±90% of 9%cO2max; µWarm¶µLow¶and µCool¶ - 3- and 3-
minutes respectively at an exercise intensity corresponding to 50±60% of 9%cO2max. Data are presented as 
mean values with error bars representing the SD. Statistics were derived from a 2-way Condition (caffeine, 
or placebo) x Time repeated measures ANOVA. Only the data recorded at minutes 9, 16, 23, and 30 were 
included in the analysis, which correspond to the end of each of the four four-minute high-intensity periods 
LHWKHVHFRQGLQHDFKSDLURIµ+LJK¶WLPHSRLQWVVHHJHQHUDOPHWKRGVVHFWLRQIRUIXOOGHWDLOVRIWKH
SURWRFRO,QGLFDWHVDVLJQLILFDQWPDLQHIIHFWRIFRQGLWLRQS,QGLFDWHVDVLJQLILFDQWPDLQHIIHFW
RIWLPHS001. n = 10.  
5.3.6. Perceptual responses during HIIT ± Affective valence 
The main effect of condition showed that FS responses to HIIT in the caffeine 
condition were statistically significantly higher than those in the placebo condition, F(1, 
9) = 9.478, p = .013. With a mean difference of .625 (95% CI, .166 to 1.084). The main 
effect of time showed that there was a statistically significant decrease in FS responses 
over time, F(1.171, 10.538) = 4.704, p = .050İ  Changes in FS responses over 
time were not dependent on which condition participants were in, as there was no 
statistically significant two-way interaction between condition and time, F(1.649, 14.841) 




Figure 5.5. displays the effect of caffeine consumption (3 PJÂNJ) or placebo, on acute feeling scale (FS) 
responses, which represent how µgood¶ or µbad¶ one feels, to HIIT. µHigh¶   2-minutes at an exercise 
intensity corresponding to 80±90% of 9%cO2max; µWarm¶ µLow¶ and µCool¶   - 3- and 3-minutes 
respectively at an exercise intensity corresponding to 50±60% of 9%cO2max. Data are presented as mean 
values with error bars representing the SD. Statistics were derived from a 2-way Condition (caffeine, or 
placebo) x Time repeated measures ANOVA. Only the data recorded at minutes 9, 16, 23, and 30 were 
included in the analysis, which correspond to the end of each of the four four-minute high-intensity periods 
LHWKHVHFRQGLQHDFKSDLURIµ+LJK¶WLPHSRLQWVVHHJHQHUDOPHWKRGVVHFWLRQIRU full details of the 
SURWRFRO,QGLFDWHVDVLJQLILFDQWPDLQHIIHFWRIFRQGLWLRQS,QGLFDWHVDVLJQLILFDQWPDLQHIIHFWRI
WLPHSQ   
5.3.7. Perceptual responses during HIIT ± Exercise-induced muscle pain 
There was no statistically significant main effect of condition, showing that there 
is no difference in PS responses to HIIT between the caffeine and placebo sessions, F(1, 
9) = 2.546, p = .145. With a mean difference of -.229 (95% CI, -.554 to .096). The main 
effect of time showed that there was a statistically significant increase in PS responses 
over time, F(1.391, 12.515) = 5.112, p  İ . Changes in PS responses over 
time were not dependent on which condition participants were in, as there was not a 
statistically significant two-way interaction between condition and time, F(3, 27) = 




Figure 5.6. displays the effect of caffeine consumption (3 mgÂkg) or placebo, on acute muscle pain (PS) 
responses to HIIT. µHigh¶   2-minutes at an exercise intensity corresponding to 80±90% of 9%cO2max; 
µWarm¶µLow¶and µCool¶ - 3- and 3-minutes respectively at an exercise intensity corresponding to 50±
60% of 9%cO2max. Data are presented as mean values with error bars representing the SD. Statistics were 
derived from a 2-way Condition (caffeine, or placebo) x Time repeated measures ANOVA. Only the data 
recorded at minutes 9, 16, 23, and 30 were included in the analysis, which correspond to the end of each of 
the four four-minute high-intensity periods (i.e., the secoQGLQHDFKSDLURIµ+LJK¶WLPHSRLQWVVHHJHQHUDO
PHWKRGVVHFWLRQIRUIXOOGHWDLOVRIWKHSURWRFRO,QGLFDWHVDVLJQLILFDQWPDLQHIIHFWRIWLPHS
n = 10.  
 
5.3.8. Self-reported fatigue & vigour reported immediately pre- and post-HIIT 
The main effect of condition showed that self-reported fatigue (BRUMS sub-
scale) in the caffeine condition was statistically significantly lower than in the placebo 
condition, F(1, 9) = 7.606, p = .022. With a mean difference of -1.000 (95% CI, -1.820 to 
-.180). There was no main effect of time, showing that there was not a statistically 
significant change in self-reported fatigue from pre-HIIT to post-HIIT, F(1, 9) = 
1.298, p = .284. Differences in self-reported fatigue between the caffeine and placebo 
conditions were not dependent on time, as there was no statistically significant two-way 
interaction between condition and time, F(1, 9) = 1.784, p = .214. 
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The main effect of condition showed that self-reported vigour (BRUMS sub-
scale) in the caffeine condition was statistically significantly higher than in the placebo 
condition, F(1, 9) = 5.234, p = .048. With a mean difference of 1.083 (95% CI, .012 to 
2.155). The main effect of time showed that there was a statistically significant increase 
in self-reported vigour from pre-HIIT to post-HIIT, F(1, 9) = 14.995, p = .004. With a 
mean change of 3.583 (95% CI, 1.490 to 5.677). Changes in self-reported vigour were 
not dependent on whether participants were in the caffeine or placebo condition, as there 
was no statistically significant two-way interaction between condition and time, F(1, 9) 
= .054, p = .821. 
 
Figure 5.7. Effects of caffeine consumption (3 mgÂkg) or placebo on pre- and post-training mood-state. (A) 
displays scores from the fatigue subscale of the Brunel Mood Scale (BRUMS). (B) displays scores from 
the Vigour subscale of the BRUMS. Data are presented as mean values with error bars representing the SD. 
*Indicates a significant main effeFWRIFRQGLWLRQS,QGLFDWHVDVLJQLILFDQWPDLQHIIHFWRIWLPHS
0.01. n = 10. 
 
5.3.9. Psychological responses post-HIIT ± 3$&(6µ/LNLQJ¶DQG6HVVLRQ53( 
PACES scores were, on average, 8.433 (95% CI, 2.441 to 14.426) higher 
immediately following HIIT in caffeine sessions than they were following placebo 
sessions. This mean difference has a large effect size and is statistically significant, t(9) 
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= 3.184, p = .011, d = 1.007. 5DWLQJVRIH[HUFLVHµ/LNLQJ¶VFRUHVZHUHRQDYHUDJH
(95% CI, .116 to .743) higher 10-minutes post-HIIT in caffeine sessions than they were 
following placebo sessions. This mean difference has a large effect size and is statistically 
significant, t(9) = 3.099, p = .013, d = -.980. Self-reported whole session RPE scores 
were, on average, -.900 (95% CI, -1.133 to -.667) lower 10-minutes post HIIT in caffeine 
sessions than they were following placebo sessions. This mean difference has a large 
effect size and is statistically significant, t(9) = -8.735, p < .001, d = -2.762. 
 
Figure 5.8. A. displays whole session ratings of perceived exertion (RPE) scores; B. exercise liking, which 
was measured using a single item Likert scale anchored by 0 - ³QRWDWDOO´DQG± ³YHU\PXFK´&3$&(6
is the physical activity enjoyment scales, a 17 item questionnaire measuring how much participants enjoyed 
each session ± higher scores suggest more enjoyment; and D. choice, this chart represents the percentages 
of choices in favour of caffeine or placebo sessions. *Indicates a significant main eIIHFWRIFRQGLWLRQS





5.3.10. Choice - preference test and content analysis 
The caffeine condition was preferred in 82 (19.889)% of the choice opportunities, 
with a mean 32 (95% CI, 17.772 to 46.227)% higher than the test value (a theoretical 
value representing equal preference), 50%, which demonstrates a highly significant 
preference for caffeine sessions, t(9) = 5.031, p = .001, d = 1.609. 
The contents analysis transcript, complete with colour coding to identify first-
order themes is available in Appendix L. A summary of the frequency of higher order 
theme occurrence is shown in Table 5.3. Following each replicated preference test, 
participants were asked why their chosen session was preferred. Participants were free to 
explain their reasoning and were not restricted in any way to the length of their answer, 
or the number of factors they could attribute their preference to. Nor were they explicitly 
asked to identify the most potent factor influencing their choice. On average, participants 
cited (M ± SD) 1.860 ± 0.997 different higher order themes in any given response. The 
highest number of themes cited in a single response was five. In the following statement 
(paUWLFLSDQW,7SUHIHUHQFHWHVW³Less pain today (pain), I felt good (affect), alert, 
and energetic (mood state). Less effort! (perception of effort) The end of the test felt like 
halfway through (time-related´ The factor most frequently attributed to determining 
choice was perception of effort, occurring in responses following 84 ± 16% of all 
preference tests. Affect, Pain, Mood state, and time-related factors occurred in 22 ± 37, 
22 ± 36, 18 ± 21, and 15 ± 20% of responses respectively, whilst factors relating to 






Table 5.3. Contents analysis summary. 
1st-order theme Higher order theme Occurrences 




Feeling Affect 22 ± 27% 
Enjoyment 
Exercise-induced pain Pain 22 ± 36% 





Time Time-related 15 ± 20% 
Monotony 










The primary aim of this study was to test whether the finding from the initial 
single-subject trial reported in chapter 4. Mainly, whether the effects of caffeine on 
psychological responses to HIIT are associated with changes in exercise behaviour, as 
determined by choice. A secondary aim was to understand the mechanisms explaining 
exercise choice behaviour by employing a qualitative explanatory analysis. It was 
K\SRWKHVLVHG WKDW FDIIHLQH ZRXOG HOLFLW DQ LQFUHDVH LQ DIIHFW µOLNLQJ¶ HQMR\PHQW DQG
vigour; a decrease in perception of effort, exercise-induced muscle pain, and fatigue; 
despite no differences in motivation or HR. The secondary hypothesis was that there 
would be a significant preference for HIIT in the caffeine condition. Additionally, this 
study sought to answer the following question: which putative target is the strongest 
determinant of behaviour change? The findings were largely in support of our hypothesis 
with caffeine once again eliciting positive perceptual and psychological responses before, 
during, and after HIIT. There are however a few instances where targets which were 
engaged in chapter 4 are not engaged here and vice versa. These will be identified and 
discussed throughout. Regarding the secondary aim of this study, to understand the 
mechanisms explaining exercise choice behaviour, our contents analysis revealed that 
perception of effort is the factor most frequently attributed to exercise choice in replicated 
preference tests. 
We revealed a trend for an increase in 9%cO2max, with a moderate effect size, at the 
end of the study (session 11) compared to the start (session 1). Although studies have 
reported significantly increased 9%cO2max after as few as six (Astorino, Allen, Roberson, & 
Jurancich, 2012) or eight (McKay, Paterson, & Kowalchuk, 2009) sessions in total, it 
should be noted that these studies used a more extreme form of SIT, which involved 
repeated 30-s (Astorino et al., 2012) or 60-s (McKay et al., 2009) sprint efforts on a cycle 
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ergometer. However, studies using AIT similar (Karstoft et al., 2013) or identical 
(Helgerud et al., 2007; Rognmo et al., 2004; Tjønna et al., 2008; Wisloff et al., 2007) to 
the protocol used in the present study have observed significant improvements in 9%cO2max 
after 24 (Helgerud et al., 2007), 30 (Rognmo et al., 2004), 36 (Wisloff et al., 2007), 48 
(Tjønna et al., 2008), or 80 (Karstoft et al., 2013) session over 8 ± 16 weeks. 
 Another measure that was included in this study which was independent of the 
pharmacological intervention, assessed once during session 1 and again during session 
11, was exercise motivation, using the BREQ-2 (Markland & Tobin, 2004). Sedentary 
PHQDQGZRPHQUHSRUWHGµOLNLQJ¶H[HUFLVHPRUHRYHUWLPHUHJDUGOHVVRf experimental 
condition (Schrader et al., 2013). If this is true liking/enjoying are both related to intrinsic 
motivation (Di Domenico & Ryan, 2017), which in turn is thought to be an important 
factor in determining long-term exercise adherence (Ryan et al., 1997). The implications 
of this are that continued engagement in an exercise training program may result in 
changes in exercise motivation. In this study we did not reveal any significant changes in 
amotivation, external regulation, identified regulation, or intrinsic regulation; however, 
introjected motivation was significantly higher at the end of the study (session 11) 
compared to the start (session 1). Introjected regulation underlies behaviour for those 
feeling compelled to take part in physical activity to avoid aversive feeling states (e.g., 
guilt over skipping a workout) or to experience ego-affirming states (e.g., pride in fitness) 
(Ersöz & Eklund, 2016). It is likely that longer time-frames are required for significant 
changes in intrinsic motivation, which would be desirable from a long-term adherence 
perspective (Gardner & Lally, 2013); however, the increase in introjected regulation 
observed here, over a relatively short period, is positive as it is conducive to habit forming 
behaviours (Gardner & Lally, 2013) which form through repeated performance in 
consistent settings (Lally, Van Jaarsveld, Potts, & Wardle, 2010). Future studies could 
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adopt a between-subject design to investigate whether changes in exercise regulation can 
be enhanced by caffeine. 
Consistent with findings from chapter 4, RPE was significantly lower during HIIT 
in the caffeine condition. This extends our current knowledge, demonstrating that RPE is 
reduced during exercise in sedentary women (chapter 4; Schrader et al., 2013) to include 
a mixed sample. There is not enough statistical power to determine whether there is a sex-
dependent effect of caffeine in the present study. However, there is little reason to doubt 
it as it is consistent with findings from studies in athletic and physically active populations 
(Doherty & Smith, 2005; Schubert et al., 2014), and the only evidence to suggest 
otherwise is from Schrader and colleagues' (2013) study, where RPE was not actually 
measured during exercise. 
We also observed improved affect (FS: pleasure/displeasure) during exercise, 
which is in agreement with chapter 4, as well as studies in endurance-trained (Backhouse 
et al., 2011) and recreationally active participants (Schubert et al., 2014). However, in 
direct conflict with chapter 4 and data published in the literature (Gliottoni et al., 2009; 
Gliottoni & Motl, 2008; Motl et al., 2003), there was no difference in PS responses to 
HIIT between the caffeine and placebo sessions in the present study. 
This is likely due to the small absolute effect, with average ratings between "Very 
faint pain" and "Weak pain" even during the final high-intensity periods, combined with 
relatively high variability (see mean plots and error bars in Figure 5.6.). The source of 
this variability may be due to the high variability in BMI in the present study (see table 
5.2.), indicated by a standard deviation of 7.12 kg/m2, as obesity can increase feelings of 
discomfort during exercise (Ekkekakis & Lind, 2006). 
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Schrader and colleagues (2013) previously reported, using Likert scales, that 
FDIIHLQHVXSSOHPHQWDWLRQLQFUHDVHGµOLNLQJ¶RISK\VLFDODFWLYLW\LQVHGHQWDU\ZRPHQDIWHU
two weeks of caffeine paired with 30 min of moderate physical activity. Although not 
measured in chapter 4, e[HUFLVHµOLNLQJ¶ZDVmeasured in the present study allowing direct 
comparison with Schrader and colleagues' (2013). We extend their findings to 
demonstrate that exercise liking is also higher following caffeine ingestion in a mixed-
sex sample of sedentary participants.  
Caffeine supplementation improved enjoyment of HIIT in a sedentary female in 
chapter 4, and during sub-maximal exercise in recreational active participants in study 
published in the literature (Schubert et al., 2014) which is corroborated by the findings of 
the present study, where we reveal that exercise enjoyment is increased following caffeine 
ingestion in sedentary participants.   
Consistent with the findings from chapter 4, caffeine had no effect on HR 
responses during HIIT. However, as was discussed in chapter 4 (section 4.4.), it is 
possible that HR is not sensitive enough to capture any metabolic effects of caffeine at 
this dose, therefore, a more thorough assessment of the metabolic effects of caffeine 
during HIIT are required (which is conducted in chapter 6). 
In chapter 4, there were only differences between conditions for ratings of fatigue 
and vigour after HIIT. Whilst in the present study fatigue was lower and vigour was 
higher in the caffeine condition both before and after HIIT. The explanation provided for 
the null effect prior to HIIT in chapter 4 was that positive mood changes may be masked 
by increases in negative mood immediately prior to HIIT, such as anxiety, or anticipation 
of exercise-related effort and discomfort (A. Smith, 2002). This explanation is not 
necessarily invalidated by the findings of the present study, rather, it may have served to 
demonstrate that the single-subject design is more sensitive to individual differences in 
103 
 
mood responses, whilst the group design reveals the average effect from a number of 
participants. Another contributory factor may be the fact that the analysis used in the 
present study, which was a 2-way (condition/time) repeated measures ANOVA is more 
powerful than the randomisation tests used in chapter 4, as well as being able to factor 
multiple time points whilst the pre-HIIT and Post-HIIT data had to be analysed separately 
in chapter 4. 
Whilst chapter 4 revealed that there was a significant increase in intrinsic 
motivation following caffeine ingestion, the present study produced conflicting results, 
with neither potential motivation, or intrinsic motivation, whilst there was a trend for an 
increase in success motivation. The potential relationship between caffeine and 
motivation is presented in chapter 4 (section 4.4.) which the conflicting results here 
suggest that more work is needed to develop a better understanding of the relationship 
between motivation parameters and pharmacological interventions targeting A2A or D2 
receptors (Di Domenico & Ryan, 2017). 
Session RPE was lower 10-minutes post HIIT, which is consistent with the 
findings in chapter 4 and those published in the literature (Killen et al., 2013), 
demonstrating for the first time that caffeine elicits a significant reduction in session RPE 
following HIIT in sedentary participants. 
In the present study, and in chapter 4, we demonstrate that there is a highly 
significant preference for caffeine sessions, compared to placebo session. When you 
engage a putative target and you see a change in behaviour, that provides evidence to 
consider the target as a determinant of behaviour (Sheeran et al., 2017). Therefore, our 
findings provide further evidence that feelings during exercise, specifically perception of 
effort and affect, are important correlates/determinants of physical activity behaviour. We 
also provide evidence to suggest a casual role of psychological variables such as mood 
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states of fatigue and vigour, as well as liking, enjoyment, and session RPE, even though 
we did it in a minor way, through choice, which is a related outcome, rather than long-
term exercise adherence.  
An aim of this study was to understand the mechanisms underlying choice 
behaviour because with replicated preference tests alone, such as in chapter 4, it is not 
possible to establish which specific putative target, or targets, are the primary 
determinants of changes in choice behaviour. For example, the perception of effort (RPE) 
and affect (FS) are distinct constructs, but negatively related to one another (Hardy & 
Rejeski, 1989). It is likely that many of the other putative targets, which have been 
measured in this study, are also inter-related, which could mean that a reduction in effort 
may explain improved affect, or enjoyment, rather than them having a direct mechanistic 
relationship between caffeine and choice. As caffeine appears to elicit significant changes 
in several of these variables it is important to establish which of the variables is the 
determining factor. To achieve this aim a qualitative explanatory analysis was conducted. 
The qualitative content analysis revealed that the factor most frequently attributed to 
determining choice was perception of effort. Affect, Pain, Mood state, and time-related 
factors, in contrast, were cited in less than one-quarter of all preference explanations 
respectively. 
This exploratory qualitative analysis has provided the first experimental evidence 
that perception of effort may be more influential in determining exercise-related choice 
compared to affect and other perceptual and psychological responses during and around 
exercise.  
Another interesting product of this analysis is that time-related factors were cited 
on 15% of all choice occasions. Factors relating to the perception of time were not 
identified in the literature, and certainly not formally associated with caffeine ingestion. 
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However, a recent study (Edwards & McCormick, 2017) tested the hypothesis of whether 
maximal exercise distorts the perception of time, which was based on literature reporting 
that when working on an enjoyable attention-demanding task, chronological time appear 
to pass quickly, but if working on a less pleasurable attentional-demanding task, it seems 
to pass slowly (Wittmann & Paulus, 2008). In Edwards and McCormick's (2017) study 
participants completed three exercise trials at intensities corresponding to RPE 11 (light) 
RPE 15 (heavy), and RPE 20 and participants indicated their perceived rate of time. 
Perceived time was significantly slower in the RPE 20 condition than it was in either of 
the lower intensity conditions. This study is the first to demonstrate that the perception of 
time is significantly influenced by exercise intensity and associated perceived exertion. It 
is speculated that as intensity of physical effort grows, so too does increased sensory 
awareness due to hyperarousal (Jansen, Van Nguyen, Karpitskiy, Mettenleiter, & Loewy, 
1995). This means a greater amount of neural information processing is likely in a shorter 
than usual time, thus making it appear as though more time has passed than is objectively 
true. It is possible, therefore, that the high effort and discomfort associated with HIIT my 
also slow perceived time relative to chronological time, and that caffeine by reducing the 
perception of effort and discomfort during HIIT could mitigate the reduction in perceived 
time. However, this is purely speculative. The contents analysis only reveals that time-
perception is a factor influencing exercise-related choice. Future studies should determine 
whether caffeine is able to manipulate time perception. 
 
5.4.1. Limitations  
An evaluation of the limitations which are shared between this study and those 





As expected, low dose caffeine ingestion induced a more positive psychological 
response to HITT corroborating the finding from chapter 4. We demonstrated for the first 
time that the psychological effect of caffeine is associated with a significant change in 
exercise behaviour, with participants preferring to exercise with caffeine. Furthermore, 
qualitative exploratory analysis of the factors underlying exercise choice in our novel 







6. Metabolic effects of low-dose oral caffeine consumption around 





Despite the changes to perceptual responses, elicited by caffeine, in chapters 4 
and 5, there was no difference in HR responses, which was the only objective 
physiological measure in those studies. This is not surprising as the metabolic effects of 
caffeine at this relatively low dose are significantly lessened (Spriet, 2014). Whilst higher 
doses (PJÂNJDUHFRPPRQO\DVVRFLDWHGZLWKLQFUHDVHG+5 and blood pressure, there 
are several studies demonstrating that a dose of 3 mgÂkg can produce an ergogenic effect, 
with no changes in cardiovascular responses (e.g., Graham & Spriet, 1995). Indeed, whilst 
serum caffeine concentration continues to rise linearly with doses up to 9 mgÂkg (Graham 
& Spriet, 1995), it is now well accepted that there is an optimal dose for psychological 
and performance-enhancing effects of caffeine, which is 3 mgÂkg. At doses higher than 3 
mgÂkg there appears to be a plateau in the performance-enhancing effects (Burke, 2008) 
and an increase in side effects.  
Caffeine has well known thermogenic effects, despite little to no change in HR 
responses, IROORZLQJORZWRPRGHUDWHFDIIHLQHGRVHVRIPJÂNJ(Woolf et al., 2008), 3 - 
4 mg.kg (Paton, Costa, & Guglielmo, 2014), or ~1.5 - ~2.9 mg.kg (Talanian & Spriet, 
2016). Caffeine is consistently reported to elicit an increase in overall energy expenditure, 
dose-GHSHQGHQWO\ DW UHVW IROORZLQJGRVHVDV ORZDVaPJÂNJ (Astrup et al., 1990; 
Dulloo, Geissler, Collins, & Miller, 1989) as well as following moderate doses between 
DQGPJÂNJ(Arciero, Gardner, Calles-Escandon, Benowitz, & Poehlman, 1995; Astrup 
et al., 1990; Bérubé-Parent, Pelletier, Doré, & Tremblay, 2005; Hursel et al., 2011; 
Schubert et al., 2014). There are also reports that serum free fatty acids concentrations 
ares increased (Arciero et al., 1995) and fat utilisation/oxidation is higher at rest following 
consumption of low to moderate doses of (Hursel et al., 2011; Schubert et al., 2014). 
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The effects of caffeine on energy expenditure and substrate utilisation during 
exercise, however, are less clear. Leelarungrayub, Sallepan, and Charoenwattana (2011) 
reported that 5 mg.kg caffeine resulted in higher oxygen uptake and lower RER, 
suggesting a shift toward fat oxidation, during moderate intensity exercise. Whilst Engels 
and Haymes (1992) utilised the same relative dose (5 mg.kg) and exercise intensity 
(moderate) but produced conflicting results, with no change in oxygen uptake, carbon 
dioxide production, or RER values. Another pair of studies, utilising a very similar dose 
(2 * 2.5 mgÂkg vs 2 * 3 mgÂkg) also revealed contradictory findings. Júdice and colleagues' 
(2013) did not observe a difference in energy expenditure between the caffeine and 
placebo condition, whilst Schubert and colleagues (2014) did. This difference may be due 
to the fact that Júdice and colleagues (2013) were measuring free-living energy 
expenditure, which included exercise bouts, whilst Schubert and colleagues (2014) 
utilised a structured, prolonged, strenuous exercise bout in addition to caffeine to 
manipulate energy expenditure, therefore, caffeine and exercise synergistically 
manipulating the sympathetic nervous system may have had an additive effect on energy 
expenditure. However, several other studies have used similar relative doses in 
combination with a structured, prolonged, strenuous exercise bout and also observed no 
effect on oxygen consumption, substrate utilisation (indicated by RER values as well as 
absolute VO2 and VCO2) or energy expenditure (Engels & Haymes, 1992; Hodgson, 
Randell, & Jeukendrup, 2013; Paton et al., 2014). These differences cannot seemingly be 
reconciled by any single explanation as there is contradictory findings across different 
exercise intensities, modalities, and caffeine doses.  
The effect of low to moderate doses of caffeine on blood lactate concentration 
around a bout of exercise is not entirely clear. Some studies have reported elevated lactate 
prior to exercise (Engels & Haymes, 1992; Hodgson et al., 2013), whilst others have not 
(Talanian & Spriet, 2016). Likewise, some studies have reported a higher increase in 
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lactate production during exercise following caffeine consumption (Astrup et al., 1990; 
Engels & Haymes, 1992; Hodgson et al., 2013), whilst others have not (Greer et al., 1998; 
Paton et al., 2014; Talanian & Spriet, 2016; Woolf et al., 2008). There are also 
inconsistencies in the literature about the effect of caffeine on blood glucose following 
caffeine consumption. One study reported higher glucose at rest and following steady-
state exercise in the caffeine condition (Hodgson et al., 2013), whilst another study 
reported a time by condition interaction with blood glucose increasing post-exercise in 
the caffeine condition where a decrease in concentration was seen in the placebo condition 
(Woolf et al., 2008). A third study revealed a decrease in blood glucose immediately 
following exercise cessation which was not dependent upon treatment condition 
(Schubert et al., 2014). 
Clearly, despite substantial research on the metabolic effects of caffeine, there is 
no certainty as to the effects of low to moderate doses of caffeine during exercise. Not 
just for its own sake, it is of great importance that these inconsistencies are reconciled as 
caffeine may have the potential to facilitate health-related behaviour change, beyond the 
ability to manipulate perceptual responses to facilitate exercise. In a groundbreaking 
study, Schubert and colleagues (2014) participants ingested 3 mgÂkg caffeine, 60-minutes 
prior to completing 60-minutes moderate intensity exercise, before 120-minutes rest. 
Metabolic measurements were not only obtained throughout, but also, participants were 
offered an ad libitum test meal where energy and macronutrient intake were recorded 
immediately following the post-exercise recovery period. They revealed that caffeine 
resulted in significantly greater energy expenditure and fat oxidation compared with 
control. As well as a trend for reduced energy and fat intake compared with control. 
Consequently, caffeine created a greater energy deficit whilst also being perceived as less 
difficult (lower RPE) and more enjoyable (PACES), which is consistent with the findings 
from chapter 4 and 5. As combining caffeine with exercise appears to create a greater 
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acute energy deficit (Schubert et al., 2014) the implication of this should be investigated 
in sedentary and overweight populations. It would also be important to determine whether 
caffeine has the same appetite suppressing effects following HIIT which is proven to be 
even more effective +HOJHUXGHWDO.DUVWRIWHWDO0LODQRYLüHWDO
Rognmo et al., 2004; Tjønna et al., 2008; Wisloff et al., 2007), from a physiological 
perspective than continuous moderate intensity exercise. 
There are limiting factors which make measuring energy expenditure during high-
intensity exercise problematic. 9%cO2 is a good indicator of aerobic metabolism, and during 
exercise intensities where the anaerobic metabolic contribution is low (i.e., RER values 
below 1) stoichiometric equations based on RER values can provide a reliable estimate 
of energy expenditure and substrate utilisation (Jeukendrup & Wallis, 2005). At higher 
intensities, anaerobic contributions cannot be accurately accounted for by 9%cO2 alone, and 
stoichiometric equations are not reliable. In fact, at intensities 75% 9%cO2max, these 
equations are not able to accurately estimate carbohydrate and fat utilisation (Jeukendrup 
& Wallis, 2005). Although there is some exciting new research (Panissa et al., 2018) 
developing equations which reliably estimate energy expenditure from high-intensity 
exercise, as a product of O2deficit, excess post-exercise oxygen consumption (EPOC), and 
blood lactate accumulation. These equations have only been validated for supramaximal 
HIIT with 10 x 1-minute bouts interspersed by 1-minutes of passive recovery. 
Metabolic effects of caffeine can be assessed at rest and during the steady-state 
intensity warm-up phase by measuring oxygen consumption and using stoichiometric 
equations. Whilst EPOC can be used as an indicator of anaerobic exercise load following 
intense bouts of exercise (Horton & Hill, 1998). Additional insight can be gleaned from 
blood glucose and lactate concentrations as well as cardiovascular measures. These 
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measures have been employed in the present study, with an aim to determine, for the first 
time, the metabolic effects of caffeine during HIIT. 
We hypothesised that caffeine would increase energy expenditure and fat 
oxidation during the steady-state warm-up period, whilst 9%cO2 and Lactate would be 
higher during HIIT and recovery. Cardiovascular measures of HR, systolic and diastolic 











Eight participants from the study detailed in chapter 4 returned to the laboratory 
to participate in a study to investigate the metabolic effect of caffeine on HIIT. See Table 
6.1. for participant characteristics. Participants average daily habitual caffeine intake was 
low or moderate (<400 mgÂkgÂday), which was estimated using the Caffeine Consumption 
Questionnaire (CCQ ± Appendix C) (Landrum, 1992). The study was approved by the 
SSES ethics committee, at the University of Kent. Participants provided informed consent 
and completed a standard medical health questionnaire (Appendix A) to confirm their 
present state of health. Participants were given an overview, detailing all procedures and 
requirements of the study, and were informed that the study was to measure the metabolic 
effects of two different substances (either tyrosine, or beta-alanine), in combination with 
caffeine during HIIT ± when in fact they received either caffeine alone or placebo. 
Consequently, the participants were naive to the true aims and hypotheses of this study 
until the final session was complete, at which point they were debriefed about its genuine 
rationale (see General Human Methods section 3³&DIIHLQHGHFHSWLRQ´IRUGHWDLOV 
 
Table 6.1. Participant characteristics. n = 8. 
Variable: Mean SD 
Age (years) 
34 13 





Body Mass Index (kg/m2) 
28.63 7.20 
Habitual Caffeine Consumption (mgÂGD\) 
214.75 141.42 





6.2.2. Experimental design 
The experiment was a double-blind repeated measures cross-over design, in which 
participants visited the laboratory on 3 occasions. Visits 1 involved a treadmill-based 
incremental test, visits 2 and 3 were experimental visits. Experimental visits encompassed 
a crossover design in which the participants completed one session in each of the two 
experimental conditions (i.e., caffeine, or placebo).  
 
6.2.3. Caffeine dose and deception 
In sessions 2 and 3, participants received either caffeine (3 mgÂkg) or placebo 
(dextrose monohydrate) in a single capsule. A deception was used to minimise the impact 
RIWKHSDUWLFLSDQWV¶IDPLOLDULW\ZLWKFDIIHLQH)RUIXUWKHUGHWDLOVRQGUXJDGPLQLVWUDWLRQ
and the deception see General Human Methods section 3 ³&DIIHLQH DQG SODFHER
FDSVXOHVDQGDGPLQLVWUDWLRQ´DQGVHFWLRQ3³&DIIHLQHGHFHSWLRQ´respectively. 
 
6.2.4. Diet and exercise control 
Participants were instructed to record their food intake the day prior to session 2 
(the first experimental trial). Participants then had to replicate this diet in the 24 hours 
prior to session 3 (the second and final experimental visit), as well as refraining from any 
exercise 24 hours prior, consume no alcohol 24 hours prior, and withdraw from any 







6.2.5. Experimental procedures 
During visit 1, a treadmill-based incremental test was completed to establish 
9%cO2max ± from which subsequent training intensities for experimental sessions were 
determined. See General Human Methods section 3.3. ³Determination of maximal 
oxygen uptake (9%cO2max)´for details. Before participants left the lab, they were given the 
capsules for the following session and instructed to ingest it 1-hour prior to arriving at the 
lab. 
Participants arrived at the lab for each of their experimental visits (visits 2 and 3) 
having ingested either their placebo or caffeine capsule 1-hour prior. After being weighted 
(Seca Alpha, Hamburg, Germany) and being given the opportunity to have a final drink 
of water, they mounted the treadmill. They sat, in a recumbent position (on a chair), 
directly on the treadmill (HP Cosmos, Pulsar) belt. Before being fitted with a HR monitor 
(Polar Electro, Kempele, Finland), and a facemask (Cortex Biophysik GmbH, Leipzig, 
Germany) which was connected to a breath by breath gas analyser (MetaLyzer 3BR2, 
Cortex Biophysik GmbH, Leipzig, Germany) that had been calibrated with gas of a 
known composition prior to use, following the manufacturers guidelines. They also had 
a blood pressure (BP) cuff wrapped around the upper left DUPZLWKWKHFXII¶VORZHUHGJH
one inch above the antecubital fossa. A fully automated electronic BP machine (GE, 
Carescape V100) was used for measurements, which displayed HR, as well as systolic 
and diastolic BP, referred to herein as SBP and DBP respectively. 
Briefly, the following procedures describe three phases of data collection with 
measurements taken throughout. These phases are resting, HIIT, and recovery. The 
µ+,,7¶ SKDVH LV GHVFULEHG LQ GHWDLO WKH *HQHUDO Human Methods (section 3 ³+,,7




Participants carried out a 5-min warm-up period at an intensity corresponding to 
50±60% of 9%cO2max before walking four intervals of 4-min at 80±90% of 9%cO2max. Between 
the intervals 3-min of walking at 50±60% of 9%cO2max was conducted. The training session 
was terminated by a 3-min cool-down period at 50±60% of 9%cO2max. This gave a total 
exercise time of 33-min. On completion of exercise, the treadmill belt was stopped, and 
inclination was set to 0% before the participant resumed their resting position, sitting 
(recumbent) on a chair directly on the treadmill belt. They remained in this position 
throughout the 10-minute recovery phase. 
Respiratory measures from breath-by-breath analysis were recorded continuously 
throughout the entire 50-minute protocol. Variables recorded include oxygen 
consumption (9%cO2); carbon dioxide production (9%cCO2); respiratory exchange ratio (RER 
- a ratio between 9%cO2 and 9%cCO2); minute ventilation (VE); and breathing frequency (BF). 
Averages from the final minute of each exercise block (i.e., Rest, Warm-up, each high-
intensity block, each low intensity block, and recovery) were calculated for all respiratory 
measures and for HR. Blood lactate (BLa) and glucose (BGlu) concentrations were 
measured in the final 30-seconds of each block (see Figure 6.1.), by FROOHFWLQJȝORI
whole fresh blood from the palm-up surface of the distal segment (fingertip) of the 
middle, ring, or index finger. All blood samples were analysed at the end of the session 
using a calibrated device (EKF Diagnostic, Biosen C-Line). BP was measured at the end 
of the resting phase only and the cuff was removed at the start of exercise.  
 
6.2.6. Rating of perceived exertion 
RPE was taken during the final 15 seconds of each block (see General Human 
Methods section 3³0HDVXULQJDFXWHSHUFHSWXDODQG+5UHVSRQVHVWR+,,7´IRUPRUH
details on RPE procedures). At the end of the recovery period, 10-minutes post-exercise 
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whole session RPE was recorded using the Borg (1970) 6-20 scale, representing a single 




Figure 6.1. Displays the schematic for sessions 2 and 3, where metabolic measures are taken around a HIIT 
session. Red droplets represent capillary blood samples. Heart symbol represents blood pressure 
measurement. Face mask picture represents respiratory measures, Polar HR monitor picture represents heart 
rate monitoring. Grey blocks indicate, low-intensity exercise blocks, black blocks indicate high-intensity 
exercise blocks. Where there are neither grey nor black blocks the participant is physically inactive, pictures 
indicate whether they were standing or sitting during these periods. 
 
6.2.7. Substrate metabolism calculations 
Substrate metabolism was measured from the respiratory output measurements of 
9%cO2 and 9%cCO2 (L/min), carbohydrate [1] (CHO) and fat oxidation [2] were estimated for 
the final minute (between minutes 4 and 5) of the rest period and during the warm-up. In 
order to calculate CHO and fat oxidation stoichiometric equations (Jeukendrup & Wallis, 
2005; Peronnet & Massicotte, 1991) were used, which assume that participants were 
exercising at a steady-state and that protein oxidation was negligible. 
Carbohydrate equation 
[1] = 4.210 9%cCO2 ± 2.962 9%cO2 
Fat oxidation equation 
[2] = 1.65 9%cO2 ± 1.701 9%cCO2 
118 
 
6.2.8. Statistical analyses  
Means and standard deviations for descriptive characteristics of participants were 
calculated. Unless otherwise stated, all other data are presented as Mean ± SEMs. The 
Shapiro-Wilk's test of normality on the studentised residuals was performed for all 
variables. Paired samples T-tests were performed to determine whether there were 
significant differences between caffeine and placebo at rest, and during the recovery, for 
the following variables: SBP, DBP, BLa, BGlu, 9%cO2, HR, BF, VE, and Session RPE 
separate 2-way (2 * condition/ 3 * time) repeated measures ANOVAs were used for 
between trial comparisons of CHO and Fat utilisation, as well as overall EE during rest, 
warm-up, and recovery. Further, separate 2-way Condition (caffeine or placebo) x Time 
(12, 16, 19, 23, 26, 30, 33, 37, & 40 min) repeated measures ANOVAs were used for 
between trial comparisons of variables measured throughout HIIT. These were: 9%cO2, HR, 
RER, VE, BF, BLa, BGlu, and RPE. Where sphericity was violated degrees of freedom 
were corrected with the Greenhouse±*HLVVHU İ (Maxwell & Delaney, 2004). When 
necessary, a Bonferroni post-hoc procedure was used for follow-up comparisons. When 
2-ZD\UHSHDWHGPHDVXUHV$129$¶VUHYHDOHGDVLJQLficant interaction between condition 
and time, simple main effects were run. Effect sizes for relevant comparisons were 
FDOFXODWHGXVLQJ&RKHQ¶VGDQGGHILQHGDVWULYLDO30), small (0.3), moderate (
0.5), and large ( 0.8), respectively (Cohen, 1992). Results were considered significant at 
S$OOWHVWVZHUHFDUULHGRXWXVLQJIBM SPSS Statistics for Windows, Version 24.0. 







6.3.1. Substrate utilisation 
There was no main effect of condition for carbohydrate utilisation, F(1, 7) = 2.249, 
p = .177. With a mean difference of .075 (95% CI, -.043 to .193) g/min between caffeine 
and placebo conditions. There was a main effect of time, showing that there was a 
statistically significant change in carbohydrate utilisation over time, F(1.121, 7.847) = 
18.054, p = . İ   . Changes in carbohydrate utilisation over time were not 
dependent on which condition participants were in, as there was not a statistically 
significant two-way interaction, F(2, 14) = 2.300, p = .137. (Figure 6.2. A). 
There was no main effect of condition for fat utilisation, F(1, 7) = .003, p = .957. 
With a mean difference of .001 (95% CI, -.042 to .044) g/min between caffeine and 
placebo conditions. There was a main effect of time, showing that there was a statistically 
significant change in fat utilisation over time, F(2, 14) = 24.303, p < .001. Changes in fat 
utilisation over time were not dependent on which condition participants were in, as there 
was not a statistically significant two-way interaction, F(2, 14) = .714, p = .507. (Figure 
6.2. B). 
There was a statistically significant interaction between condition and time for 
energy expenditure F(2, 14) = 3.814, p  SDUWLDOȘ2 = .353. Therefore, simple main 
effects were run. Energy expenditure was statistically significantly different in the 
caffeine condition (1.667 ± .464 kcal/min) compared to placebo (1.411 ± .430 kcal/min) 
at rest, t(7) = 2.639, p = .033, d = .933, a mean difference of .256 (95% CI, .027 to .486) 
kcal/min. Energy expenditure was also statistically significantly different in the caffeine 
condition (6.295 ± 2.101 kcal/min) compared to placebo (5.708 ± .1.991 kcal/min) during 
the warm-up, t(7) = 3.747, p = .007, d = 1.325, a mean difference of .586 (95% CI, .216 
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to .956) kcal/min. However, energy expenditure was not statistically significantly 
different in the caffeine condition (1.743 ± .548 kcal/min) compared to the placebo 
condition (1.655 ± .120 kcal/min) during the 10-minute post-exercise recovery 
period, t(7) = .586, p = .577, d = .207. (Figure 6.2. C). 
 
Figure 6.2. displays carbohydrate utilisation (g/min) (A) fat utilisation (g/min) (B), and energy expenditure 
(kcal/min) (C) rates at rest, during a 5-minute warm-up (steady-state exercise at 50 - 60% 9%cO2max), and 
during recovery (10-minutes post-HIIT), 1 hour following ingestion of caffeine (3 mgÂkg), or placebo. All 
YDOXHVDUHSUHVHQWHGDVPHDQV6(06LJQLILFDQWPDLQHIIHFWRIWLPH36LJQLILFDQWPDLQHIIHFW
of FRQGLWLRQ3). * 6LJQLILFDQWFRQGLWLRQ[WLPHLQWHUDFWLRQ3:KHUHDVLJQLILFDQWLQWHUDFWLRQ
LVSUHVHQW>D@UHSUHVHQWVDVLJQLILFDQWGLIIHUHQFHEHWZHHQFRQGLWLRQV3IURP%RQIHUURQLSRVW-hoc 
tests. n = 8. 
 
6.3.2. Capillary blood samples 
There were no statistically significant differences between conditions for blood 
lactate concentration at rest or during recovery from HIIT, with mean differences of -.069 
(95% CI, -.735 to .597) mmol/L, t(7) = -.244, p = .814, d = -.086, and .121 (95% CI, -.861 
to 1.103) mmol/L, t(7) = .292, p = .779, d = .103, respectively. (Table 6.2.). 
There was a main effect for condition, showing that caffeine elicited statistically 
significantly higher lactate concentration than placebo during HIIT, with a mean 
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difference of .624 (95% CI, .126 to 1.121) mmol/L, F(1, 7) = 8.787, p = .021. There was 
a main effect of time, showing that there was a statistically significant change in lactate 
concentration during HIIT, F(1.974, 13.819) = 11.738, p    İ  Changes in 
lactate concentration during HIIT were not dependent on which condition participants 
were in, as there was not a statistically significant two-way interaction, F(3.623, 25.361) 
= .553, p  İ )LJXUH$ 
 
Table 6.2. Effects of caffeine (3 mgÂkg), or placebo, during rest, immediately prior, and 10-minutes post-
HIIT. n = 8. 
 Rest Recovery 
 Placebo Caffeine Placebo Caffeine 
Heart rate  
(beat/min) 74.79 ± 3.80 72.59 ± 3.39 95.38 ± 4.17 97.10 ± 2.18 
Systolic blood pressure  
(mmHg) 115.88 ± 3.47 121.38 ± 3.52 N/A N/A 
Diastolic blood pressure 
(mmHg) 70.88 ± 3.19 70.75 ± 3.47 N/A N/A 
Oxygen consumption 
(ml·kgí ·  miní) 3.26 ± 0.29 3.99 ± 0.35 * 3.99 ± 0.38 4.07 ± 0.18 
Breathing frequency 
(breaths/min) 18.45 ± 1.23 19.01 ± 1.54 20.81 ± 1.18 21.59 ± 2.41 
Ventilation  
(L/min) 10.09 ± 0.82 11.62 ± 0.97* 11.91 ± 0.58 13.04 ± 1.60 
Blood lactate concentration  
(mmol/L) 1.89 ± 0.16 1.83 ± 0.28 3.18 ± 0.49 3.30 ± 0.43 
Blood glucose concentration  
(mmol/L) 5.06 ± 0.21 5.03 ± 0.26 4.75 ± 0.21 4.80 ± 0.21 
Session RPE 
(Borg 6 - 20) N/A N/A 15.44 ± 0.37 14.75 ± 0.63 
* Significant differences between caffeine and placebo conditions p  .05. 
 
There are no statistically significant differences between conditions for blood 
glucose concentration at rest or during recovery from HIIT, with mean differences of -
.029 (95% CI, -.726 to .669) mmol/L, t(7) = -.097, p = .925, d = -.034, and .048 (95% CI, 
-.496 to .591) mmol/L, t(7) = .206, p = .842, d = .073, respectively. (Table 6.2.). 
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There was no main effect of condition for glucose concentration during HIIT, F(1, 
7) = .008, p = .930. With a mean difference of -.014 (95% CI, -.377 to .349) mmol/L 
between caffeine and placebo conditions. There no main effect of time, showing that there 
was not a statistically significant change in glucose concentration during HIIT, F(2.134, 
14.936) = 3.371, p = .0 İ  . There was not a statistically significant two-way 
interaction, F(2.889, 20.222) = 1.401, p = .İ . (Figure 6.3. B). 
 
Figure 6.3. displays capillary blood lactate concentration (mmol/L) (A) and capillary blood glucose 
concentration (mmol/L) (B) during HIIT 1 hour following ingestion of caffeine (3 mgÂkg) or placebo. All 
YDOXHVDUHSUHVHQWHGDVPHDQV6(0 Significant main effect of time 301). * Significant main 
HIIHFWRIFRQGLWLRQ3 n = 8. 
 
6.3.3. Respiratory responses 
Oxygen consumption at rest was, on average, .729 (95% CI, .058 to 1.400) 
ml·kgí1 ·  miní1 higher in the caffeine condition than it was in the placebo condition. 
Which was statistically significantly different, t(7) = 2.568, p = .037, d = .908. Whilst, 
during recovery, oxygen consumption was, on average, .080 (95% CI, -.656 to .817) 
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ml·kgí1 ·  miní1 higher in the caffeine condition than in the placebo condition. Which was 
not statistically significantly different, t(7) = .258, p = .804, d = .091. (Table 6.2.). 
There was a main effect for condition, showing that caffeine elicited statistically 
significantly higher oxygen consumption than placebo during HIIT, with a mean 
difference of .706 (95% CI, .168 to 1.243) ml·kgí1 ·  miní1, F(1, 7) = 9.642, p = .017. 
There was a main effect of time, showing that there was a statistically significant change 
in oxygen consumption during HIIT, F(1.536, 10.751) = 179.301, p   İ   
Changes in oxygen consumption during HIIT were not dependent on which condition 
participants were in, as there was not a statistically significant two-way 
interaction, F(3.873, 27.112) = .965, p  İ )LJXUH6.4. A). 
There was not a main effect for condition, showing that there was no statistically 
significant difference between RER in the caffeine condition, compared to the placebo 
condition during HIIT, F(1, 7) = 3.805, p = .092. There was a main effect of time, showing 
that there was a statistically significant change in RER during HIIT, F(1.946, 13.620) = 
22.907, p İ &KDQJHVLQ5(5GXULQJ+,,7ZHUHQRWGHSHQGHQWRQZKLFK
condition participants were in, as there was not a statistically significant two-way 
interaction, F(2.079, 14.550) = .784, p  İ )LJXUH6.4. B). 
There are no statistically significant differences between conditions for BF at rest 
or during recovery from HIIT, with mean differences of .555 (95% CI, -3.413 to 4.523) 
breaths/min, t(7) = .331, p = .751, d = .117, and .779 (95% CI, -3.432 to 4.990) 
breaths/min, t(7) = .437, p = .675, d = .155, respectively. (Table 6.2.). 
There was a main effect for condition, showing that caffeine elicited a statistically 
significantly higher BF, compared to placebo, during HIIT, with a mean difference of 
1.175 (95% CI, .028 to 2.322) breaths/min, F(1, 7) = 5.871, p = .046. There was a main 
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effect of time, showing that there was a statistically significant change in BF during 
HIIT, F(1.748, 12.239) = 25.623, p İ &KDQJHVLQ%)GXULQJ+,,7ZHUHQRW
dependent on which condition participants were in, as there was not a statistically 
significant two-way interaction, F(4.013, 28.094) = .371, p  İ )LJXUH6.4. 
C). 
VE at rest was, on average, 1.528 (95% CI, .109 to 2.947) L/min higher in the 
caffeine condition than it was in the placebo condition. Which was statistically 
significantly different, t(7) = 2.546, p = .038, d = .900. Whilst, during recovery, VE was, 
on average, 1.132 (95% CI, -1.843 to 4.106) L/min higher in the caffeine condition than 
in the placebo condition. Which was not statistically significantly different, t(7) = .900, p 
= .398, d = .318. (Table 6.2.). 
There was a main effect for condition, showing that caffeine elicited a statistically 
significantly higher VE, compared to placebo, during HIIT, with a mean difference of 
2.890 (95% CI, .016 to 5.764) L/min, F(1, 7) = 5.652, p = .049. There was a main effect 
of time, showing that there was a statistically significant change in VE during 
HIIT, F(1.111, 7.774) = 31.177, p İ 139. Changes in VE during HIIT were not 
dependent on which condition participants were in, as there was not a statistically 







Figure 6.4. displays oxygen consumption (ml·kgí1 ·  miní1) (A), respiratory exchange ratio (B), breathing 
frequency (breaths/min) (C), and ventilation (L/min) (D). During HIIT 1 hour following ingestion of 
caffeine (3 mgÂkg), or placebo. $OOYDOXHVDUHSUHVHQWHGDVPHDQV6(06LJQLILFDQWPDLQHIIHFWRI







6.3.4. Cardiovascular responses to HIIT 
There are no statistically significant differences between caffeine and placebo for 
any cardiovascular measures. Resting SBP was, on average 5.5 (95% CI, -.240 to 11.240) 
mmHg higher in the caffeine condition than the placebo condition. This mean difference 
has a large effect size, but is not statistically significant, t(7) = 2.266, p = .058, d = .801. 
Whilst for resting DBP there was a trivial, non-significant, mean difference of -.125 (95% 
CI, -8.321 to 8.072) mmHg, t(7) = -.036, p = .972, d = -.012. (Table 6.2.). 
Resting HR in the caffeine condition, was not statistically different to resting HR 
in the placebo condition, t (7) = -1.477, p = .183, d = -.522. There was a moderate effect 
size, with HR being, on average 2.198 (95% CI, -5.716 to 1.321) bpm lower in the 
caffeine condition. Likewise, there was not a statistically significant difference between 
conditions, with HR being on average 1.726 (95% CI, -5.585 to 9.036) bmp higher in the 
caffeine condition, compared to placebo, during recovery, t (7) = .558, p = .594, d = .197. 
(Table 6.2.). 
There was no main effect of condition for HR, showing that there was not a 
statistically significant difference between conditions for HR during HIIT, F(1, 7) = .168, 
p = .694. With a mean difference of 1.067 (95% CI, -5.091 to 7.225) bpm. There was a 
main effect of time, showing that there was a statistically significant change in HR 
throughout HIIT, F(1.576, 11.035) = 235.881, p < .001İ  Changes in HR over 
time were not dependent on which condition participants were in, as there was not a 








Figure 6.5. displays the effect of caffeine consumption (3 mgÂkg) or placebo, on acute heart (HR) rate 
responses to HIIT. Data are presented as mean values with error bars representing the SEM. ,QGLFDWHV
DVLJQLILFDQWPDLQHIIHFWRIWLPHS n = 8. 
 
6.3.5. Rating of perceived exertion 
There was a moderate effect size for lower session RPE in the caffeine condition 
compared to the placebo condition, with a mean difference of -.687 (95% CI, -2.029 to 
.654), which not statistically significant, t (7) = -1.212, p = .265, d = -.428. (Table 6.2.). 
There was not a main effect of condition for RPE, showing that caffeine 
consumption did not elicit a significant reduction in RPE scores throughout HIIT, with a 
mean difference of -.146 (95% CI, -1.299 to 1.007), F(1, 7) = .089, p = .774. There was 
a main effect of time, showing that there was a statistically significant change in RPE 
throughout HIIT, F(2.029, 14.205) = 68.443, p İ 254.  Changes in RPE over 
time were not dependent on which condition participants were in, as there was not a 
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statistically significant two-way interaction, F(3.725, 26.076) = 1.154, p = .343İ  .466. 
(Figure 6.6.). 
 
Figure 6.6. displays the effect of caffeine consumption (3 mgÂkg) or placebo, on acute rating of perceived 
exertion scale (RPE) responses to HIIT, used here to measure the perception of effort. Data are presented 
as mean values with error bars representing the SEM. ,QGLFDWHVDVLJQLILFDQWPDLQHIIHFWRIWLPHS










The aim of this study was to determine the metabolic effects of caffeine during HIIT. To 
achieve this aim, online gas analysis, as well as cardiovascular and capillary blood 
responses were monitored at rest, during a HIIT session, and during 10-minutes recovery. 
In a within-subject crossover design, participants completed both caffeine (3 mgÂkg) and 
placebo conditions. Consistent with our hypotheses, energy expenditure was greater at 
rest and during steady-state exercise. Oxygen consumption, minute ventilation, and blood 
lactate accumulation were also high in the caffeine condition during HIIT. However, there 
was no evidence of an increase in EPOC during the recovery period. Nor were there any 
differences in cardiovascular or perceptual responses. 
The most commonly reported alteration in substrate utilisation following caffeine 
consumption is a shift towards increased fat oxidation (Hursel et al., 2011; Schubert et 
al., 2014). However, despite consistent reports that fat mobilisation is increased following 
caffeine ingestion, indicated by elevated concentrations of serum free fatty acid (Engels 
& Haymes, 1992; Hodgson et al., 2013; Woolf et al., 2008) there is limited data to suggest 
that this increase in mobilisation is substantiated by an actual increase in fat utilisation 
during moderate or low-intensity exercise (Hodgson et al., 2013) (Engels & Haymes, 
1992), instead this may be an effect which is only measurable at rest (Hursel et al., 2011) 
or during relatively long bouts of exercise (Schubert et al., 2014). Therefore, due to the 
high-intensity protocol used in the present study, which may prevent a shift to fat 
oxidation in order to meet the high energy demand, it is not surprising that RER was not 
different between conditions at rest, during recovery, or at any point during HIIT and that 
there were no differences in carbohydrate or fat substrate utilisation at any time point. 
Energy expenditure and oxygen consumption, on the other hand, were higher in 
the caffeine condition during rest, which is consisted with the body of research reporting 
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the thermogenic effects of caffeine (e.g., Arciero et al., 1995; Astrup et al., 1990; Bérubé-
Parent et al., 2005; Dulloo et al., 1989; Hursel et al., 2011; Schubert et al., 2014). Energy 
expenditure and oxygen consumption were also higher during the steady-state warm-up 
period in the caffeine condition compared to placebo. Whilst this is consistent with some 
studies (Schubert et al., 2014; Wallman et al., 2010), it is inconsistent the findings of 
several other studies which have reported no effect of caffeine on energy expenditure 
during exercise (Engels & Haymes, 1992; Hodgson et al., 2013; Paton et al., 2014).  
It is difficult to reconcile this finding as there are differences and similarities 
between each of the studies that are or are not in agreement. There is no deeper 
explanation here, just the simple observation that the studies reporting no effect of 
caffeine on energy expenditure are either exclusively male participants (Engels & 
Haymes, 1992; Hodgson et al., 2013; Júdice et al., 2013) or equally mixed (Paton et al., 
2014). Conversely, studies by Schubert and colleagues (2014) and Wallman and 
colleagues (2010), which did report a significant increase in energy expenditure following 
caffeine ingestion, included only women. Interestingly, participants in the present study 
were mainly women (6, compared to 2 men). It is possible that the effects of caffeine on 
oxygen consumption and energy expenditure is more pronounced in women. Indeed, 
there is some evidence that there are sex differences in physiological responses to 
caffeine, supposedly related to variation in steroid hormone concentrations (Temple & 
Ziegler, 2011). However, further research will be needed to establish the extent of these 
potential differences in relation to exercise. Another factor, which is not possible to 
explore with the current sample is that the effect of caffeine on energy expenditure at rest 
appears to be greater in lean women (Bracco, Ferrarra, Arnaud, Jéquier, & Schutz, 1995) 
and men (Dulloo et al., 1989) compared to their obese counterparts, which may have 
implication regarding the use of caffeine to increase energy deficits by simultaneously 
reducing appetite and increasing energy expenditure (as proposed by Schubert and 
131 
 
colleagues, 2014) in obese populations. Which is the population for whom this approach 
would theoretically be most beneficial. 
There was no evidence of greater EPOC in the caffeine condition, as there were 
no differences in energy expenditure or oxygen consumption during the 10-minute 
recovery period post-HIIT (Børsheim & Bahr, 2003). However, this should be interpreted 
with caution as the sample period in the present study was relatively short at 10-minutes, 
compared to 120-minutes in the study by Schubert and colleagues (2014) which did report 
higher energy expenditure during recovery.  
Minute ventilation was higher at rest and during HIIT in the caffeine condition, 
whilst breathing frequency was only higher in the caffeine condition during HIIT. This is 
consistent with literature reporting that minute ventilation following ingestion of a higher 
(5 mgÂkg) caffeine dose (Engels & Haymes, 1992), and provides objective data which 
echoes a feeling that was identified by a participant in chapter 5 during their preference 
test explanation (Appendix L, participant IT002 following experimental session 5) "I 
don't feel as out of breath, but it feels harder work", said following a placebo session. 
There was a moderate effect size for lower session RPE in the caffeine condition 
compared to the placebo condition, which was not statistically significant. RPE during 
HIIT was not different. This contradicts our hypothesis, as well as data from chapter 4 
and 5 and findings from the literature which demonstrate an overwhelming consistency 
in the ability for caffeine to reduce the perception of effort, both in terms of acute 
responses during (Doherty & Smith, 2005; Schubert et al., 2014) and JOREDOµUHIOHFWLYH¶
ratings after (via session RPE) exercise (Killen et al., 2013). However, there are studies 
which have reported a similar effect, for example, Wallman and colleagues (2010) 
reported an increase in 9%cO2 and energy expenditure during steady-state exercise 
following caffeine ingestion, whilst RPE was not different. A potential explanation is that 
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the increase in BF and VE (discussed above) observed here as an effect of caffeine, may 
interact with the fact that participants are wearing, and breathing through, a face mask for 
online gas analysis. Therefore, the increase in breathing frequency and volume, combined 
with the higher (however marginal) breathing restriction and resistance may result in a 
diminished effect of caffeine on RPE. This potential explanation needs to be explored 
with experimental work in the future as it may have important implications for studies 
simultaneously recording metabolic/physiological and perceptual/psychological 
measures. Although it may be particularly prevalent for online gas analysis, it would 
likely extend to trials with invasive procedures for blood and tissue sampling or any other 
procedures that are in themselves uncomfortable or painful. If this proves to be the case, 
the approach taken here, that is to separate perceptual and physiological assessments as 
per chapter 5 and the present study, would be preferable when psychological aspects are 
pertinent to the research question.  
Consistent with Talanian & Spriet (2016) who did not observe elevated lactate at 
rest following either 1.5, or 2.9 mgÂkg, it is likely that the 3 mgÂkg dose use here was 
lower than is required to elevate lactate at rest, as is shown with 5 mgÂkg in other studies 
(Engels & Haymes, 1992; Hodgson et al., 2013). During HIIT capillary blood lactate 
concentration was higher in the caffeine condition compared to placebo, which is 
potentially due to increased glycolysis (although there was not a statistically significant 
difference in CHO oxidation it does appear to be elevated in the caffeine condition (figure 
6.2. A)). Clearly the protocol used in the present study was both intense enough and long 
enough to observe a significant difference in lactate production during exercise, unlike 
single or multiple supramaximal exercise protocols using 30-s sprints, which have been 
shown not to show an effect of caffeine on lactate accumulation during exercise (Greer et 
al., 1998; Woolf et al., 2008) and therefore not able to determine any additional effect of 
caffeine. The effect in the present study is more similar to studies using lower intensities 
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and longer durations (Astrup et al., 1990; Engels & Haymes, 1992; Hodgson et al., 2013), 
whilst the shorter overall exercise duration in the present study may account for the fact 
that there are no differences 10-minutes post-exercise, whereas studies using a longer 
exercise duration have reported elevated lactate concentration post-exercise (Engels & 
Haymes, 1992). Whilst there were no differences between conditions in capillary blood 
glucose concentrations at rest, during HIIT or during recovery. As identified in the 
introduction, there are inconsistencies in the literature, with studies reporting higher 
glucose at rest and during exercise following (Hodgson et al., 2013), whilst another has 
observed an increase only after exercise (Woolf et al., 2008). The data from the present 
study does little to consolidate these finding, however, it is possible that the lower dose 
used here (3 mgÂkg rather than 5 mgÂkg) may be responsible for the null finding.  
As expected, there were no differences in any of the cardiovascular measures at 
any time point. This is consistent with the finding from chapters 4 and 5, as well as 
literature demonstrating that at low doses caffeine has little to no effect on cardiovascular 
measures (Paton et al., 2014; Talanian & Spriet, 2016; Woolf et al., 2008). 
 
6.4.1. Limitations  
There is evidence to suggest that there is substantial inter-individual variation in 
metabolic responses to caffeine (Doepker et al., 2016). Some factors which have been 
shown to moderate the metabolic effects of caffeine have been controlled for. High 
habitual caffeine users, smokers, and pregnant women were excluded as these are all 
factors which have been shown WRDOWHUFDIIHLQH¶VKDOI-life (D. G. Bell & McLellan, 2002; 
Doepker et al., 2016; Schreiber et al., 1988). However, further differences related to 
genetic factors, for example (Yang, Palmer, & De Wit, 2010), were not taken into 
consideration. Other studies have taken measures to account for this, by monitoring serum 
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concentrations of caffeine and/or its primary metabolite paraxanthine to determine the 
rate of absorption and decay (e.g., Schubert et al., 2014). There is also some evidence to 
suggest that obesity (Bracco et al., 1995; Dulloo et al., 1989) and sex (Temple & Ziegler, 
2011) are moderators of caffeine¶VPHtabolic effects. The present study is therefore also 
limited in this regard as the primary inclusion criteria was baseline physical activity levels 
rather than fitness or obesity and thus there is substantial variation in participant 
characteristics. Although this variation may increase the external validity of these data it 
impedes on internal validity. Future studies may wish to sample more homogenous 
groups by setting multiple inclusion criteria, for example, sedentary and overweight, or 
sedentary and unfit. Alternatively, a larger sample would allow some of these factors to 
be controlled for statistically.  
An evaluation of the limitations which are shared between this study and those 
presented in chapters 4 and 5 will be provided in the Human Discussion (chapter 7). 
 
6.4.2. Conclusion 
Caffeine appears to have thermogenic effects, both increasing energy expenditure 
at rest and during steady-state exercise whilst also increasing oxygen consumption, 
minute ventilation, breathing frequency and blood lactate accumulation during HIIT. 
Consistent with previous work in recreationally active participants, the present study 
demonstrated for the first time that caffeine increases metabolic activity during HIIT in 
sedentary people. This has implications for the use of caffeine in physical activity 








7.1. A summary of outcomes 
The aim of Part I of this thesis was to conduct a full test (Path D of the EM 
approach). Full tests determine whether an intervention strategy or a set of strategies 
changes physical activity behaviour, or a related outcome, via their effects on specified 
targets (Figure 1.1., Path D). Therefore, in this case, we sought to determine whether 
caffeine was able to influence exercise preference via its effects on feelings during 
exercise. Work presented in chapter 4 utilised a single-subject experimental design as a 
preliminary trial. We demonstrated that caffeine elicited significant engagement of 
several specific putative targets, ZLWKLQWKHEURDGHUFRQWH[WRI³IHHOLQJVGXULQJH[HUFLVH´ 
(identified as the global putative target in the General Introduction, section 1.3.). Further, 
we provided the first experimental evidence that pharmacological intervention can 
influence physical activity choice behaviour by manipulating feelings during and around 
exercise training. In chapter 5, a group trial was conducted to build on the initial findings 
from chapter 4. The group trial corroborated many of the psychological and perceptual 
effects of caffeine observed in chapter 4, further demonstrating that pharmacological 
intervention can facilitate exercise by manipulating psychological and perceptual 
experiences during, and around, exercise. Beyond simply corroborating the findings, 
however, chapter 5 included a qualitative exploratory analysis of the factors underlying 
exercise choice. This analysis suggested that perception of effort was the primary 
determinant of exercise preference.  
It can be argued that this is weak, as the behavioural outcome measure is choice, 
rather than long term adherence to exercise, for example, and the link between the 
putative target (perception of effort) and the behaviour is qualitative, but it should not be 
ignored. Ivanova and colleagues (2015) provided the first indirect test of Path D of the 
EM approach (as discussed in section 1.8.), though unknowingly. Where they 
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demonstrated that commitment and acceptance therapy was able to engage the putative 
target (reducing the perception of effort), resulting in improved exercise tolerance, which 
is an alternative physical activity related outcome. The present study progresses this by 
providing further validation of Path B, which is the relationship between the perception 
of effort and physical activity behaviour. Also, it provides initial proof of Path D, as 
physical activity choice behaviour change, elicited by the caffeine intervention, was 
associated with putative target engagement. 
The next step in the line of research should be to investigate whether this 
preference can increase long-term adherence to HIIT. Although we have provided an 
initial test of Path D using an outcome related to physical activity behaviour, the reality 
is that we do not know what a clinically relevant reduction in perception of effort is. In 
the present study, the difference between RPE values during HIIT and session RPE is 
DSSUR[LPDWHO\DaSRLQWGLIIHUHQFHRQ%RUJ¶V(1970) 6 ± 20 scale. A full RCT is now 
required to determine whether this 1-point change in perception of effort is sufficient to 
produce practically relevant changes in chronic exercise behaviour (i.e., improved 
exercise adherence). Alternatively, an intermediate step would be to determine whether 
the change in exercise preference, established here, results in a change in engagement. 
This could be assessed by adopting an effort based decision-making paradigm (e.g. Kool 
et al., 2010; Treadway et al., 2012; Wardle, Treadway, Mayo, Zald, & de Wit, 2011) to 
look at acute effects of caffeine on exercise engagement. 
Chapter 6 investigated the metabolic effects of caffeine during HIIT. There is 
evidence to suggest that caffeine can elicit a dual function of increasing non-exercise 
thermogenic activity, as well as increasing energy expenditure during exercise, whilst 
also facilitating exercise by reducing effort and increasing enjoyment during continuous 
moderate intensity exercise (Schubert et al., 2014). We extend these findings by 
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demonstrating that caffeine is also associated with a higher metabolic stress (chapter 6) 
and desirable psychological responses to HIIT (chapter 4 and 5), which is particularly 
significant as HIIT may be maximally beneficial from a health perspective. 
 
7.2. Limitations and future directions 
A general limitation of each of the studies in this part of the thesis is the heavy 
reliance on self-report measures. Whilst all of the self-report measures are well validated 
and proven to be reliable, there is evidence to suggest that self-report measures can alter 
the affect that one is trying to measure (Kassam & Mendes, 2013). Which makes 
unobtrusive and objective measures desirable. There are a few studies which have used 
neuroimaging techniques to identify areas of the brain that are associated with the 
perception of effort during physical tasks (Staiano & Marcora, 2014). Whilst EEG has 
been used to establish neural correlates of the perception of effort (de Morree et al., 2012). 
Other work has attempted to used facial EMG as an objective correlate of perception of 
effort (de Morree & Marcora, 2012). Similarly, it is thought that facial and vocal 
recognition software may offer unobtrusive insight into what participants are feeling and 
how that changes over time and in response to new information (Sheeran et al., 2017). 
However, these measures are currently far less accurate than the currently available self-
report measures. This is an area that will undoubtedly develop along with technological 
advances. Though, for now, it seems that perceptual rating scales for affect and effort 
related constructs, at least, are the best available option.  
There are other measures that have relied on self-report in the present study, 
however, which could be improved with currently and readily available technology. For 
example, in the present study inclusion criteria were based on self-reports of current 
occupational and recreational physical activity, as determined by the OSTPAQ 
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(Appendix B). Whilst this simple questionnaire was quick and efficient it lacks resolution. 
Accelerometry can provide an option for passive measurement of free-living activity and, 
if included in a preliminary observation period, could provide an objective basis to 
include/exclude from experimental work based on habitual activity levels. This would be 
costly, financially and in terms of time. However, if studying populations based on 
variation in habitual physical activity is the primary objective it this would provide a more 
rigorous profiling tool.  
Likewise, although the purpose, and indeed a strength of the present study, was 
the use of caffeine to facilitate exercise in a formally structured training session, caffeine 
may also have effects on free-living physical activity (Júdice et al., 2013). What has not 
yet been explored, however, is whether the compensatory reduction in free-living 
physical activity that is often reported after exercise (King et al., 2007; King, Hopkins, 
Caudwell, Stubbs, & Blundell, 2008) is mediated by caffeine ingestion. Therefore a 
combination of a formal exercise trial (as used in the present study) combined with 
subsequent measurement of free-living physical activity, via accelerometry, as used by 
Júdice and colleagues (2013) could provide valuable and novel insight. 
 The qualitative analysis in chapter 5 provides initial evidence that perception of 
effort is the primary determinant, rather than a correlate (Bauman et al., 2012), of physical 
activity behaviour. However, it was not possible to perform a mediation analysis to 
determine the causal roles of specific targets as the choice measure was binary in nature. 
Future research should seek behavioural measures which are compatible with mediation 
analysis. As this will allow the causal role of perception of effort, as well as other feelings 
during exercise, on physical activity behaviour change following pharmacological 
intervention to be established.  
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Perhaps the greatest threat to internal validity in each of these human studies is 
the lack of dietary control. To maximise external validity, participants were able to 
consume their usual diet and were only restricted from caffeine consumption for 3-hours 
prior to each session. Participants were given food diaries; however, these were for self-
monitoring purposed only and were not collected. Consequently, although participants 
were instructed to keep their diet as similar ahead of each session as possible, there was 
no way to quantify dietary variation. There are two relatively simple solutions to this 
issue, which should be addressed with future studies. Food diaries are often used in 
caffeine-related studies (e.g., $OL 2¶'RQQHOO 6WDUFN 	 5XWKHUfurd-Markwick, 2015; 
Arciero et al., 1995; Laurence et al., 2012; Wallman et al., 2010). Alternatively, to avoid 
placing additional demands on participants, controlled diets can be provided, which 
instead places extra demand and resourcing in the hands of the researcher.  
A related issue is the fact that high habitual caffeine intake can influence responses 
to caffeine (D. G. Bell & McLellan, 2002). For this reason, high habitual caffeine users 
were excluded from the present study, or they were required to reduce their daily caffeine 
intake to low/moderate levels before participating. However, the combination of the 
caffeine consumed during the study and their typical habitual intake may have resulted in 
VRPHSDUWLFLSDQWFRQVXPLQJµKLJK¶OHYHOVRIFDIIHLQHWKURXJKRXWWKHVWXG\7KLVZDVQRW
considered or controlled for in any way, thus, responses to caffeine the present study may 
have been altered over time. It can be argued that any potential effect would be diminished 
here, since participants received treatments in an alternating fashion, meaning they had a 
minimum of one dose and a maximum of only two doses per week. This issue may be 
more prevalent in RCTs adopting between-subject designs where some participants could 
receive the caffeine treatment 3 times per week. Future studies could adjust inclusion 
criteria regarding habitual caffeine consumption to mitigate this potential confound. 
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Another area for future research is regarding caffeine delivery. Caffeine in capsule 
form, as used in the present study, needs to be ingested in the hours before exercise to 
allow sufficient absorption time through the hepatic system (Astorino & Roberson, 2010). 
However, chewing caffeinated gum allows absorption directly into the bloodstream via 
the buccal mucosa, thereby bypassing hepatic metabolism, speeding up caffeine delivery 
DQG HQKDQFLQJ FDIIHLQH¶V ELRDYDLODELOLW\ (Kamimori et al., 2002; Paton et al., 2014; 
Wickham & Spriet, 2018). There are not currently any readily available taste matched 
placebos for caffeinated chewing gum, therefore, administering caffeine in a capsule is a 
sensible solution, particularly in studies utilising a within-subject design where 
alternative treatments are experienced by the same participants and differences in taste 
would be easily identified. However, as was suggested in the previous section, in 
conducting the proposed RCT RUµIXOOWHVW¶, to investigate the effect of chronic caffeine 
consumption on exercise adherence, caffeinated chewing gum may be a desirable 
alternative to capsules. 
7.3. Conclusion 
In Part I of this thesis we demonstrated for the first time that caffeine is effective 
at facilitating HIIT in sedentary participants. We also provide the first experimental 
evidence demonstrating that pharmacological intervention can influence physical activity 
choice behaviour by manipulating feelings during and around HIIT. Furthermore, 
qualitative exploratory analysis of the factors underlying exercise choice, in our novel 
behavioural measure, identified perception of effort as the primary determinant of 
exercise preference. Finally, we revealed that caffeine appears to have thermogenic 
effects, both increasing energy expenditure at rest and increasing metabolic stress during 
HIIT in sedentary people. This may have implications for the use of caffeine in physical 






A standard efficacy trial (Path X): Developing a preclinical model to test the 









Standard efficacy trials (Figure 1.1. Path X), are traditionally concerned with 
whether, not how, interventions promote health behaviour change and often fail to 
identify mechanisms by which interventions have elicited their effect on the primary 
behavioural outcome. However, with carefully controlled laboratory studies manipulating 
factors related to decisional costs in behavioural paradigms (for example), mechanistic 
inferences can be made. This approach is suitable for use in preclinical models, where it 
is not possible to collect self-report perceptual data relating to how one feels. 
 
8.2. Effort-based exercise-related decision-making 
Research has sought to characterise the role that multiple brain structures (e.g., 
amygdala, anterior cingulate cortex, ventral pallidum) and neurotransmitters (adenosine, 
GABA) play in effort-related choice behaviour (see Salamone et al., 2012, 2016 for a 
review). Briefly, the emphasis has been placed on dopamine/adenosine interactions. 
Dopamine-rich brain areas, including the neostriatum and the nucleus accumbens, have a 
high concentration of adenosine A2A receptors (DeMet & Chicz-DeMet, 2002; Ferré et 
al., 2004; Schiffmann, Jacobs, & Vanderhaeghen, 1991). There is considerable evidence 
of cellular interactions between dopamine D2 and adenosine A2A receptors (Ferré et al., 
1997; Fink et al., 1992; Fuxe et al., 2003; Hillion et al., 2002). Drugs that act upon 
adenosine A2A receptors, such as caffeine and other methylxanthines, which are 
adenosine antagonists, can profoundly affect instrumental response output and effort-
related choice behaviour (Farrar et al., 2010; Font et al., 2008; Mingote et al., 2008; Mott 




Formal models of effort-related dysfunction have been developed and widely 
adopted in translational research. It is accepted that these are not necessarily functioning 
as models of a particular disorder, but rather are focussed upon specific symptom 
dimensions and circuits that span multiple disorders, such as schizophrenia, 3DUNLQVRQ¶V, 
and depression (Salamone et al., 2016). These generic models allow the study of effort 
mediated behaviour. The commonality between each of the conditions that have utilised 
this translational research approach is that they (i.e., VFKL]RSKUHQLD 3DUNLQVRQ¶V DQG
depression etc.) are associated with low, asymmetrical, or otherwise impaired dopamine 
function. Dopaminergic dysfunction manifests slightly differently across these 
conditions, but, they all impact decisional balance of cost vs reward, resulting in affected 
individuals becoming less willing to expend effort tR UHFHLYH UHZDUG 7KH µUHDO OLIH¶
implications of this dopamine-mediated effect on behaviour include states of apathy, 
social withdrawal, psychomotor slowing, fatigue, and physical inactivity (Salamone et 
al., 2016).  
Interestingly, there is a growing body of evidence implicating dopamine in the 
regulation of physical activity behaviour. A review of animal and human studies 
suggested that dopaminergic activity is negatively correlated with physical inactivity 
(Knab & Lightfoot, 2010). Exercise is a behaviour which demands effort and the role of 
effort in exercise-based decision-making has been demonstrated by literature identifying 
effort and perceived exertion as primary barriers to engaging in exercise (Sechrist, 
Walker, & Pender, 1987; Steinhardt & Dishman, 1989). So, the emerging link between 
physical activity and dopamine function is not surprising. 
Lower dopaminergic activity could mediate a reduction in voluntary physical 
activity in two ways. Firstly, according to MIT, if perceived effort exceeds potential 
motivation individuals will disengage from a task. For example, low dopamine in 
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sedentary people may affect decisional balance, with the effort required to engage in 
exercise exceeding their motivation towards this (very important) health-related 
behaviour. Secondly, low dopamine activity may blunt the psychological reward 
DVVRFLDWHGZLWKH[HUFLVHRIWHQUHIHUUHGWRDVWKHµUXQQHUVKLJK¶ 'LVKPDQ	2¶&RQQRU
2009). Based on this hypothesis, physically inactive individuals may lack motivation for, 
and psychological reward from exercise, in part, due to low dopamine function impacting 
intentions for exercise and feelings during exercise.  
Although it is not on the agenda of leading research scientists investigating effort-
related dysfunction, there is a clear link with physical activity behaviour. Translational 
studies linking research with animal models, human volunteers, and clinical populations 
is already beginning to revolutionise the understanding of the neural basis of effort-related 
motivational dysfunction (Salamone et al., 2016). In this thesis, for the first time, I 
propose that effort-based decision-making paradigms, traditionally used to study effort-
related dysfunction, can be extended to include voluntary physical activity/exercise 
behaviour. 
 
8.3. Aim of thesis Part II 
The aim of Part II of this thesis is to develop a relevant and translatable pre-clinical 
model to measure the behavioural effects of pharmacological interventions on physical 
activity behaviour. Testing the effects of pharmacological intervention on physical 
activity in animals is not a new concept; however, there are several inconsistencies with 
currently available models, relating to access, mode of activity, time-of-day, and activity 
duration, for example. The following sections of this chapter will discuss literature which 
informed the initial development of our model. Subsequent experimental work 
progressing this model is detailed in chapters 10, 11 and 12. 
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8.4. The nature of physical activity in mice 
In order to develop a valid translational model of behaviour-based interventions 
across species, fundamentally, relevant behaviours need to be both translatable and 
measurable. A review (Garland et al., 2011) provided an overview of the biological 
control of voluntary exercise and spontaneous physical activity (SPA) (also referred to as 
non-exercise activity thermogenesis (NEAT)), relating to energy expenditure and obesity 
in humans and rodents. This review makes a strong case in demonstrating the species 
crossover in understanding physical activity behaviour (PAB), identifying that there is a 
clear separation in the measurement of SPA and voluntary exercise in rodents but not in 
humans, where there is a higher degree of methodological cross-over. 
Locomotion FRQVWLWXWHVDNH\HOHPHQWRIDQLPDOEHKDYLRXUWKRXJKµORFRPRWLRQ¶
is an inherently broad term which can be broken into various behaviour types. 
Locomotion required in the search for food, shelter, and mates, interacting with 
competitors, and avoiding predators can be classified as obligatory locomotion which is 
often referred to as SPA. )RUDKXPDQ63$ZRXOGEH«³SHUIRUPLQJDOORIRXUGDLO\WDVNV
VXFKDVZDONLQJWDONLQJ\DUGZRUNDQGILGJHWLQJ´ (Levine, Nygren, Short, & Nair, 2003) 
p. 169. Other behaviours which are considered not to be directly required for survival, 
homeostasis, or driven by any external factors can be described as voluntary activity 
(Garland et al., 2011). Voluntary exercise behaviour in humans is clearly very complex 
(Dishman, Berthoud, & Booth, 2006)ZKHUHDVZLWKODERUDWRU\URGHQWV¶VRFLHWDOHIIHFWV
are absent making it a somewhat simpler.  
Voluntary exercise in rodents is usually measured with wheel-running (Clark et 
al., 2010; Kelly & Pomp, 2013; Sasse et al., 2008; Sugihara et al., 2013; Vyazovskiy, 
Ruijgrok, Deboer, & Tobler, 2006). It has been argued that voluntary wheel-running in 
rodents may be a reasonable model of human voluntary exercise (Garland et al., 2011; 
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Kelly et al., 2010; Rezende, Gomes, Chappell, & Garland Jr., 2009). For example, the 
day-to-day variability in wheel-running by individual mice from lines selectively bred for 
high voluntary wheel-running and from a non-selected control line was found to be 
similar to that observed for activity levels of free-living human children, adolescents and 
young adults. This has been interpreted as evidence that biological mechanisms influence 
daily levels of physical activity (Eisenmann, Wickel, Kelly, Middleton, & Garland, 
2009). Although wheel-running is simpler than human exercise behaviour it is still 
extremely complex. Wheels come in a variety of sizes, made of different materials with 
differing textures and can be configured in several ways as part of a home, or novel cage 
environment (De Bono, Adlam, Paterson, & Channon, 2006; Sherwin, 1998). Though 
counting devices may differ (Eikelboom, 2001) wheel-running can be quantified as total 
revolutions, time active, and/or exercise intensity (Dlugosz, Chappell, McGillivray, 
Syme, & Garland, 2009; Girard, Rezende, & Garland Jr., 2007; Gomes et al., 2009; 
Rezende et al., 2009). Additional information quality can be gleaned by video analysis, 
for example, detailing the degree of intermittency and for identifying variants such as 
running on the outside of the wheel (Waters et al., 2008). 
Based on experiments showing rats lever pressing for access to the wheel (Iversen, 
1993) and rats that run long distances each day show withdrawal symptoms (including 
anger) when the wheel is removed, or if access is blocked (Hoffmann, Thorén, & Ely, 
1987), it has been assumed that voluntary wheel-running is rewarding for rodents. In fact, 
comparative psychologists have considered it to represent the classic self-motivated 
behaviour (Jónás et al., 2010). A review (Sherwin, 1998) of early work utilising wheel-
running found evidence indicating that various species are highly motivated to run on 
wheels, even when absent from external reward. However, the nature of wheel-running 
is quite a contentious topic. There have been claims that it is merely a response to 
captivity, though a recent study observed frequent repeated wheel-running activity by 
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mice in the wild (Meijer & Robbers, 2014). This quite elegantly demonstrates that wheel-
running, even in wild mice, can be an elective behaviour. Though voluntary activity, 
particularly measured via wheel-running, is the most directly relevant parallel to human 
exercise behaviour (such as going for a walk/jog/run), to gain the full picture of physical 
activity behaviour, observations of SPA is also required. 
The assessment of SPA in rodents can be measured in several ways including 
photobeams to form a grid-like division of the cage, with force plates or with passive 
infrared motion detectors (Garland et al., 201 *ܗEF]\ĔVNL 	 .RQDU]HZVNL . 
Though these measures are many and varied they each have the same ultimate function, 
which is to record non-specific movement. Video analysis is required to distinguish 
between different obligatory exercise behaviours which combine to form SPA, however, 
a measurement of total movement (not accounting for individual activities) is akin to the 
use of accelerometry data which is often used to quantify general movement in humans 
(e.g., Schrader et al., 2013), which was discussed earlier in the general introduction 
(chapter 1 section 1.9.). 
A further distinction can be made with these measurements. Activity can be 
recorded in the home cage or in a novel environment such as in open-field tests (Hesse, 
Dunn, Heldmaier, Klingenspor, & Rozman, 2010; Viggiano, 2008) where SPA is 
assessed over a short period in a novel environment. Tests such as these are often used to 
measure the acute effects of drugs on SPA. Although very useful measurements in the 
right context, issues arise if they are interpreted inappropriately, such as making 
inferences about general behaviour based on behaviour in a novel environment (Careau, 
Bininda-Emonds, Ordonez, & Garland, 2012). 
Having access to a running wheel in the home cage has been shown to increase 
food consumption in rodents (R. R. Bell, Spencer, & Sherriff, 1997; Tokuyama, Saitot, 
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& Okuda, 1982). If wheel access causes an increase in food consumption, it can be 
assumed that the energy cost of the wheel-running is not fully compensated for by 
reducing other forms of home cage based physical activity. Unfortunately, very few 
studies have concurrently measured home-cage SPA and wheel-running so the extent to 
which increased voluntary exercise may cause compensatory reductions in SPA is 
unclear. One study that did concurrently measure wheel-running and SPA monitored mice 
exposed to either a fixed (accessible but not able to turn) or free wheel. SPA was lower 
in the free wheel condition (Koteja, Swallow, Carter, & Garland, Jr., 1999), suggesting 
that the increased energy required in wheel-running can be at least partly compensated by 
reducing SPA. Later investigations found that during a 6-day period mice decreased 
home-cage activity when allowed simultaneous access to a wheel but increased the total 
amount of time in activity (i.e., SPA and wheel-running combined) (De Visser, Van Den 
Bos, & Spruijt, 2005).  
 
8.5. Periodical wheel exposure  
Typically, animals that have access to a running wheel have it freely available 
throughout the entire 24-hour day cycle. There are many studies reporting physiological 
adaptation in response to wheel exposure, but a paucity of work intentionally using wheel-
running to elicit a training response, or as a model of human exercise behaviour. Those 
that experiment with reduced exposure to the wheels are often interested in outcomes 
other than a training response, such as its use as a non-photic stimulus for behavioural 
entrainment (Reebs & Mrosovsky, 1989; Sinclair & Mistlberger, 1997). Other studies 
obtain an acute behavioural measure of wheel-running as an equivalent to an open field 
experiment where animals are placed in a novel wheel outside of their home-cage 
environment (Antle, Steen, & Mistlberger, 2001; Sinclair & Mistlberger, 1997).  
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There is presently only one study that specifically uses restricted wheel exposure 
(i.e., less than 24-hr) as a training intervention (Leasure & Jones, 2008). Other studies 
have experimented with wheel movement restriction, where for portions of the day the 
wheel is able to move freely (Edgar & Dement, 1991).  Others restrict animals to their 
wheels (i.e., for a portion of the day the animal is enclosed within the wheel) (Antle et al., 
2001). The question that remains is which form of restriction is most appropriate for 
translation to human exercise behaviour. This issue will be discussed in more detail in 
chapter 10. 
 
8.6. Forced vs self-paced wheel-running 
When searching for literature relating to training interventions in animal models 
the most common exercise modality is treadmill running but µswimming¶ is also used. It 
can be argued that neither are truly representative of human exercise behaviour because 
of the forced nature of these exercise paradigms. For example, the gold standard treadmill 
test in rodents requires the use of a shock plate to provide electric shocks to animals who 
do not run (Booth, Laye, & Spangenburg, 2010). In this instance, volitional exhaustion is 
determined by the stage at which animals chose to receive the shock, rather than 
attempting to return to the moving belt of the treadmill (Booth et al., 2010; Jodar, 1995). 
/LNHZLVH ZLWK µVZLPPLQJ¶ WDVNs, rodents are not choosing to swim, instead there is 
usually insufficient purchase to stand and they are merely trying not to drown 
%RJGDQRYD .DQHNDU '¶$QFL 	 5HQVKDZ  -RGDU . Here, volitional 
exhustion is determined by the animal being unable to remain above the surface of the 
water (i.e., would drown without intervention). A study looked at both cold-and warm-
water forced swims, white noise, as well as continuous or intermittent inescapable foot 
shock stress (Fischman, Pero, & Kelly, 1996) finding that psychogenic stress induces 
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chromosomal and DNA damage. A recent study confirmed the hypothesis that 
involuntary exercising rats undergo more physical and also mental stress than voluntary 
exercising rats (Li, Kuo, Yen, Tsai, & Yang, 2014). With Treadmill running as the 
involuntary model and wheel-running as voluntary, rats performed locomotor exercise 
with wireless recording of hippocampal electroencephalogram (EEG). They found 
different theta signals across the two activities, specifically different changes in 
hippocampal theta rhythm and divergences in heart rate that may represent effects of an 
additional emotional state or sensory interaction during involuntary running. Similarly, a 
study compared forced wheel-running (motorised wheel) with self-paced wheel-running 
over a 1-hour period on activation of hypothalamic corticotropin-releasing hormone 
neurons in rats (Yanagita, Amemiya, Suzuki, & Kita, 2007). The authors reported that 
although there was no difference in terms of distance ran between the forced wheel-
running and self-paced wheel-running groups, there was a marked increase in the number 
of double Fos/CRH-positive cells in the hypothalamic paraventricular nucleus for the 
forced wheel-running group. Whereas there was only a small increase for the self-paced 
wheel-running group, suggesting that spontaneous wheel-running is a milder stressor than 
forced wheel-running. A study sought to test the hypothesis that equivalent amounts of 
forced and voluntary exercise would exert different effects on physiological, behavioural, 
and neural parameters previously shown to be influenced by exercise (Leasure & Jones, 
2008). Rats exercised five days per week and total activity was matched daily between 
self-paced wheel-running and forced wheel-running groups. After 8 weeks training, in an 
open-field test, forced exercisers were significantly less active and entered significantly 
fewer central squares than voluntary exercisers or sedentary controls. Forced exercise 
also increased defecation, a measure of emotionality in rodents. These results suggest that 
long-term forced exercise influences affect-related behaviours.  
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Together, these three studies suggest that there is no clear advantage of using 
forced exercise as a training stimulus in rodents. In most cases, total work was no greater 
than in free running rats but there is undue stress that appears to have long-term negative 
consequences to activity behaviour. This is a very important implication for the 
development of our model. Clearly, with the primary objective of this thesis being to 
examine the effects of pharmacological intervention on feelings during exercise, the 
increased psychological stress associated with forced exercise on a treadmill or motorised 
wheel, for example, would not be appropriate. Instead, a freely movable wheel allowing 
self-paced running activity would provide a more suitable model of human voluntary 
exercise behaviour. 
 
8.7. Nocturnal vs diurnal ± time of day 
Another important factor in developing a translational model of physical activity 
is time and how it relates to daily activity. Through history mammals have evolved to be 
active (or indeed, inactive) at times of day and night, to suit their needs. Success in the 
essential roles of hunting, prey avoidance and raising offspring are key determinates in 
species survival. Optimal timing of behaviour leads to distinct activity-sleep patterns 
emerging such as nocturnal, or diurnal, where species are predominantly active during 
the night, or day, respectively (Refinetti, 2016).  
Light has the greatest influence on circadian rhythms. In circadian biology timing 
FXHVVXFKDVOLJKWVRQRUOLJKWVRIIDUHUHIHUUHGWRDVµ]HLWJHEHUV¶DQGXQGHUDQ\FRQWUROOHG
regime, time is referred to as Zeitgeber Time (ZT) (Golombek & Rosenstein, 2010). Each 
ZT unit is equal to one conventional hour with the timing of the cue, zeitgeber, set 
according to the physical day. The usual convention has ZT12 as the time of lights off 
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when nocturnal animals will be driven by the cue to become active. For diurnal species, 
such as humans, the onset of activity would coincide with ZT0.  
Recorded locomotor activity may be plotted graphically as an actogram to 
demonstrate timing of daily activity onsets and offsets relative to the external day along 
with the intensity and duration of activity bouts. In mice, a standard regime of 12 hours 
light/12 hours dark results in episodes of activity largely confined to the dark hours with 
an absence of activity during the light (see Figure 8.1.). In mice, characteristically, 
activity is low during the light phase, intense when lights go off, a nadir mid-way through 
the dark phase, with higher levels of activity returning toward the end of the dark phase 
(see Figure 8.2.). 
Regarding human equivalent times, ZT12 marks the start of the active phase in 
mice which would correspond with human morning time. The nadir in the third quarter 
of the active phase ZT18-21 would represent a human equivalent afternoon time. These 
two periods are potentially suitable, as models of morning or afternoon/early evening 
exercise in humans respectively.  
 
Figure 8.1. Representative actogram of nocturnal activity in a mouse demonstrating synchronisation to 
12:12-hour light-dark (LD) cycle. Dark vertical plots represent activity via infrared motion detection over 





Figure 8.2. Displays a rhythm plot of infrared motion detection activity throughout the LD cycle. 
Characteristically, activity is low during the light phase, intense when lights go off, a nadir mid-way through 
the dark phase, with higher levels of activity toward the end of the dark phase. Black/White bar at the 
bottom of the graph denotes LD cycle. 
 
8.8. Dose conversion between animals and humans 
Understanding the concept of extrapolation of dose between species is important 
when initiating new animal or human experiments. Interspecies allometric scaling 
considers the differences in body surface area in relation to mass for dose conversion 
from animal to human studies and vice versa (Nair & Jacob, 2016). A correction factor 
(Km) is estimated by dividing the average body weight (kg) of a species by its body surface 
area (m2). The example, provided by Nair and Jacob (2016), is that the average human 
body weight is 60 kg, and the body surface area is 1.62 m2. Therefore, the Km factor for 
humans is calculated by dividing 60 by 1.62, which is 37 (Table 8.1.). The Km factor 
values of various animal species (Table 8.1.) can be used to estimate the Human 
equivalent dose (HED) as: 
156 
 
HED ( mgÂkg) = Animal dose (mgÂkg) × (Animal Km / Human Km) 
The Km ratio (i.e., Animal Km / Human Km) values provided in table 8.1. are 
obtained by dividing human Km factor by animal Km factor or vice versa. For instance, 
the Km ratio values for mice are 12.333 and 0.081, obtained by dividing 37 (human Km 
factor) by 3 (animal Km factor) and vice versa, respectively. To obtain the HED values 
(mgÂkg), one can either divide or multiply the animal dose (mgÂkg) by the Km ratio 
provided in Table 8.1. For example, for a caffeine dose of 40 mgÂkg in mice, the HED 
would be 3.24 mgÂkg. 




8.9. The effects of Caffeine on SPA and wheel-running 
The first piece of research investigating the effect of caffeine administration on 
activity in rodents was conducted by Dews (1953). Using group housed mice and home-
cage motion detection total activity was recorded. For doses between 2.5 and 40 mgÂkg 
activity increased, whereas, for 80 mgÂkg activity decreased (Dews, 1953). Caffeine also 
stimulates activity in animals that are individually housed (Halldner et al., 2004; 
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Pettijohn, 1979; Yacoubi, Ledent, Ménard, et al., 2000), when activity is measured by 
open-field (Halldner et al., 2004; Yacoubi, Ledent, Ménard, et al., 2000) and wheel-
running (Antle et al., 2001; Pettijohn, 1979), at doses between 5 and 45 mgÂkg (Antle et 
al., 2001; Halldner et al., 2004; Meliska & Loke, 1984; Yacoubi, Ledent, Ménard, et al., 
2000). In some cases, doses above 50 mgÂkg either fail to increase activity or reduce 
activity (Antle et al., 2001; Yacoubi, Ledent, Ménard, et al., 2000), and the toxic dose for 
mice is between 125 and 500 mgÂkg (Seale et al., 1984). Together these studies suggest 
that doses lower than 50 mgÂkg ought to be selected to avoid a potential suppression in 
physical activity. 
 Generally, with these acute studies intraperitoneal (IP) injections have been used, 
however, with repeated doses, it is more common to see a mixture, with some studies 
using IP injections and others using oral administration (caffeinated drinking water). With 
any differences in methodology it is important to interpret with caution, but in this case 
there is some research directly comparing the two. Although compared using food 
reinforcement rather than a measure of physical activity, Wang and Lau (1998) found that 
FDIIHLQH¶VXSWDNHSKDUPDFRNLQHWLFVDQGEHKDYLRXUDOHIIHFWVDUHVLPLlar if injected IP or 
consumed orally in rats. In a study measuring physical activity, there was a difference, it 
seems that tolerance develops faster with IP than with oral administration (Lau & Falk, 
1994).  
Repeated exposure to adenosine receptor ligands (particularly to A1 receptor 
ligands and caffeine) can lead to a rapid development of tolerance, which is evident in 
both motor and cardiovascular responses (J. F. Chen, Eltzschig, & Fredholm, 2013; 
Fredholm et al., 1999) and is insurmountable even by high doses (Holtzman & Finn, 
1988). One particular study reported that after 24 days chronic caffeine injections, whilst 
measuring open field activity daily, behavioural tolerance developed as quickly as 2-3 
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days, but was dose-dependent. With a dose of 10 mgÂkg tolerance was incomplete, 
whereas, with a dose of 80 mgÂkg the tolerance was complete (Lau & Falk, 1995). Other 
studies have used intermediary doses, finding that with IP doses of 40 mgÂkg tolerance 
was incomplete after 21 doses (Lau & Falk, 1994). An inevitable consequence of 
substance tolerance is withdrawal, which was the subject of one particular study. Chronic 
oral ingestion of caffeine in mice caused a marked reduction in SPA, following which, 
At least 4 days of withdrawal were required to restore activity to normal levels, and 7 
days withdrawal for normal dose responses 1LNRGLMHYLü-DFREVRQ	'DO\.  
Despite evidence suggesting that pharmacokinetics of caffeine are similar when 
administered IP or orally, the reduced chance of developing behavioural tolerance to the 
IP route makes it desirable. Also, contrary to oral administration, there is the additional 
advantage of being able to standardise the exact time and quantity of the dose, rather than 
calculating the dose by measuring consumption after the fact. 
While tolerance implies a lessening of drug effect, some behavioural adaptations 
to drugs involve enhancement of the effect of the drug (Meliska & Trevor, 1978) this is 
referred to as sensitisation (Stewart & Badiani, 1993). Sensitisation is where a substance 
becomes more effective with each dose (Cauli, Pinna, Valentini, & Morelli, 2003; Simola, 
Morelli, & Seeman, 2008). With caffeine this effect may be attributed to an increase in 
dopamine receptors, specifically, rats that are sensitised to caffeine have been shown to 
express an increase of 126% in striatal D2 high-affinity receptors (Simola et al., 2008). 
In one of the pioneering studies observing caffeine and behaviour, rats experienced with 
caffeine wheel-running ran more wheel revolutions than those without prior experience 
of caffeine (Meliska & Loke, 1984). A subsequent study sought to disentangle whether 
this sensitisation was a result of 1) prior drug 2) prior wheel-running, or 3) prior combined 
drug and wheel-running experience. They found that neither prior drug nor wheel-running 
159 
 
experience moderated wheel-running with caffeine, whereas experience in combined 
caffeine and wheel-running produced increased stimulation (Meliska, Landrum, & Loke, 
1985). It seems this effect also extends to open field assessments of physical activity, as 
long as caffeine is consumed on intermittent rather than consecutive days the effect is 
consistent. With the consumption of caffeinated water every other day, despite rats 
consuming significantly less over time (i.e., their self-selected dose reduced), physical 
activity stimulation increased (Ball & Poplawsky, 2011). In another study, interestingly, 
caffeine produced cross sensitisation to nicotine and amphetamine (i.e., caffeine 
sensitisation made rats more sensitive to nicotine and amphetamine too), suggesting that 
they have similar central mechanisms (Celik, Uzbay, & Karakas, 2006). In light of these 
studies, it seems that treatment with caffeine would ideally be given on alternate days, 
rather than consecutive days to potentially elicit behavioural sensitisation rather than 
tolerance. 
 
8.10. Summary of implications for model development 
The primary objective of this thesis is to examine the effects of pharmacological 
intervention on feelings during exercise, rather than on general physical activity or SPA. 
Therefore, voluntary exercise behaviour is the primary outcome, however, it makes 
theoretical sense to also monitor general cage activity in order to identify any 
compensation in physical activity following exercise. The model should use caffeine 
doses of lower than 50 mgÂkg to avoid a potential suppression in physical activity. In 
terms of scientific rigour and to elicit desirable behavioural effects, IP injections should 
be used rather than oral administration. There seems to be a strong rationale, related to 
potential behavioural sensitisation for caffeine to be administered on alternative rather 
than consecutive days. Both ZT12 and ZT18 provide potentially suitable human 
160 
 
equivalent times, corresponding to morning and afternoon respectively, to test the 
behavioural effects of pharmacological intervention. 
Regarding the exercise paradigm directly, there does not appear to be any 
advantage of using a forced exercise paradigm. Instead, a freely movable wheel allowing 
self-paced running activity would provide a more suitable model of human behaviour. 
There is one thing, however, which is not at all clear in relation to wheel access. How 
much wheel exposure should animals have? Should they be enclosed within the wheel or 








9.1. Animal model 
(Used in chapters 10, 11, & 12) 
Male Wild Type C57BL/6J -$;6WUDLQPLFH, obtained from Charles River 
Laboratories (Kent), were used in all experimental procedures. 
 
9.2. Home-cage environment and wheel enclosure 
(Used in chapters 10, 11, & 12) 
Mice were individually housed in polypropylene cages measuring approximately 
34 cm (l) x 16 cm (W) x 13 cm (h). During the enclosed EFWR observation period a 
running wheel was introduced to the home-cage environment. Running wheels were of 
cardboard construction, 81mm in diameter, and 55mm wide. A cap was fitted to enclose 
mice within the freely movable wheel. The cap is clear and with breathing holes, however, 
it does block access to food and water for the duration of the EFWR observation period. 
Outside of EFWR procedures food and water were available ad libitum, however, the 
home cages did not have access to a running wheel. 
 
9.3. Adenosine Antagonist ± Caffeine 
(Used in chapters 10, 11, & 12) 
Two different doses of caffeine (Sigma-Aldrich, Dorset, UK) were used (20 
mgÂkg, and 40 mgÂkg), administered via intraperitoneal (Ip) injection. The 20 mgÂkg 
caffeine solution was at a concentration of 20.6 mM and mice received 5µl/g. For 
example, a mouse of 25 g would receive 150 µl, a dose of 0.5 mg. For the higher, 40 
mgÂkg, dose of caffeine, the solution was at a higher concentration of 41.2 mM whilst 
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mice also received 5 µl/g. For example, the 150 µl given to a mouse weighing 25 g would 
be a dose of 1 mg.  
 
9.4. Dopamine antagonist ± Haloperidol 
(Used in chapter 12) 
Haloperidol (Sigma-Aldrich, Dorset, UK), was administered at a dose of 0.2 
mgÂkg. The vehicle for haloperidol was a 0.3% tartaric acid (Love Brewing Limited, 
Chatsworth Road Chesterfield, UK) solution, which has been used previously in mice 
(Correa et al., 2016). The haloperidol solution was at a concentration of 106.425µM and 
mice received 5µl/g. For example, a mouse of 25g would receive 150µl, a dose of 5µg. 
 
9.5. IP injection procedure 
(Used in chapters 10, 11, & 12) 
Individually, mice were briefly removed from their home cages and weighed. 
With mass recorded, a 1ml syringe, with a 0.5 (25G) x 16mm hypodermic needle, was 
charged with the correct volume of solution. The conscious mouse was manually 
restrained (Simmons & Brick, 1970) and held in a supine position with its posterior end 
slightly elevated. The needle was pushed in at an approximately 10° angle between the 
needle and the abdominal surface in the lower-left, or lower-right, quadrant of the 
abdomen (Simmons & Brick, 1970). To avoid leakage from the puncture point, the needle 
ran through subcutaneous tissue in a cranial direction for 2±3 mm and then inserted 
through the abdominal wall (Cunliffe-Beamer & Las, 1987). Once the needle had reached 
the intraperitoneal cavity the solution was released from the syringe. After injections had 
been administered mice were promptly returned to their home-cage.  
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9.6. Wheel-running activity monitoring and data acquisition 
(Used in chapters 10, 11, & 12) 
Running wheels have a small magnet built in that is detected each time a full wheel 
revolution is completed. Wheel revolutions were recorded in 1-minute bins (total number 
of revolutions for per minute) using Chronobiology Kit (Stanford Software Systems, 
Santa Cruz, CA, USA).  
 
Measurements for analysis were as follows: 
Distance (m) covered in the 2-hour observation period, which was calculated by 
multiplying the number of revolutions by the internal circumference of the wheel. 
Average speed (across the entire 120 min observation period), and maximum speed (from 
the most intense minute of activity), were calculated by the following equation: (S = speed 
(m/minute); d = distance (m); and t = time (mins)) 
ܵ ൌ ݀Ȁݐ 
Sedentary time (expressed as a percentage) was calculated by dividing the number of 
minutes for which zero whole wheel revolutions were recorded, by the total number of 
minutes (120) x 100. 
 
9.7. Infrared motion detection and data acquisition 
(Used in chapters 10, 11, & 12) 
Motion detection sensors were mounted directly above each cage; these sensors 
use a passive system that detects infrared energy. Each time movement is detected a trip 
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is switched ± which resets after 3 seconds. Motion sensor trips (counts) were recorded in 
1-minute bins using Chronobiology Kit (Stanford Software Systems, Santa Cruz, CA, 
USA). Although motion detection can give an intensity output, with the maximum 
capacity of 20 trips per minute LHHYHU\VHFRQGVLWGRHVQ¶WKDYHWKHUHVROXWLRQRI
wheel-running ± where upwards of 10 revolutions may be recorded over the same 
duration. Infrared motion detection LQGLFDWHVJHQHUDODQGZKDWFDQEHWHUPHGµREOLJDWRU\¶
or spontaneous physical activity (SPA), such as collecting food, exploring, or playing.  
 
Measurements for analysis were as follows: 
Spontaneous physical activity. Taken as the average number of counts per minute 
(count/min) over a given period. For example, over the remainder of the active phase, 






10. Effects of caffeine administration at ZT12 on subsequent 
wheel-running activity during open vs enclosed free wheel-




The aim of Part II of this thesis is to develop a pre-clinical model, to test the 
efficacy of using long-term repeated drug administration to increase physical activity 
behaviour. We are developing the model using caffeine though, if successful, it will 
provide a platform to test other substances in the future. The animal introduction (chapter 
8) identified a gap in the literature that will need to be addressed before progressing to 
experimental trials.  
For the pre-clinical trial, it is essential that the frequency, intensity, time, and type 
of activity are as relevant for human populations as possible. The use of open-field (novel 
environments for activity assessment) experiments or forced exercise (on either a 
motorised treadmill or wheel) have been ruled out for reasons discussed in chapter 8. 
Therefore, a self-paced wheel-running paradigm is preferred. 
 In previous studies, typically, animals that have access to a running wheel have 
it freely available throughout their 24-hour cycle. There are many studies reporting 
physiological adaptation in response to wheel exposure, but a paucity of work 
intentionally using wheel-running to elicit a training response. Those that experiment with 
reduced exposure to the wheels are often interested in outcomes other than a training 
response. As discussed in chapter 8, there is currently only one study that specifically 
uses restricted wheel exposure (i.e., less than 24-hr) as a training intervention (Leasure & 
Jones, 2008), where rats ran on wheels for a limited time, based on distance covered each 
day.  
 Studies have experimented with wheel movement restriction, where the wheel is 
only able to move freely for portions of the day (Edgar & Dement, 1991), whilst others 
restrict animals to their wheels (i.e., for a portion of the day the anim
168 
 
the wheel) (Antle et al., 2001). The question here is: which form of restriction is most 
appropriate for our model?  
The two exercise paradigm options to be considered are: Open free wheel-running 
(OFWR) (i.e., having a wheel available in the home cage for a period); or enclosed free 
wheel-running (EFWR) (i.e., enclosing the animal in the wheel for a period). The other 
primary consideration is time on the wheel, which will represent the exercise period 
GXUDWLRQ,Q/HDVXUHDQG-RQHV¶(2008) study, where they compared spontaneous vs forced 
wheel-running, their exercise period was determined by the time to complete a set 
distance, which increased throughout the study. However, this meant that the spontaneous 
runners, by running significantly faster, ran for shorter periods than the forced runners. 
Other studies have controlled for the duration, opting for 1 (Antle et al., 2001; Wickland 
& Turek, 1991), 2 (Reebs & Mrosovsky, 1989), 3 (Sinclair & Mistlberger, 1997) or 6 - 
12 hours (Edgar & Dement, 1991). There are two key considerations for our model: 1) 
the duration must be sufficient to observe the maximum effect of our intervention; 2) it 
cannot be so long that it is not appropriate for inferences and application to human 
populations to be made. 6 ± 12 hours in the gym, for example, would not be an appropriate 
model for human voluntary exercise behaviour. 
The primary objective in conducting this study was to determine the most 
appropriate form of wheel access to use in our pre-clinical model to assess the effects of 






Fifteen male Wild Type (C57 BL/6J) mice were obtained from Charles River 
Laboratories (Kent). Mice were 4-7 months of age, weighing (M ± SD) 29 ± 1g, 
individually housed (as described in General Animal Methods section 9.2.) under a 12:12 
light:dark cycle (01:00 ± 13:00). Food and water were available ad libitum, except for 
during EFWR trials. 
 
10.2.2. Study design 
This study utilised a fully within-subject design, where all mice completed each 
of the experimental conditions. Subjects completed two baseline trials (receiving no 
treatment), as well as four experimental trials, which were completed in a randomised 
order (randomization.com). There was a minimum of 48 hours between each trial.  
 
10.2.3. Experimental procedures 
Following baseline measurements of OFWR and EFWR for a 2-hour observation 
period between ZT12 and ZT15, subjects were randomly allocated to a treatment order to 
complete the four experimental conditions (there are 24 possible permutations of four 
conditions). The four experimental conditions were: A) OFWR following 20 mgÂkg 
caffeine; B) EFWR following 20 mgÂkg caffeine; C) OFWR following physiological 
saline (0.9% NaCl); and D) EFRW following physiological saline (0.9% NaCl). 
Treatments were administered IP (See General Animal Methods section 9.5. for details). 
During all four experimental trials, mice were first briefly removed from their home cages 
and weighed. With mass recorded, a syringe was charged with the correct volume of 
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either caffeine or saline solution. After the treatment had been administered the mice were 
promptly returned to their home cage. As soon as mice returned to their respective home 
cages they either had open wheel access (OFWR condition) or were enclosed within the 
wheel (EFWR condition) (see General Animal Methods section 9.2. and 9.6 for details). 
On completion of a 2-hour observation period of OFWR or EFWR, wheels were removed. 
 
Figure 10.1. Shows the initiation time for experimental procedures in relation to the light-dark cycle. 
Treatment administration is marked by an illustrated syringe. 
 
 





10.2.4. Statistical analysis 
Separate 2-way (wheel access/treatment) repeated measures ANOVAs were used 
for between trial comparisons of wheel-running activity. The Shapiro-Wilk's test of 
normality on the studentised residuals was performed for all variables. Following a 
significant interaction between wheel access and treatment, simple main effects were run. 
5HVXOWVZHUHFRQVLGHUHGVLJQLILFDQWDWS$OOWHVWVZHUHFDUULHGRXWXVLQJIBM SPSS 






There was a statistically significant interaction between wheel access and 
treatment F(2, 26) = 22.913, p < .001SDUWLDOȘ2 = .638. Therefore, simple main effects 
were performed.  
In the open condition, baseline wheel-running (623.143 ± 104.261 revolutions) 
was statistically significantly higher than following saline (368.404 ± 72.033 
revolutions), or caffeine (179.124 ± 37.400 revolutions), with mean differences of 
254.739 (95% CI, 123.132 to 386.347), p = .001, and 444.019 (95% CI, 276.447 to 
611.590) p < .001, respectively. Furthermore, wheel-running following caffeine 
treatment was statistically lower than following the saline treatment, p = .001, with a 
mean difference of -189.279 (95% CI, -284 to -94.321). 
In the enclosed condition, baseline wheel-running (379.616 ± 78.951 revolutions) 
was statistically significantly higher than following caffeine (252.369 ± 42.829 
revolutions), p = .017, with a mean difference of 127.248 (95% CI, 26.416 to 228.080). 
There was not a statistically significant difference between baseline and saline (306.834 
± 49.680 revolutions), p = .066, or between saline and caffeine, p = .051, with mean 
differences of 72.782 (95% CI, -5.495 to 151.060) and -54.466 (95% CI, -109.155 to 
.224) respectively. 
Wheel-running activity was statistically significantly lower in the enclosed 
condition compared to the open condition at baseline t(13) = -4.281, p = .001, with a mean 
difference of -243.53 (95% CI, -366.423 to -120.630) revolutions. There was no 
difference between wheel-running activity in the enclosed condition compared to the 
open condition following saline injections, t(13) = 1.686, p = .116, a mean difference of 
61.569 (95% CI, -17.316 to 140.454).  Whilst wheel-running activity was higher in the 
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enclosed condition compared to the open condition following caffeine injections, with a 
mean difference of 73.24 (95% CI, -.962 to 147.451), this was not statistically significant, 
t(13) = 2.13, p = .053. (See Figure 10.3.). 
 
Figure 10.3. Enclosed (EFWR) vs open (OFWR) free wheel-running activity, during a 2-hour observation 
period, at baseline and following injections of physiological saline or 20 mgÂkg caffeine. The time of day 
was ZT12 (start of the active phase). All values are presented as means ± SEM. Indications of significance 
derive from 2-way RM ANOVAs and subsequent simple main effects.  Significant main effect of wheel 
access 301). # Significant main effect of treatment 3 *** (horizontal) Significant wheel access 
x treatment LQWHUDFWLRQ301). * (vertical) indicates significant simple main effect of treatment DW3





The primary objective of this study was to determine the most appropriate form 
of wheel access to use in our pre-clinical model. Specifically, a within-subject design was 
employed to test two different wheel access paradigms. These were EFWR and OFWR. 
Each of these paradigms was completed in three treatment conditions: at baseline (no 
treatment), following saline (control), and following 20 mgÂkg caffeine. These two forms 
of wheel access have both been used previously in the literature but never compared 
experimentally so a directional hypothesis was not formulated. 
Although there is a consensus among the literature that caffeine stimulates 
locomotive activity, observed frequently with analysis of open field behaviour (Halldner 
et al., 2004; Yacoubi, Ledent, Ménard, et al., 2000), and voluntary wheel-running (Antle 
et al., 2001; Pettijohn, 1979). The results from this study suggest the opposite, with 
caffeine administration either failing to increase wheel-running (in the EFWR condition) 
or in fact depressing wheel-running (in the OFWR condition).  
Unfortunately, there is a disconnect in the literature between rodent exercise 
training studies and studies observing the effects of caffeine, where may lie an 
explanation for this unexpected result. In training studies, utilising wheel-running or 
treadmills, the exercise is mostly completed at the start of the dark period (their active 
phase) (e.g., Leasure & Jones, 2008; Oudot, Larue-Achagiotis, Anton, & Verger, 1996) 
which corresponds to a humans¶ morning. Whereas caffeine studies, where the time of 
day is reported (scarcely so), in 12h light/dark cycles caffeine is typically administered 
during the day (inactive period) (e.g., Halldner et al., 2004; Yacoubi et al., 2000), whilst 
other studies place the rodents in to a 24h light cycle and do not report time of day at all 
(Meliska et al., 1985; Meliska & Loke, 1984). In any case, it seems that few, if any studies 
have investigated the effects of caffeine administration during the night (active phase) on 
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wheel-running, thus, there is no context to place the results of our study in. There are two 
potential explanations, however. Though acute administration of caffeine has been shown 
to stimulate home cage, and wheel-running activity acutely (during the inactive phase), 
the effect of behavioural sensitisation must also be considered. There is also the 
possibility that there is an issue with our home cage and/or wheels, which is preventing 
us from observing any possible effect. 
Sensitisation is a specific form of tolerance where the behavioural effect of a 
pharmacological intervention becomes more effective with repeat administrations (Cauli 
et al., 2003; Simola et al., 2008). Though, as previously mentioned, caffeine acutely 
increased physical activity, there are cases where the increases in activity are not 
statistically significant until multiple doses are given (e.g. Meliska, Landrum, & Loke, 
1985). Therefore, it is clear that a more thorough investigation of the effects of repeated 
doses of caffeine on physical activity, at times that are relevant to human behaviour (i.e., 
ZT12 and/or ZT18), is needed. However, it is also important to ascertain whether the 
unexpected effect of caffeine reported in this experiment is a true effect or whether it is 
an artefact, resulting from a un-identified issue with our home cage environment or 
running wheel, as setups vary between labs (De Bono et al., 2006; Sherwin, 1998). 
Therefore, the next phase of development should also LQFOXGHDµSURRIRIFRQFHSW¶, testing 
this wheel-running paradigm at a time corresponding to studies demonstrating the 
stimulatory effects of caffeine published in the literature (i.e., during the inactive phase). 
The suppression of wheel-running activity was an unexpected finding from this 
study, but it has led to the generation of ideas in several areas which will feed into 
subsequent work. The other factor, which was the primary objective of this study was 
regarding the wheel access paradigms.  
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At baseline, wheel-running activity was significantly lower in the EFWR 
paradigm than it was in the OFWR paradigm. This can either be taken as evidence 
supporting Ryan DQG'HFL¶V (2000) SDT, as animals appear to complete more voluntary 
wheel-running in the OFWR paradigm, when they are provided autonomy over their 
behaviours, i.e., they can choose to: eat, drink, play, climb, or indeed run on the wheel. 
Whilst in the EFWR paradigm, where they are enclosed within the wheel, there are only 
two options: run, or do not run. An alternative explanation is that the EFWR paradigm 
captures a more specific form of behaviour, which is whole body movement (i.e., walking 
or running), whilst the OFWR paradigm allows mice to access the top of the wheel via 
the side of the cage where they could push the wheel. Likewise, mice can stand beside 
the wheel and push or pull the wheel using only their upper body, or even a single limb. 
Qualitatively, these behaviours are relatively complex and have been described by studies 
using cameras to gain additional information quality (Waters et al., 2008). The dilemma 
here is that the OFWR paradigm seems more ecologically valid, and translates very 
clearly to human behaviour, where, for example, humans may go to the gym and chose 
to engage in a few different activities, at will, including using the treadmill. Whilst the 
EFWR paradigm is akin to a human being put on a treadmill with a leash and seeing how 
far they are willing to walk/run. The issue, however, with the OFWR paradigm is that it 
is not possible to quantify workload of these alternative behaviours. Using the previous 
example of a human in the gym choosing activities at will. If it was only possible to 
measure activity when they chose to use the treadmill, the full effect of an intervention 
could not be capturing. When the mouse is inside the wheel it cannot coast, so they need 
to maintain full body movement for the wheel to rotate, whereas, from the outside mice 
can push/pull the wheel and then step away allowing it to spin freely. The other issue that 
it presents it that it introduces the factor of intent. The purpose of this thesis is to facilitate 
H[HUFLVH E\ PDQLSXODWHG IHHOLQJV µGXULQJ¶ ZKLFK VKRXOG VXEVHTXHQWO\ LPSDFW IXWXUH
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decision to engage in physical activity. It is not, however, necessarily to influence 
intention to engage in general physical activity.  
Although activity is lower in the EFWR paradigm at baseline (as discussed 
above), this effect is not true in either of the treatment conditions. There is no difference 
between conditions following the saline treatment. Whilst there is a trend for higher 
activity in the EFWR paradigm following caffeine treatment, which is not significant. 
Wheel-running activity was different between all treatments (i.e., baseline vs saline, 
baseline vs caffeine, and saline vs caffeine) in the OFWR paradigm. Whilst in the EFWR 
paradigm, activity was lower following the caffeine treatment than it was at baseline, but 
there were no further differences. Broadly, comparing OFWR to EFWR we see a 
regression to the mean. With more variation in voluntary physical activity in OFWR than 
in EFWR. Together, the higher variability in physical activity in the OFWR paradigm 
supports the argument presented above, that the OFWR paradigm is capturing various 
non-specific activity behaviours. Therefore, the EFWR paradigm seems to be a more 
appropriate way to capture the specific behavioural outcome that we are targeting, which 
is voluntary physical activity behaviour, in a way that is translatable to humans. 
The other factor that would be important to clarify in future work is with regard 
to the caffeine dose that was used here. Although 20 mgÂkg is within the effective dose 
range published in the literate (see Animal Introduction section 8.9) it is possible that it 
was not sufficient to elicit an increase in wheel-running. 
 
10.4.1. Conclusion 
In conclusion, in this study, there were some unexpected findings. Caffeine 
seemed to suppress activity rather than simulate it. However, it is unclear whether this 
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unexpected finding can be attributed the single dose that was administered here, rather 
than repeated doses. Or whether there is an unidentified issue with our home cage 
environment or wheel setup. Or whether the dose used here was insufficient to stimulate 
wheel-running exercise in either the OFWR or EFWR paradigms. Consequently, 
experimental work detailed in the following chapter (chapter 11) will investigate each of 
these issues.  
In relation to the wheel-running access paradigms, it appears that wheel-running 
activity is more variable in the OFWR which has a potential psychological explanation 
(discussed above) and a strictly practical one. The simplest of the two explanations for 
this finding is that OFWR presents a more general physical activity paradigm, whereas 
EWFR directly captures the behavioural output that we are targeting with our 
pharmacological intervention. Therefore, it seems that EFWR presents the most suitable 
wheel access paradigm to observe the behavioural effects of pharmacological intervention 




11. Examining time-of-day and caffeine dose effects on physical 





In the previous chapter, a study was conducted to determine the most appropriate 
wheel access paradigm to assess the effects of pharmacological intervention on physical 
activity behaviour. The conclusion was that enclosed free wheel-running (EFWR), where 
mice are enclosed within the wheel for a 2-hour observation period following treatment, 
was better able to capture the specific behavioural outcome that is being targeted than the 
OFWR paradigm, where mice were freely able to access the wheel and engage in other 
activities in their home cage. The other finding was that caffeine did not stimulate activity 
in either wheel access paradigm. Three potential issues were discussed. These were: 1) 
Only a single dose of caffeine was administered, rather than repeated doses on different 
days; 2) There may be an identified issue with our home cage environment or running 
wheel setup that is confounding the effect of the intervention; 3) the dose (20 mgÂkg) used 
may have been insufficient to stimulate wheel-running in the EFWR paradigm.  
Sensitisation is where a drug¶s effect is enhanced with repeated doses, which is a 
concept that was introduced and discussed in the Animal Introduction (section 8.9.) and 
presented as a possible explanation for the suppressing effect of caffeine on wheel-
running in chapter 10 (section 4). Meliska and Loke (1984) provided early evidence of a 
sensitisation effect to wheel-running following caffeine administration (15 mgÂkg and 45 
mgÂkg). They found that although activity was increased, the increase did not become 
statistically significant until the third dose. In a subsequent study (Meliska et al., 1985) 
rats received repeated doses of caffeine (15 mgÂkg, injected IP) and wheel-running 
activity was measured. There was a trend for an increase in wheel-running activity for the 
first dose (p = 0.1), which also became significant after repeated doses. As they did not 
analyse wheel-running activity after every dose it is not possible to determine how many 
doses were required to elicit a significant increase in activity. All that can be concluded 
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is that it was significantly increased (compared to control (distilled water)) by the eighth 
dose (p = 0.01). In a study a few years later (Meliska, Landrum, & Landrum, 1990), albeit 
delivering caffeine via drinking water rather than IP injections and monitoring wheel-
running activity continuously throughout a 24/h period. Wheel-running (which was 
analysed for each day) increased with each dose, becoming statistically significant after 
the fifth dose. Although only Meliska and Loke (1984) used a comparable EFWR 
paradigm, this sensitisation effect appears prevalent regardless of wheel access. 
Therefore, at least 3 ± 5 repeated intermittent doses of caffeine should be administered to 
account for this effect. 
As was discussed in the previous chapter (10), in studies investigating the effect 
of caffeine on physical activity behaviours in rodents, where the time of day is reported 
(scarcely so), in 12h light/dark cycles caffeine is typically administered during the day 
(inactive period) (e.g., Halldner et al., 2004; Yacoubi et al., 2000), whilst other studies 
place the rodents in to a 24h light cycle and do not report time of day at all (e.g., Meliska 
et al., 1985; Meliska & Loke, 1984). In any case, it seems that few, if any studies have 
investigated the effects of caffeine administration during the night (active phase). In order 
to identify whether there is an unidentified issue with our home cage environment and/or 
running wheels, it is necessary to test the EFWR paradigm at a time of day corresponding 
to that used by studies reporting increased wheel-running following caffeine ingestion. 
This would serve as a µproof of concept¶ and confirm the suitability of the EFWR 
paradigm used herein. 
In addition to repeated doses and exploring a potential time-of-day dependent 
effect of caffeine, the other factor that was identified as a limitation of the previous 
chapter was the inclusion of only one caffeine dose. The initial dose of 20 mgÂkg is 
approximately the midpoint of the effective dose range reported to stimulate wheel-
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running activity in the literature. Which is between 5 and 45 mgÂkg (Antle et al., 2001; 
Halldner et al., 2004; Meliska & Loke, 1984; Pettijohn, 1979; Yacoubi, Ledent, Ménard, 
et al., 2000). The other reason this dose was chosen is that it corresponds to a HED of 
1.622 mgÂkg, (i.e., ~2 cups of coffee, or 3-4 cups of tea, for an average sized human) (Nair 
& Jacob, 2016). As it cannot be ascertained from the results in chapter 10 whether the 
caffeine dose was insufficient to elicit a behavioural response or whether there is an 
alternative explanation. It is, therefore, necessary to include an additional dose. For 
example, 40 mgÂkg in mice would correspond with a HED of 3.24 mgÂkg, which is similar 
to the dose was shown to be effective (3 mgÂkg) at facilitating exercise in chapters 4 and 
5. 
This chapter presents the experimental work from three studies which have been 
designed to address each of the issues identified here. Study I serves as a proof of concept, 
testing the EFWR paradigm during the inactive phase, which corresponds to studies in 
the literature reporting an increase in wheel-running following caffeine administration. 
Study II and III test the EFWR paradigm at the start of the active phase and in the middle 
of the active phase respectively. In each of the three studies no fewer than 6 repeated 
intermittent doses were administered, on separate days, to account for a potential 
sensitisation effect. Finally, an additional dose of 40 mgÂkg was included.  
 The primary hypothesis of this study is that with repeated doses of caffeine will 
elicit an increase in wheel-running activity. Further, it is expected that the higher dose 
will elicit a greater increase in wheel-running. 
A secondary hypothesis is that sensitisation will account for a delayed stimulatory 
effect of caffeine when administered during the active phase. Therefore, after multiple 




11.2.1. Study design 
The schematic presented in Figure 11.1. illustrates the protocol followed in each 
of the three studies described herein. All three studies utilise a mix-model study design, 
with one within-subject factor, of time (treatment occasion/trial), and one between-
subject factor, of treatment group. Universally, subjects completed baseline trials with no 
treatment, where EFWR and SPA data were recorded. Next, subjects entered the 
experimental phase of the study, where they were allocated to either a treatment group or 
a control group. Subjects completed a total of 6 trials, where their respective treatment 
was administered via IP injection. After which, subjects were enclosed within a running 
wheel, in their home-cage, for a 2-hour EFWR observation period (see General Animal 
Methods section 9.2. and 9.6 for details). Once subjects were removed from their wheel, 
SPA was passively monitored throughout the ensuing light and dark periods (see General 
Animal Methods section 9.7 for details). Details, such as subject numbers, group 
allocation, the time of day in which procedures were initiated, and the periods and 
duration of SPA monitoring are provided in the following sections. 
 
Figure 11.1. General study schematic. Syringe indicates treatment administration.  
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Study i) Effects of caffeine administration at ZT06 (human equivalent night-time) on 
subsequent EFWR and SPA 
11.2.2. Subjects 
Fifteen male Wild Type (C57 BL/6J) mice were obtained from Charles River 
Laboratories (Kent). Mice were 12-15 months of age, weighing (M ± SD) 37 ± 4g, 
individually housed (as described in General Animal Methods section 9.2.) under 12:12 
light:dark cycle (01:00 ± 13:00). Food and water were available ad libitum, except for 
during the EFWR procedure. 
 
Figure 11.2. Shows the initiation time for experimental procedures in study i, in relation to the light-dark 
cycle. Treatment administration is marked by an illustrated syringe. 
 
11.2.3. Experimental procedures 
Following baseline measurements of EFWR for a 2-hour observation period 
between ZT06 and ZT09 and subsequent SPA, subjects were randomly allocated 
(randomization.com) to one of three treatment groups. In experimental trials, mice 
received injections at ZT06 (see Figure 11.2.) (administered IP), of either saline (n = 5), 
20 mgÂkg caffeine (n = 5), or 40 mgÂkg caffeine (n = 5). Once treatments had been 
administered mice were returned to their home-cage and placed within their running 
wheel. On completion of a 2-hour EFWR period, wheels were removed. SPA was 
measured continuously, and three time periods were extracted for analysis in this study. 
These were: between ZT09 (+3h) and ZT12 (+6h) (the remainder of the inactive phase); 
between ZT12 (+6h) and ZT00 (+18h) (the following active phase); and between ZT00 
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(+18h) and ZT12 (+30h) (the next inactive phase). Average SPA was calculated from 
each of these blocks and used for statistical analysis. 
 
Study ii) Effects of caffeine administration at ZT12 (human equivalent morning-time) on 
subsequent EFWR and SPA 
11.2.4. Subjects 
Eleven male Wild Type (C57 BL/6J) mice were obtained from Charles River 
Laboratories (Kent). Mice were 6-9 months of age, weighing (M ± SD) 32 ± 2g, 
individually housed (as described in General Animal Methods section 9.2.) under 12:12 
light:dark cycle (01:00 ± 13:00). Food and water were available ad libitum, except for 
during the EFWR procedure. 
 
Figure 11.3. Shows the initiation time for experimental procedures in study ii, in relation to the light-dark 
cycle. Treatment administration is marked by an illustrated syringe. 
 
11.2.5. Experimental procedures 
Following baseline measurements of EFWR for a 2-hour observation period 
between ZT12 and ZT15 and subsequent SPA, subjects were randomly allocated 
(randomization.com) to one of two treatment groups. Initially, mice received injections 
at ZT12 (see Figure 11.3.) (administered IP), of either saline (n = 5), or 20 mgÂkg caffeine 
(n = 6). Subsequently, the protocol was repeated with the same mice receiving either 
saline (n = 5) or 40 mgÂkg caffeine (n = 6). In both instances, once treatments had been 
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administered mice were returned to their home-cage and placed within their running 
wheel. On completion of a 2-hour EFWR period, wheels were removed. SPA was 
measured continuously, and two time periods were extracted for analysis in this study. 
These were: between ZT15 (+3h) and ZT24 (+12h) (the remainder of the active phase); 
and between ZT00 (+12h) and ZT12 (+24h) (the following inactive phase). Average SPA 
was calculated from each of these blocks and used for statistical analysis. 
 
Study iii) Effects of caffeine administration at ZT18 (human equivalent afternoon-time) 
on subsequent EFWR and SPA 
11.2.6. Subjects 
Fifteen male Wild Type (C57 BL/6J) mice were obtained from Charles River 
Laboratories (Kent). Mice were 9-12 months of age, weighing (M ± SD) 35 ± 3g, 
individually housed (as described in General Animal Methods section 9.2.) under 12:12 
light:dark cycle (01:00 ± 13:00). Food and water were available ad libitum, except for 
during the EFWR procedure. 
 
Figure 11.4. Shows the initiation time for experimental procedures in study iii, in relation to the light-dark 
cycle. Treatment administration is marked by an illustrated syringe. 
 
11.2.7. Experimental procedures 
Following baseline measurements of EFWR for a 2-hour observation period 
between ZT12 and ZT15 and subsequent SPA, subjects were randomly allocated 
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(randomization.com) to one of two treatment groups. Initially, mice received injections 
at ZT12 (see Figure 11.4.) (administered IP), of either saline (n = 7), or 20 mgÂkg caffeine 
(n = 8). Subsequently, the protocol was repeated with the same mice receiving either 
saline (n = 7) or 40 mgÂkg caffeine (n = 8). In both instances, once treatments had been 
administered mice were returned to their home-cage and placed within their running 
wheel. On completion of a 2-hour EFWR period, wheels were removed. SPA was 
measured continuously, and two time periods were extracted for analysis in this study. 
These were: between ZT21 (+3h) and ZT00 (+6h) (the remainder of the active phase); 
and between ZT00 (+6h) and ZT12 (+18h) (the following inactive phase). Average SPA 
was calculated from each of these blocks and used for statistical analysis. 
 
11.2.8. Statistical analyses 
Separate ANCOVAs were performed, using baseline activity as a covariate 
(Vickers & Altman, 2001), for SPA for each period (i.e., remainder of inactive/active, 
following inactive/active/ and next inactive/active). The assumption of homogeneity of 
regression slopes was tested by examining the interaction between the covariate (baseline 
values), and the independent variable (treatment group), which was accepted if the 
interaction term was not statistically significant S. Standardised residuals for the 
interventions and for the overall model were normally distributed, as assessed by Shapiro-
Wilk's test (p > .05). Homoscedasticity and homogeneity of variances were assessed by 
visual inspection of a scatterplots and Levene's test of homogeneity of variance (p = > 
.05), respectively.  
In some instances, EFWR variables violated the assumption of homogeneity of 
regression slopes (as described above). ANCOVA is not robust to violations of this 
important assumption, therefore, a decision was made to perform separate two-way mixed 
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model ANOVAs on change scores (Vickers & Altman, 2001). Here, post-intervention 
values are subtracted from baseline values at each time point (trial/dose) to create a 
negative or positive value indicating a decrease or increase from pre-intervention levels. 
For consistency, this analysis was used for all EFWR variables (i.e., distance, sedentary 
time %, average speed, and maximum speed) in each of the three studies described in this 
chapter. The Shapiro-Wilk's test of normality on the studentised residuals was performed 
for all variables. Where sphericity was violated degrees of freedom were corrected with 
the Greenhouse±*HLVVHUİ(Maxwell & Delaney, 2004). When necessary, a Bonferroni 
post-hoc procedure was used for follow-up comparisons. Effect sizes for relevant 
comparisons were calculated usiQJ&RKHQ¶VGDQGGHILQHGDVWULYLDO30), small (
0.3), moderate ( ), and large ( 0.8), respectively (Cohen, 1992). Results were 
FRQVLGHUHGVLJQLILFDQWDWS$OOWHVWVZHUHFDUULHGRXWXVLQJIBM SPSS Statistics 




11.3. Results  
Study i) Effects of caffeine administration at ZT06 (human equivalent night-time) on 
subsequent EFWR and SPA 
11.3.1. ZT06 EFWR distance 
There was a statistically significant two-way interaction between group and time 
for running distance during EFWR, F(10, 60) = 2.353, p = .020. Simple main effects for 
group were performed. Change scores in the caffeine 40 mgÂkg treatment group (57.940 
± 63.153 m) were statistically significantly higher at dose 4 compared to the saline group 
(-144.057 ± 39.834). With a mean difference of 201.996 (95% CI 64.213 to 339.780) m, 
p = .008. There were no other statistically significant differences between groups. Simple 
main effects for time did not reveal any statistically significant differences over time for 
any group. (Figure 11.5. A). 
 
11.3.2. ZT06 EFWR sedentary time  
There was a main effect for group, showing that change scores were statistically 
significantly different between groups, F(2, 12) = 21.372, p < .001. There was no 
statistically significant main effect of time, F(5, 60) = 2.723, p = .028. There no 
statistically significant two-way interaction between group and time for sedentary time 
during EFWR, F(10, 60) = 1.599, p = .129. Post hoc analysis was performed with a 
Bonferroni adjustment, revealing that change scores for sedentary time during EFWR 
were statistically significantly higher in the saline group (31.967 ± 6.680%) than they 
were in the caffeine 20 mgÂkg (-11.220 ± 6.680%), or caffeine 40 mgÂkg (-27.867 ± 
6.680%) groups. With mean differences of 43.187 (95% CI 22.604 to 63.770)%, p = .001, 
and 59.833 (95% CI 39.250 to 80.417)%, p < .001, respectively. There was no statistically 
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significant difference between sedentary time change scores in the caffeine 20 mgÂkg 
group, compared to the caffeine 40 mgÂkg group, with a mean difference of -16.646 (95% 
CI -37.229 to 3.937)%, p = .103. (Figure 11.5. B). 
 
11.3.3. ZT06 EFWR average speed 
There was a statistically significant two-way interaction between group and time 
for average running speed during EFWR, F(10, 60) = 2.022, p = .046. Simple main effects 
were performed for group and for time. There were no statistically significant simple main 
effects for group or time factors. (Figure 11.5. C). 
 
11.3.4. ZT06 EFWR maximum speed 
There was a statistically significant two-way interaction between group and time 
for maximum running speed during EFWR, F(10, 60) = 2.360, p = .020. Simple main 
effects for group revealed that maximum speed change scores were statistically 
significantly lower in the caffeine 20 mgÂkg group (-2.879 ± .466 m/min) compared to 
the saline group (-.876 ± .431 m/min) at dose 1. With a mean difference of -2.003 (95% 
CI -3.988 to -.018) m/min, p = .048. There were no further statistically significant group 
differences. There were not statistically significant simple main effects of time for any 




Figure 11.5. Enclosed free wheel-running activity, during a 2-hour observation period, at baseline and 
following multiple treatment occasions. The time of day was ZT6 (middle of the inactive phase). Mice 
received injections (administered IP) of either saline (n = 5), 20 mgÂkg caffeine (n = 5), or 40 mgÂkg caffeine 
(n = 5). A) total distance covered B) percentage of sedentary time. C) average running speed. D) maximum 
running speed. All values are presented as means ± SEM. Indications of significance derive from ANOVAs 
completed on within-VXEMHFWFKDQJHVFRUHYDOXHV6LJQLILFDQWPDLQHIIHFWRIWLPH36LJQLILFDQW
PDLQHIIHFWRIFRQGLWLRQ36LJQLILFDQWFRQGLWLRQ[WLPHLQWHUDFWLRQ3:KHUHDVLJQLILFDQW







11.3.5. ZT06 SPA 
 Between ZT09 (+3h) and ZT12 (+6h) (the remainder of the inactive phase) there 
was a statistically significant difference in SPA between groups, F(2, 9) = 18.719, p = 
SDUWLDOȘ Post hoc analysis was performed with a Bonferroni adjustment. 
SPA was significantly lower in the saline compared to the 20 mgÂkg caffeine (mean 
difference of .815 (95% CI, .2890 to 1.349) counts/min, p = .005) and 40 mgÂkg caffeine 
(mean difference of 1.094 (95% CI, .522 to 1.666) counts/min, p = .001) groups. There 
was not a statistically significant difference in SPA between 20 mgÂkg caffeine and 40 
mgÂkg caffeine (mean difference of 0.279 (95% CI, -.329 to .887) counts/min, p = .632) 
(see also Table 11.1.). 
Between ZT12 (+6h) and ZT00 (+18h) (the following active phase) SPA did not 
differ significantly between groups, of saline (1.16a ± .10 counts/min), 20 mgÂkg caffeine 
(.82a ± .09 counts/min), or 40 mgÂkg (.82a ± .10 counts/min), F(2, 9) = 4.01, p = .057, 
SDUWLDOȘ (see also Table 11.1). 
Between ZT00 (+18h) and ZT12 (+30h) (the next inactive phase) there was a 
statistically significant difference in SPA between groups, F(2, 9) = 6.561, p = .017, 
SDUWLDOȘ Post hoc analysis was performed with a Bonferroni adjustment. SPA 
was significantly lower in the saline compared to the 40 mgÂkg caffeine (mean difference 
of .093 (95% CI, .018 to .168) counts/min, p = .017). Whilst there was not a statistically 
significant difference in SPA between saline and 20 mgÂkg caffeine (mean difference of 
0.059 (95% CI, -.020 to .138) counts/min, p = .165), or between 20 mgÂkg caffeine and 
40 mgÂkg (mean difference of 0.034 (95% CI, -.034 to .101) counts/min, p = .532) (see 




Table 11.1. Adjusted and unadjusted means and variability for SPA, in a home-cage environment, 
following IP injections of high-dose caffeine (40 mgÂkg), low-dose caffeine (20 mgÂkg), or saline at ZT18 
and a 2-hour period of enclosed wheel-running, with baseline SPA as a covariate. M = Mean, SD = Standard 
Deviation, SEM = Standard Error of the Mean. Activity was measured in counts/min. 
Dose administration: ZT06 
Wheel: ZT06 (+0h) ± ZT09 (+3h) 
 Unadjusted Adjusted 
N M SD M SEM 
ZT09 (+3h) ± ZT12 (+6h) 
UHPDLQLQJµLQDFWLYH¶SKDVH 
Saline 4 1.08 .06 1.08a .13 
Caffeine 
20 mgÂkg 5 1.76 .27 1.90
a * .13 
Caffeine 
40 mgÂkg 4 2.34 .53 2.17
a * .14 
ZT12 (+6h) ± ZT00 (+18h) 
)ROORZLQJµDFWLYH¶SKDVH 
Saline 4 1.16 .13 1.16a .10 
Caffeine 




40 mgÂkg 4 .82 .20 .82
a
 .10 
ZT00 (+18h) ± ZT12 (+30h) 
1H[WµLQDFWLYH¶SKDVH 
Saline 4 .18 .04 .17a .02 
Caffeine 




40 mgÂkg 4 .26 .05 .26
a
 * .02 




Study ii) Effects of caffeine administration at ZT12 (human equivalent morning-time) on 
subsequent EFWR and SPA 
11.3.6. ZT12 EFWR distance 
There was not a main effect of condition, showing that distance change scores 
were not statistically significantly different between the caffeine 20 mgÂkg, and saline 
groups, F(1, 9) = .123, p = .734. With a mean difference of -9.674 (95% CI, -72.110 to 
52.763) m. There was no statistically significant main effect of time, F(5, 45) = 1.035, p = 
.409. There was not a statistically significant two-way interaction between group and 
time, F(5, 45) = .347, p = .882. (Figure 11.6. A). 
The main effect of condition showed that distance change scores were statistically 
significantly lower in the caffeine 40 mgÂkg group compared to the saline group, F(1, 9) 
= 8.645, p = .016. With a mean difference of -136.718 (95% CI, -241.904 to -31.533) m. 
There was no statistically significant main effect of time, F(2.878, 25.898) = 1.027, p = 
.395, İ = .576. There was not a statistically significant two-way interaction between group 
and time, F(2.878, 25.898) = 1.836, p = .167, İ = .576. (Figure 11.7. A). 
 
11.3.7. ZT12 EFWR sedentary time  
The main effect of condition showed that sedentary time change scores were 
statistically significantly lower in the caffeine 20 mgÂkg group compared to the saline 
group, F(1, 9) = 14.372, p = .004. With a mean difference of -13.151 (95% CI, -20.999 
to -5.304)%. There was no statistically significant main effect of time, F(5, 45) = .704, p = 
.623. There was not a statistically significant two-way interaction between group and 
time, F(5, 45) = .822, p = .541. (Figure 11.6. B). 
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There was not a main effect of condition, showing that sedentary time change 
scores were not statistically significantly different between the caffeine 40 mgÂkg and 
saline groups, F(1, 9) = 2.420, p = .154. With a mean difference of -7.099 (95% CI, -
17.423 to 3.224)%. There was no statistically significant main effect of time, F(5, 45) = 
.917, p = .479. There was not a statistically significant two-way interaction between 
group and time, F(5, 45) = .752, p = .589. (Figure 11.7. B). 
 
11.3.8. ZT12 EFWR average speed 
There was not a main effect of condition, showing that average speed change 
scores were not statistically significantly different between the caffeine 20 mgÂkg, and 
saline groups, F(1, 9) = 3.243, p = .105. With a mean difference of -.662 (95% CI, -1.493 
to .169) m/min. There was no statistically significant main effect of time, F(5, 45) = 
.783, p = .567. There was not a statistically significant two-way interaction between 
group and time, F(5, 45) = 1.203, p = .323. (Figure 11.6. C). 
The main effect of condition showed that average speed change scores were 
statistically significantly lower in the caffeine 40 mgÂkg group compared to the saline 
group, F(1, 9) = 15.769, p = .003. With a mean difference of -1.574 (95% CI, -2.471 to -
.677) m/min. There was no statistically significant main effect of time, F(5, 45) = 
.717, p = .614. There was not a statistically significant two-way interaction between 






11.3.9. ZT12 EFWR maximum speed 
There was not a main effect of condition, showing that maximum speed change 
scores were not statistically significantly different between the caffeine 20 mgÂkg, and 
saline groups, F(1, 9) = .014, p = .907. With a mean difference of -.148 (95% CI, -2.930 
to 2.635) m/min. There was no statistically significant main effect of time, F(5, 45) = 
.528, p = .754. There was not a statistically significant two-way interaction between 
group and time, F(5, 45) = .884, p = .500. (Figure 11.6. D). 
The main effect of condition showed that maximum speed change scores were 
statistically significantly lower in the caffeine 40 mgÂkg group compared to the saline 
group, F(1, 9) = 6.525, p = .031. With a mean difference of -3.501 (95% CI, -6.602 to -
.401) m/min. There was no statistically significant main effect of time, F(5, 45) = 
.537, p = .747. There was not a statistically significant two-way interaction between 






Figure 11.6. Enclosed free wheel-running activity, during a 2-hour observation period, at baseline and 
following multiple treatment occasions. The time of day was ZT12 (start of the active phase). Mice received 
injections (administered IP) of either saline (n = 5), or 20 mgÂkg. caffeine (n = 6). A) total distance covered 
B) percentage of sedentary time. C) average running speed. D) maximum running speed. All values are 






Figure 11.7. Enclosed free wheel-running activity, during a 2-hour observation period, at baseline and 
following multiple treatment occasions. The time of day was ZT12 (start of the active phase). Mice received 
injections (administered IP) of either saline (n = 5), or 40 mgÂkg. caffeine (n = 6). A) total distance covered 
B) percentage of sedentary time. C) average running speed. D) maximum running speed. All values are 








11.3.10.  ZT12 SPA 
 Between ZT15 (+3h) and ZT24 (+12h) (the remainder of the active phase) there 
was not a statistically significant difference between spontaneous physical activity the 
saline group (1.24a ± .11 counts/min) compared to the caffeine group (1.37a ± .11 
counts/min), a mean difference of -.128 (95% CI, -.498 to .243) counts/min, F(1, 7) = 
S SDUWLDOȘ Between ZT00 (+12h) and ZT12 (+24h) (the following 
inactive phase) spontaneous physical activity was statistically significantly higher in the 
saline group (.17a ± .01 counts/min) compared to the caffeine group (.12a ± .01 
counts/min), a mean difference of -.054 (95% CI, .012 to .090) counts/min, F(1, 7) = 
S SDUWLDOȘ (see also Table 11.2.).  
 Between ZT15 (+3h) and ZT24 (+12h) (the remainder of the active phase) there 
was not a statistically significant difference between spontaneous physical activity the 
saline group (1.26a ± .06 counts/min) compared to the caffeine group (1.40a ± .06 
counts/min), a mean difference of .137 (95% CI, -.072 to .347) counts/min, F(1, 6) = 
S SDUWLDOȘ %HWZHHQ=7KDQG=7KWKHIROORZLQJ
inactive phase) spontaneous physical activity was statistically significantly higher in the 
saline group (.18a ± .01 counts/min) compared to the caffeine group (.14a ± .01 
counts/min), a mean difference of -.039 (95% CI, -.064 to -.013) counts/min, F(1, 6) = 







Table 11.2. Adjusted and unadjusted means and variability for SPA, in a home-cage environment, 
following IP injections of caffeine (20 mgÂkg) or saline at ZT12 and a 2-hour period of enclosed wheel-
running, with baseline SPA as a covariate. M = Mean, SD = Standard Deviation, SEM = Standard Error of 
the Mean. Activity was measured in counts/min. 
Dose administration: ZT12 
Wheel: ZT12 (+0h) - ZT15 (+3h) 
 Unadjusted Adjusted 
N M SD M SEM 
ZT15 (+3h) ± ZT00 (+12h) 
µ$FWLYHSKDVH¶ 
Saline 5 1.26 .12 1.24a .11 
Caffeine 8 1.35 .41 1.37a  .11 
ZT00 (+12h) ± ZT12 (+24h) 
µ,QDFWLYHSKDVH¶ 
Saline 5 .17 .02 .17a .01 
Caffeine 8 .12 .02 .12a * .01 
* Indicates that adjusted means are significantly different from saline treatment group (p  .05). 
 
Table 11.3. Adjusted and unadjusted means and variability for SPA, in a home-cage environment, 
following IP injections of caffeine (40 mgÂkg) or saline at ZT12 and a 2-hour period of enclosed wheel-
running, with baseline SPA as a covariate. M = Mean, SD = Standard Deviation, SEM = Standard Error of 
the Mean. Activity was measured in counts/min. 
Dose administration: ZT12 
Wheel: ZT12 (+0h) - ZT15 (+3h) 
 Unadjusted Adjusted 
N M SD M SEM 
ZT15 (+3h) ± ZT00 (+12h) 
µ$FWLYHSKDVH¶ 
Saline 4 1.23 .12 1.26a .06 
Caffeine 5 1.42 .28 1.40a .06 
ZT00 (+12h) ± ZT12 (+24h) 
µ,QDFWLYHSKDVH¶ 
Saline 4 .18 .02 .18a .01 
Caffeine 5 .14 .02 .14a * .01 







Study iii) Effects of caffeine administration at ZT18 (human equivalent afternoon-time) 
on subsequent EFWR and SPA 
11.3.11. ZT18 EFWR distance 
There was not a main effect of condition, showing that distance change scores 
were not statistically significantly different between the caffeine 20 mgÂkg, and saline 
groups, F(1, 13) = .348, p = .566. With a mean difference of -26.856 (95% CI, -125 to 
71.539) m. There was a statistically significant main effect of time, F(2.498, 32.469) = 
3.560, p = .031. Changes over time did not depend on group as there was not a statistically 
significant two-way interaction between group and time, F(2.498, 32.469) = 2.340, p = 
.İ  (Figure 11.8. A). 
There was not a main effect of condition, showing that distance change scores 
were not statistically significantly different between the caffeine 40 mgÂkg, and saline 
groups, F(1, 13) = .484, p = .499. With a mean difference of -27.849 (95% CI, -114.371 
to 58.673) m. There was a statistically significant main effect of time, F(2.951, 38.367) 
= 3.209, p = .034İ 90. Changes over time did not depend on group as there was not 
a statistically significant two-way interaction between group and time, F(2.951, 38.367) 
= 1.832, p = .158İ 90. (Figure 11.9. A). 
 
11.3.12. ZT18 EFWR sedentary time  
The main effect of condition showed that sedentary time change scores were 
statistically significantly lower in the caffeine 20 mgÂkg group compared to the saline 
group, F(1, 13) = 8.742, p = .011. With a mean difference of -12.456 (95% CI, -21.557 
to -3.335)%. There was also a statistically significant main effect of time, F(5, 65) = 
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4.178, p = .002. There was not a statistically significant two-way interaction between 
group and time, F(5, 65) = .894, p = .491. (Figure 11.8. B). 
The main effect of condition showed that sedentary time change scores were 
statistically significantly lower in the caffeine 40 mgÂkg group, compared to the saline 
group, F(1, 13) = 26.664, p < .001. With a mean difference of -25.951 (95% CI, -36.809 
to -15.094)%. There was no statistically significant main effect of time, F(5, 65) = 
1.781, p = .129. Differences between groups does depend on time (dose) as there is a 
statistically significant two-way interaction between group and time, F(5, 65) = 
2.730, p = .027. Simple main effects were performed for group differences at each time-
point (dose). At dose 1 sedentary time change scores were statistically significantly lower 
in the caffeine 40 mgÂkg (-12.718 ± 3.834%) group compared to the saline (2.734 ± 
4.314%) group, F(1, 13) = 7.221, p = .019. At dose 2 sedentary time change scores were 
statistically significantly lower in the caffeine 40 mgÂkg (-10.984 ± 2.999%) group 
compared to the saline (10.053 ± 3.966%) group, F(1, 13) = 18.448, p = .001. At dose 3 
sedentary time change scores were statistically significantly lower in the caffeine 40 
mgÂkg (-15.359 ± 3.720%) group compared to the saline (14.304 ± 4.337%) group, F(1, 
13) = 27.283, p < .001. At dose 4 sedentary time change scores were statistically 
significantly lower in the caffeine 40 mgÂkg (-13.484 ± 5.237%) group compared to the 
saline (20.443 ± 5.772%) group, F(1, 13) = 19.031, p = .001. At dose 5 sedentary time 
change scores were statistically significantly lower in the caffeine 40 mgÂkg (-13.796 ± 
3.340%) group compared to the saline (12.297 ± 4.080%) group, F(1, 13) = 24.821, p < 
.001. At dose 6 sedentary time change scores were statistically significantly lower in the 
caffeine 40 mgÂkg (-14.525 ± 5.825%) group compared to the saline (15.012 ± 4.493%) 




11.3.13. ZT18 EFWR average speed 
There was not a main effect of condition, showing that average speed change 
scores were not statistically significantly different between the caffeine 20 mgÂkg, and 
saline groups, F(1, 13) = 1.884, p = .193. With a mean difference of -.541 (95% CI, -
1.393 to .311) m/min. There was no statistically significant main effect of time, F(2.471, 
32.117) = 1.846, p = .167 İ  494. There was not a statistically significant two-way 
interaction between group and time, F(2.471, 32.117) = 2.624, p = .077İ 494. (Figure 
11.8. C). 
The main effect of condition showed that average speed change scores were 
statistically significantly lower in the caffeine 40 mgÂkg group compared to the saline 
group, F(1, 13) = 9.309, p = .009. With a mean difference of -.921 (95% CI, -1.572 to -
.269) m/min. There was also a statistically significant main effect of time, F(2.845, 
36.984) = 3.055, p = .043 İ  569. There was not a statistically significant two-way 
interaction between group and time, F(2.845, 36.984) = 1.819, p = .163İ . (Figure 
11.9. C). 
 
11.3.14. ZT18 EFWR maximum speed 
There was not a main effect of condition, showing that maximum speed change 
scores were not statistically significantly different between the caffeine 20 mgÂkg, and 
saline groups, F(1, 13) = .008, p = .928. With a mean difference of -.076 (95% CI, -1.878 
to 1.725) m/min. There was no statistically significant main effect of time, F(5, 65) = 
2.007, p = .089. There was not a statistically significant two-way interaction between 
group and time, F(5, 65) = .532, p = .751. (Figure 11.8. D). 
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There was not a main effect of condition, showing that maximum speed change 
scores were not statistically significantly different between the caffeine 40 mgÂkg group 
and the saline group, F(1, 13) = .959, p = .345. With a mean difference of -.872 (95% CI, 
-2.796 to 1.052) m/min. There was no statistically significant main effect of 
time, F(2.930, 38.093) = 2.031, p = .127İ 86. There was not a statistically significant 
two-way interaction between group and time, F(2.930, 38.093) = 1.312, p = .284 İ  







Figure 11.8. Enclosed free wheel-running activity, during a 2-hour observation period, at baseline and 
following multiple treatment occasions. The time of day was ZT18 (middle of the active phase). Mice 
received injections (administered IP) of either saline (n = 7), or 20 mgÂkg. caffeine (n = 8). A) total distance 
covered B) percentage of sedentary time. C) average running speed. D) maximum running speed. All values 
are presented as means ± SEM. Indications of significance derive from ANOVAs completed on within-





Figure 11.9. Enclosed free wheel-running activity, during a 2-hour observation period, at baseline and 
following multiple treatment occasions. The time of day was ZT6 (middle of the active phase). Mice 
received injections (administered IP) of either saline (n = 7), or 40 mgÂkg caffeine (n = 8). A) total distance 
covered B) percentage of sedentary time. C) average running speed. D) maximum running speed. All values 
are presented as means ± SEM. Indications of significance derive from ANOVAs completed on within-
VXEMHFW FKDQJH VFRUH YDOXHV  6LJQLILFDQW PDLQ HIIHFW RI WLPH 3   6LJQLILFDQW PDLQ HIIHFWRI
FRQGLWLRQ36LJQLILFDQWFRQGLWLRQ[WLPHLQWHUDFWLRQ3:KHUHDVLJQLILFDQWLQWHUDFWLRQLV
SUHVHQW>D@UHSUHVHQWVVLJQLILFDQWGLIIHUHQFHVEHWZHHQFRQGLWLRQVDWWKHWLPHSRLQWV LQGLFDWHG3






11.3.15. ZT18 SPA 
 Between ZT21 (+3h) and ZT00 (+6h) (the remainder of the active phase) there was 
not a statistically significant difference between spontaneous physical activity in the 
saline group (1.44a ± .11 counts/min) compared to the caffeine group (1.54a ± .09 
counts/min), a mean difference of -.098 (95% CI, -.406 to .209) counts/min, F(1, 10) = 
S SDUWLDOȘ %HWZHHQ=7KDQG=7KWKHIROORZLQJ
inactive phase) there was not a statistically significant difference between spontaneous 
physical activity in the saline group (.21a ± .01 counts/min) compared to the caffeine 
group (.17a ± .01 counts/min), a mean difference of -.034 (95% CI, -.070 to .002) 
FRXQWVPLQ) S SDUWLDOȘ (see also Table 11.4.).  
 Between ZT21 (+3h) and ZT00 (+6h) (the remainder of the active phase) there was 
not a statistically significant difference between spontaneous physical activity in the 
saline group (1.55a ± .10 counts/min) compared to the caffeine group (1.60a ± .08 
counts/min), a mean difference of .051 (95% CI, -.242 to .344) counts/min, F(1, 10) = 
S SDUWLDOȘ %HWZHHQ=7KDQG=7KWKHIROORZLQJ
inactive phase) spontaneous physical activity was statistically significantly higher in the 
saline group (.20a ± .01 counts/min) compared to the caffeine group (.14a ± .01 
counts/min), a mean difference of -.058 (95% CI, -.102 to -.014) counts/min, F(1, 10) = 







Table 11.4. Adjusted and unadjusted means and variability for SPA, in a home-cage environment, 
following IP injections of caffeine (20 mgÂkg) or saline at ZT18 and a 2-hour period of enclosed wheel-
running, with baseline SPA as a covariate. M = Mean, SD = Standard Deviation, SEM = Standard Error of 
the Mean. Activity was measured in counts/min. 
Dose administration: ZT18 
Wheel: ZT18 (+0h) ± ZT21 (+3h) 
 Unadjusted Adjusted 
N M SD M SEM 
ZT21 (+3h) ± ZT00 (+6h) 
µ$FWLYHSKDVH¶ 
Saline 5 1.45 .26 1.44a .11 
Caffeine 5 1.54 .21 1.54a .09 
ZT00 (+6h) ± ZT12 (+18h) 
µ,QDFWLYHSKDVH¶ 
Saline 5 .21 .02 .21a .01 
Caffeine 5 .17 .03 .17a .01 
 
Table 11.5. Adjusted and unadjusted means and variability for SPA, in a home-cage environment, 
following IP injections of caffeine (40 mgÂkg) or saline at ZT18 and a 2-hour period of enclosed wheel-
running, with baseline SPA as a covariate. M = Mean, SD = Standard Deviation, SEM = Standard Error of 
the Mean. Activity was measured in counts/min. 
Dose administration: ZT18 
Wheel: ZT18 (+0h) ± ZT21 (+3h) 
 Unadjusted Adjusted 
N M SD M SEM 
ZT21 (+3h) ± ZT00 (+6h) 
µ$FWLYHSKDVH¶ 
Saline 5 1.45 .26 1.55a .10 
Caffeine 8 1.66 .38 1.60a .08 
ZT00 (+6h) ± ZT12 (+18h) 
µ,QDFWLYHSKDVH¶ 
Saline 5 .21 .02 .20a .01 
Caffeine 8 .14 .03 .14a * .01 









11.4.1. Effects of caffeine administration at ZT06 (Study i) 
Mice in the 40 mgÂkg caffeine group ran further than mice in the saline group 
following dose 4. However, rather than an increase in activity, it appears that the higher 
caffeine dose attenuated a decrease in running distance elicited by a saline injection. It is 
possible that the IP injection procedure caused a stress response which reduced wheel-
running (Ryabinin, Wang, & Finn, 1999). Whilst caffeine, which is reported to have an 
analgesic effect (Sawynok, 2011), may have protected against discomfort associated with 
the injection. Although these data provide partial support for the hypothesis that caffeine 
would stimulate wheel-running activity, the percentage of sedentary time demonstrates 
the effect more clearly. Percentage of sedentary time is simply the number of minutes in 
which the mice did not complete any wheel revolutions as a percentage of the total 
number of minutes in the 2-hour EFWR observation period (i.e., 120-minutes). Sedentary 
time was lower in the 20 mgÂkg and 40 mgÂkg caffeine groups than it was in the saline 
group. Meaning that mice receiving caffeine were physically active for a higher 
percentage of the EFWR observation period. This is the net effect of increased sedentary 
time in the saline groups and decreased sedentary time in the caffeine groups compared 
to baseline. 
SPA was higher in the 20 mgÂkg and 40 mgÂkg groups than it was in the saline 
groups during the remainder of the inactive phase, immediately following the EFWR 
observation period. This is not surprising as although the half-life of caffeine in mice is 
relatively short, between, 40 and 60 minutes, it can take 4 to 5 hours for complete 
elimination from serum and tissues (Hartmann & Czok, 1980). It is therefore likely that 
the higher SPA was a consequence of lasting effects of caffeine after EFWR cessation. 
Although not statistically significant, there is a trend for lower SPA in the following active 
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phase. This may either be due to a compensation in physical activity (Garland et al., 2011; 
Lark et al., 2018; Pontzer et al., 2016) following increase energy expenditure in the 
previous inactive period, or a symptom of circadian rhythm disturbance. Circadian 
rhythms can be shifted or entrained by light and by arousing nonphotic stimuli, such as 
wheel-running. In fact, EFWR for a 3-hour period at ZT4 (very similar to the present 
study) has been shown to alter intrinsic pacemaker properties in hamsters (Sinclair & 
Mistlberger, 1997). Although there was no difference for the 20 mgÂkg caffeine group, 
SPA in the 40 mgÂkg was significantly higher than in the saline group during the next 
inactive phase, which may be a lasting effect of circadian rhythm disruption (Sinclair & 
Mistlberger, 1997) from completing 2-hours EFWR in the middle of the inactive phase. 
 
11.4.2. Study ii, and iii) Effects of caffeine administration at ZT12 and ZT18 (Study ii, 
and iii) 
Together the findings from study ii and iii suggest that caffeine, when 
administered at times relevant to human exercise behaviour is resulting in mice being 
active for a higher percentage of the time during the EFWR observation period, however, 
this is not universally resulting in higher overall distance covered and is actually, 
particular with the higher dose, reducing average speed, and, during the human equivalent 
morning time (ZT12) when activity is usually most intense, maximum speed. 
SPA during the following inactive phase was higher in the 20 mgÂkg and 40 mgÂkg 
caffeine group at ZT12, and in the 40 mgÂkg caffeine group at ZT18. Similarly, where 
wheel-running stimulation at ZT06 may have induced a compensatory decrease in SPA, 
here the wheel-running suppression may have resulted in a compensatory increase in 
ensuing SPA (Lark et al., 2018; Pontzer et al., 2016). However, this proposed 
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compensatory relationship has not been tested in this direction (i.e., low exercise results 
in higher SPA) so it is purely speculative.  
These findings are concurrent with those from the previous chapter, as caffeine 
does not appear to stimulate wheel-running activity at times that are relevant to human 
exercise behaviour. In the previous chapter it was not possible to identify an explanation 
as there were several possibilities. However, this study has included multiple repeated 
intermittent doses on separate days, to investigate whether behavioural sensitisation to 
the effect of caffeine on wheel-running was limiting the acute effect. There is no evidence 
of sensitisation in any of the three studies detailed in this chapter. The other potential 
explanation was that the dose may have been too low to stimulate a significant increase 
in activity in our 2-hour EFWR paradigm. However, although the higher 40 mgÂkg 
caffeine dose appears to be more potent stimulating activity during the inactivity phase, 
it is arguably having a stronger suppressing effect during the active phase than the 20 
mgÂkg caffeine dose. The third potential explanation was that our home cage environment 
or wheel setup was somehow WKZDUWLQJ WKHHIIHFWRIFDIIHLQHKRZHYHURXU µSURRIRI
FRQFHSW¶ (study i) has demonstrated that caffeine does elicit a significant increase in 
wheel-running activity at times corresponding to studies reporting thus in the literature, 
effectively dispelling concerns about our procedures and environment. There must, 
therefore, be an alternative explanation.  
Although not directly related to physical activity, there is a study that is consistent 
with our findings, in relation to a time-of-day dependent caffeine effect. In this study 
(Hauber & Bareiß, 2001) theophylline (a metabolite of caffeine) elicited a significant 
improvement in performance in a working spatial memory task in rats. However, this 
effect was observed during the inactive phase only. When they repeated the procedure 
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during the active phase there was no difference in performance between rats the 
theophylline and saline condition. 
Caffeine appears to only be effective at increasing activity in mice when it is 
habitually low. This may be due to the fact that mice and other rodents find running 
inherently rewarding (Correa et al., 2016) and are highly motivated to do so. It is possible, 
therefore, that their wheel-running activity is already at a point of saturation and caffeine 
is unable to increase further. There is literature suggesting that running speed among 
rodents is tightly linked to dopamine turnover in the striatum (Freed & Yamamoto, 1985; 
Hattori, Naoi, & Nishino, 1994) and that dopaminergic activity is higher in mice bred 
selectively for high wheel-running (J. S. Rhodes, Gammie, & Garland, 2005b). A study 
(Renteria Diaz, Siontas, Mendoza, & Arvanitogiannis, 2013) demonstrated that among 
rats who completed high levels of wheel-running habitually, cocaine (10 mgÂkg), a 
dopamine agonist, did not increase locomotion in an open-field test. Whilst among 
relatively low wheel-running rats, locomotion was significantly increased. As caffeine 
(an adenosine antagonist) directly impacts on dopamine release (Josselyn & Beninger, 
1991; Nehlig et al., 1992), it is possible that our mice are similarly protected from 
behavioural sensitisation of caffeine due to altered dopaminergic activity associated with 
high wheel-running (J. S. Rhodes et al., 2005b).  
Interestingly, running is rewarding, but when dopaminergic activity has been 
suppressed preference shifts away from wheel-running. A recent study (Correa et al., 
2016) demonstrated that, although wildtype mice selected wheel-running over obtaining 
a high sucrose food under typical conditions, when mice were pre-treated with haloperidol 
(a dopamine antagonist) there was a significant decrease in selection for wheel-running 
and an increase in selection for obtaining a high sucrose food. Similarly, to examine the 
effects of adenosine antagonists on conditions of effort-related dysfunction, first 
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impairments are induced by creating lesions in areas of the brain responsible for 
calculating decision costs, or through pharmacological intervention to block dopamine 
(Salamone et al., 2012).  
 As for the suppressing effect of caffeine during our 2-hour EFWR paradigm, 
particularly with the higher (40 mgÂkg) dose. J. S. Rhodes and colleagues (2005) provide 
a suitable working hypothesis based on their work using mice bred for high wheel-running 
as a model of ADHD, which is characterised by hyperactivity. They found that opposing 
treatments of apomorphine (stimulates dopamine receptors) and raclopride (blocks 
dopamine receptors) both reduced wheel-running in mice. The authors reconcile this 
conflict by suggesting that if dopamine is necessary for wheel-running, then it seems 
likely that it would have to function at a specific level and that a pharmacological 
manipulation that disturbs the dopaminergic system in any way would have the potential 
to interfere with wheel-running. Thus, it is feasible that caffeine has disrupted 
dopaminergic regulation that impacts wheel-running. 
 
11.4.3. Conclusion 
In conclusion, we have found partial support for the hypothesis that caffeine 
would increase activity during the day. However, despite testing two (human equivalent) 
doses, and administering 6 repeated intermittent doses there was no evidence of 
behavioural sensitisation to caffeine. Therefore, we must reject the hypothesis that 
sensitisation would account for a delayed stimulatory effect of caffeine when 
administered during the active phase. It may be possible that these mice are simply not 
an appropriate model of human physical inactivity, which is an issue that is discussed in 
the next chapter (12). 
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12. A mouse model of human sedentary behaviour: Reversing the 






In the two previous chapters, we demonstrated for the first time that caffeine does 
not stimulate EFWR in mice at times of the day that are relevant to human exercise 
behaviour. Whilst we corroborate findings published in the literature which show that 
caffeine does effectively stimulate wheel-running at times when activity is otherwise 
habitually low. For example, during the inactive phase (human equivalent night time). 
We used two different doses of caffeine, at different times of the day, and following 
multiple repeated intermittent doses. It is remarkable that this finding has not before been 
published, however, there is some literature which indirectly supports our data.  
Although not relating to exercise behaviour per se, a similar time-of-day 
dependent effect of an adenosine antagonist (theophylline ± a metabolite of caffeine) has 
been observed. Theophylline administration elicited an improvement in spatial memory 
performance in rats during the inactive phase but not the active phase, where performance 
was higher than during the inactive phase but not altered by the drug (Hauber & Bareiß, 
2001). In other work, dopamine agonists (specifically these are dopamine transporter 
blockers) including Ritalin and Cocaine, which typically elicit a similar effect to caffeine, 
actually suppressed wheel-running activity among mice selectively bred for high levels 
of wheel-running, whereas in µFRQWURO¶PLFH wheel-running was slightly increased (J. S. 
Rhodes & Garland, 2003). Drawing a parallel to our work, it is possible that we have not 
been unable to elicit an increase in wheel-running activity because activity levels are 
already high, at a point of behavioural saturation. This hypothesis is supported by the fact 
that mice are highly motivated to run (J. S. Rhodes et al., 2005b) and find wheel-running 
intrinsically rewarding (Salamone et al., 2016). Which begs the question, are mice and 




Translational models are used ubiquitously in the development of drugs and in 
determining targets. In fact, it has been suggested that because of the interest in 
identifying novel treatments for energy-related symptoms of many psychological and 
neurological disorders (which conceptually extends to include physical inactivity) it is 
important to characterise the effects of adenosine antagonists in both human clinical trials 
and animal models (Pardo et al., 2013). It is common to alter baseline behaviours in 
animal models to mimic those of a target population, which is a concept that was 
introduced in the Animal Introduction (section 8.2.). This can be achieved through 
selective breeding (e.g. Zombeck, Deyoung, Brzezinska, & Rhodes, 2011), genetic 
modification (J. W. Young, Powell, Scott, Zhou, & Geyer, 2011), the production of 
lesions or depletions in specific brain areas (e.g. Kennerley, Walton, Behrens, Buckley, 
& Rushworth, 2006), or indeed pharmacologically.  
With gene editing technology candidate genes, hypothesised to play a role in the 
etiology of a disorder, can be altered and the behavioural consequences studied (e.g., 
Gainetdinov, Jones, & Caron, 1999). However, a clear disadvantage of this approach is 
that only one or two genes can be targeted at one time, whilst most behaviours are 
influenced by many genes (J. S. Rhodes et al., 2005b). Selective breeding, for example 
VHOHFWLQJIRUµOD]\¶PLFH, would provide a powerful alternative to genetic engineering but 
generation cycles can be several months and the development of the model itself required 
considerable time before a formal investigation can begin. Brain lesions and depletions, 
as well as pharmacological intervention, on the other hand, provide quick results and can 
identify differences in function that might arise from many different types of mechanisms.  
Lesions and dopamine depletions in the anterior cingulate gyrus (ACg ± part of 
the ACC) have been shown to cause rats to shift their choice behaviour from high 
effort/high reward options to low effort/low reward alternatives (Hauber & Sommer, 
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2009; Schweimer, Saft, & Hauber, 2005), for example. However, a major limitation of 
this approach is that lesions in brain areas such as the anterior cingulate cortex, which is 
implicated in the processing of decision cost (Kennerley et al., 2006),  can also impede 
motor control (Holec, Pirot, & Euston, 2014). This can be particularly problematic when 
using a complex behavioural output such as wheel-running. Whilst a common 
pharmacological intervention used to induce µSV\FKRPRWRUVORZLQJ¶, the dopamine D2 
antagonist Haloperidol, was shown to reduce voluntary wheel-running (Pardo et al., 2013) 
whilst not apparently impeding motor function (Correa et al., 2016). This was determined 
by video assessment of ataxia and coordination (i.e., gait), as well as paw placement on 
the floor of the running wheel. 
A study, which was introduced in the discussion of the previous chapter (section 
11.4.), utilised a combination of genetic engineering and pharmacology (Correa et al., 
2016). A T-maze paradigm was used to evaluate decisional costs. On one side of the 
junction, mice were presented with a freely accessible running wheel. On the other side, 
mice had access to a highly rewarding (high sucrose content) food. Haloperidol injections 
increased time spent consuming sucrose and decreased the time spent in the running 
wheel (see Figure 12.1.). This is not surprising as dopamine has been implicated in the 
regulation of physical inactivity (Knab & Lightfoot, 2010). Interestingly, in the same 
study (Correa et al., 2016) there was no change in choice behaviour among adenosine 
A2A Knockout (KO) mice, suggesting that the effect of haloperidol on choice behaviour 
is mediated by adenosinergic pathways. This is also supported by earlier studies which 
showed that A2A KO mice were also resistant to the effects of haloperidol on spontaneous 
physical activity via open field assessment, as well as wheel-running (Pardo et al., 2013) 





Figure 12.1. Effect of different doses of haloperidol (0.0, 0.05, 0.1, and 0.2 mgÂkg) on time spent in a 
running wheel or consuming sucrose. Data are presented as mean (± SEM) seconds in 15 minutes. Black 
bars represent sucrose consumption; grey bars represent wheel-running. * p  .05, ** p  .01 significantly 
different from 0.0 mgÂkg haloperidol for the same reinforcer. Taken from Correa and colleagues (2016). 
 
Dopamine/adenosine interactions (specifically at D2/A2A receptors) in the 
nucleus accumbens (NAc) are known to be important for effort-related processes (Farrar 
et al., 2010; Pardo et al., 2012; Santerre et al., 2012). Furthermore, previous studies 
reported that adenosine A2A antagonists (MSX-3, and MSX-4) reverse the effort-related 
effects of DA D2 antagonists (Pardo et al., 2012; Santerre et al., 2012). This presents an 
ideal candidate for pharmacologically inducing human sedentary-like behaviours in the 
development of our model, and specifically, the ability of caffeine to reverse the effects 
of haloperidol. Correa and colleagues (2016) ZHUH WKHILUVWWR UHFRJQLVH+DORSHULGRO¶V
psychomotor slowing effects as a model for human inactivity. Applying this adenosine 
dopamine interaction paradigm to the paper discussed above (Correa et al., 2016). It 
would have been interesting to determine whether the reduced preference for wheel-
running and increased preference for high sucrose food may be reversed by the 
subsequent administration of an adenosine antagonist, such as caffeine, theophylline, or 
MSX-3/4. A previous study in the same lab found that the behavioural suppression 
elicited by haloperidol was indeed effectively reversed with administration of 
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theophylline, which is a metabolite of caffeine and a selective A2A receptor antagonist. 
However, the wheel-running paradigm that was employed (Pardo et al., 2013) was a very 
short (30-minute) exposure following a single acute dose, under soft light conditions (at 
an unknown time of day). Therefore, direct inferences to our model are unfortunately 
limited. A very recent study (López-Cruz et al., 2018) however, also from the same lab, 
used VMAT-2 inhibitor tetrabenazine (TBZ) to deplete dopamine in rats. Rats were able 
to choose between wheel-running, or sedentary behaviours of eating or sniffing a neutral 
odour. In agreement with Correa and colleagues (2016) the dopamine depletion resulted 
in a shift from active to sedentary reinforcers. Where this study differs is that it 
subsequently administered caffeine which reversed this shift, which is consistent with the 
findings from the previous study by Pardo and colleagues (2013). 
The aim of the present study is to validate the use of haloperidol as a 
pharmacological intervention to induce human sedentary-like behaviour in mice. 
It was hypothesised that haloperidol would reduce EFWR activity, but this 
pharmacologically induced reduction in activity would be reversed by subsequent 







Nineteen male Wild Type (C57 BL/6J) mice were obtained from Charles River 
Laboratories (Kent). Mice were 6-12 months of age, weighing (M ± SD) 34 ± 6g, 
individually housed (as described in General Animal Methods, section 9.2.) under 12:12 
light:dark cycle (01:00 ± 13:00). Food and water were available ad libitum, except for 
during the EFWR procedure. 
 
12.2.2. Study design 
This study utilised a repeated measures crossover design. Where a 2-hour EFWR 
observation period, and subsequent monitoring of SPA in the home-cage environment, 
were completed at baseline and preceding three different treatment conditions. Subjects 
completed two baseline trials (receiving no treatment), as well as two trials for each 
treatment. There was 48 hours between the first and second trial with each treatment, and 
a minimum of 5 days between the initiation of each new treatment. 
 
12.2.3. Experimental procedures 
Treatments (received in a randomised order and administered via IP injection) 
were:  µVKDP¶ 7DUWDULF $FLG  ZKLFK LV WKH YHKLFOH VROXWLRQ IRU +DORSHULGRO 
followed by physiological saline (0.9% NaCl); 2) haloperidol 0.2 mgÂkg, followed by 
physiological saline (0.9% NaCl); and 3) 0.2 mgÂkg haloperidol, followed by 40 mgÂkg 
caffeine. Procedures started at ZT12 (start of the active phase). Injections alternated 
between the lower-left and lower-right quadrant of the abdomen to minimise the impact 
of repeated doses. After the first injection mice were returned to their home-cage, without 
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a running wheel present, and food and water available ad libitum. Approximately 30-
minutes later the second injection was administered, following which, mice were returned 
to their home-cage and enclosed within their running wheel. Once enclosed within the 
wheel, a 2-hour EFWR observation period and subsequent monitoring of home-cage SPA 
ensued (see General Animal Methods sections 9.3., 9.4., and 9.5., for details about drugs 
and administration; and sections 9.6. and 9.7. for details on activity monitoring). 
 
12.2.4. Statistical analyses  
One-way repeated measures (RM) ANOVAs were used to determine whether 
there was a statistically significant difference between treatments for EFWR variables of 
distance, sedentary time %, average running speed, and maximum running speed. As well 
as SPA activity during the remaining active phase, and the following inactive phase. The 
Shapiro-Wilk's test of normality on the studentised residuals was performed for all 
variables. Where sphericity was violated degrees of freedom were corrected with the 
Greenhouse±*HLVVHUİ (Maxwell & Delaney, 2004). When necessary, a Bonferroni post-
hoc procedure was used for follow-up comparisons. Effect sizes for relevant comparisons 
ZHUHFDOFXODWHGXVLQJ&RKHQ¶VGDQGGHILQHGDVWULYLDO30), small (0.3), moderate 
(), and large ( 0.8), respectively (Cohen, 1992). Results were considered significant 
DWS$OOWHVWVZHUHFDrried out using IBM SPSS Statistics for Windows, Version 





12.3.1. EFWR parameters following drug administration at ZT12 
EFWR distance was statistically significantly different between conditions, 
F(2.130, 38.339) = 13.985, p < .001İ 710. Post hoc analysis was performed with a 
Bonferroni adjustment. Mice ran statistically significantly further at baseline (99.100 ± 
21.019 m) than they did in the control (45.520 ± 12.500 m), and haloperidol conditions 
(37.660 ± 10.653). With mean differences of 53.571 (95% CI, 29.220 to 77.921) m, p < 
.001, and 61.438 (95% CI, 31.079 to 91.797) m, p < .001, respectively. Mice also ran 
statistically significantly further in the caffeine condition (104.960 ± 18.336 m) than in 
the haloperidol condition, with a mean difference of 67.298 (95% CI, 36.526 to 98.071) 
m, p < .001. No other differences between conditions were statistically significant. 
(Figure 12.2 A). 
EFWR sedentary time was statistically significantly different between conditions, 
F(3, 54) = 48.594, p < .001. Post hoc analysis was performed with a Bonferroni 
adjustment. During the 2-h EFWR activity, there was statistically significantly more 
sedentary time in the control (72.863 ± 3.251%) and haloperidol conditions (76.661 ± 
3.471%), compared to baseline (48.784 ± 4.177%). With mean differences of 24.079 
(95% CI, 15.546 to 32.612)%, p < .001, and 27.877 (95% CI, 18.788 to 36.965)%, p < 
.001, respectively. There was also statistically significantly less sedentary time in the 
caffeine condition (36.767 ± 4.475%), compared to the baseline and haloperidol 
conditions. With mean differences of -12.017 (95% CI, -20.602 to -3.433)%, p = .009, 
and -39.894 (95% CI, -47.319 to -32.470)%, p < .001, respectively. No other differences 
between conditions were statistically significant. (Figure 12.2 B). 
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EFWR average speed was statistically significantly different between conditions, 
F(2.261, 40.699) = 3.520, p = .0 İ= .754. Post hoc analysis was performed with a 
Bonferroni adjustment. During the 2-h EFWR activity average running speed was 
statistically significantly lower in the control (1.137 ± 0.130 m/min) and haloperidol 
(1.061 ± 0.132 m/min) conditions compared to baseline (1.402 ± 0.177 m/min). With 
mean differences of -.265 (95% CI, -.466 to -.065) m/min, p = .012, and -.341 (95% CI, 
-.612 to -.070) m/min, p = .017, respectively. No other differences between conditions 
were statistically significant. (Figure 12.2. C). 
EFWR maximum speed was statistically significantly different between 
conditions, F(3, 54) = 9.537, p < .001. Post hoc analysis was performed with a Bonferroni 
adjustment. During the 2-h EFWR maximum running speed was statistically significantly 
lower in the control (3.547 ± 0.399 m/min), and haloperidol (3.370 ± 0.430 m/min) 
conditions compared to baseline (4.868 ± 0.481 m/min). With mean differences of -1.321 
(95% CI, -2.066 to -.576) m/min, p = .002, and -1.499 (95% CI, -2.298 to -.700) 
m/min, p = .001, respectively. Whilst maximum speed in the caffeine condition (4.480 ± 
0.401 m/min) was statistically significantly higher than maximum speed in the control 
and haloperidol conditions. With mean differences of .933 (95% CI, .381 to 1.485) 
m/min, p = .002, and 1.111 (95% CI, .428 to 1.793) m/min, p = .003, respectively. No 





Figure 12.2. Enclosed free wheel-running activity, during a 2-hour observation period, at baseline and 
following 3 treatment conditions. Treatments (received in a randomised order and administered via IP 
injection) were: haloperidol vehicle followed by saline (control); haloperidol, followed by saline; and 
haloperidol, followed by 40 mgÂkg caffeine. The time of day was ZT12 (start of the active phase). A) total 
distance covered B) percentage of sedentary time. C) average running speed. D) maximum running speed. 
All values are presented as means ± SEM. * Indicates a significant difference between conditions at P < 
0.05, ** at P < 0.01, and *** at P < 0.001. 
 
12.3.2. SPA following drug administration at ZT12 and 2-h EFWR 
During the remainder of the active phase (ZT15 - ZT00), immediately following 
2-h EFWR, SPA was not statistically significantly different between conditions, F(3, 18) 
= 2.079, p  SDUWLDOȘ = .257. With SPA of .803 ± .082 counts/min at baseline; .583 
± .104 counts/min in control (vehicle + saline); .610 ± .063 counts/min in haloperidol 
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(haloperidol + saline); and .656 ± .063 counts/min in the caffeine (haloperidol + caffeine) 
condition. (Figure 12.3. A). 
During the following inactive phase (ZT00 ± ZT12), 9-h after 2-h EFWR, SPA 
was statistically significantly different between conditions, F(3, 18) = 7.390, p = .002, 
SDUWLDOȘ = .552. Post hoc analysis was performed with a Bonferroni adjustment. SPA 
was statistically significantly higher at baseline (.521 ± .049 counts/min) than it was in 
the control (.296 ± .061 counts/min), haloperidol (.293 ± .054 counts/min), and caffeine 
(.255 ± .029 counts/min) conditions. Compared to baseline, SPA in the control condition 
decreased by .225 (95% CI, .132 to .318) counts/min, p = .001, d = 2.232. SPA in the 
haloperidol condition, SPA decreased by .228 (95% CI, .032 to .423) counts/min, p = 
.029, d = 1.077. In the Caffeine condition SPA decreased by .266 (95% CI, .177 to 0.355) 
counts/min, p < .001, d = 2.268. There were no other statistically significant differences 
between conditions. (Figure 12.3. B). 
 
Figure 12.3. SPA measured via infrared motion detection, in a home-cage environment, after completing 
2-h enclosed free wheel-running, at baseline and following 3 treatment conditions. Treatments (received in 
a randomised order and administered via IP injection) were: haloperidol vehicle followed by saline 
(control); haloperidol, followed by saline; and haloperidol, followed by 40 mgÂkg caffeine. Drugs were 
administered at ZT12 (start of the active phase). A) during the remaining active phase (ZT15 ± ZT00); B) 
during the following inactive phase (ZT00 ± ZT12). All values are presented as means ± SEM. * Indicates 





The key finding here is that haloperidol-induced suppression in all EFWR 
parameters (i.e., decreased distance, average speed, and maximum speed, as well as 
increased sedentary time %). This is consistent with our hypothesis and congruent with 
literature demonstrating that haloperidol shifts behavioural decision making from high to 
low effort outcomes, in terms of lever pressing and barrier climbing (Pardo et al., 2012), 
SPA (via open field assessment) and wheel-running for short periods (Pardo et al., 2013), 
and literature demonstrating that haloperidol reduces preference for wheel-running in a 
T-maze choice paradigm (Correa et al., 2016). Importantly, by using a duration and time 
of day that is appropriate for translation to human exercise behaviour, this also serves to 
validate the use of haloperidol as a pharmacological intervention to induce human 
sedentary-like behaviour in mice, which was originally proposed by Correa and 
colleagues (2016). 
It was also hypothesised that the behavioural effects of haloperidol (i.e., EFWR 
suppression) would be reversed by subsequent administration of caffeine. This is largely 
supported by our data as EFWR distance and maximum speed were both higher, and 
sedentary time was lower, in the haloperidol + caffeine condition compared to the 
haloperidol + saline condition. It seems that the behavioural suppression induced by 
haloperidol was entirely reverse by caffeine as there was no difference in EFWR distance 
maximum, or average speed in the haloperidol + caffeine condition compared to baseline. 
This is consistent with literature demonstrating the reversal effects of MSX-3, MSX-4, 
theophylline, and caffeine, on impaired suppressed dopamine function, either elicited by 
dopamine depletions (Kennerley et al., 2006; López-Cruz et al., 2018), or through 
dopamine antagonism, such as via haloperidol or eticlopride (another selective dopamine 
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D2 receptor antagonist) (Ishiwari et al., 2007; Pardo et al., 2012, 2013; Santerre et al., 
2012).  
Consistent with the finding from the previous chapter, sedentary time was 
significantly lower in the haloperidol + caffeine condition than it was at baseline. Similar, 
albeit more selective, adenosine antagonists such as MSX-3, MSX-4, and theophylline 
have been shown to reverse the behavioural effects of haloperidol on wheel-running 
(Pardo et al., 2013), and caffeine has been shown to reverse the shift from active to 
sedentary reinforcers following dopamine depletions (López-Cruz et al., 2018). However, 
the present study is the first to demonstrate the ability for caffeine to elicit this reversal 
following treatment with haloperidol. This is particularly significant as caffeine is readily 
available without prescription and mirrors our human work (detailed in Part I). 
One surprising finding is that there is not a statistically significant difference for 
any of the EFWR variables (i.e., distance, sedentary time %, average speed, or maximum 
speed) in the vehicle + saline condition compared to haloperidol + saline. It was 
hypothesised that haloperidol would reduce EFWR, however, seeing the equivalent 
suppression in the control group was not foreseen. It is possible that this is a consequence 
of mice received two injections within a relatively short period (i.e., 30 minutes). The 
additional stress of receiving the extra injection may have had a negative response equal 
to receiving haloperidol, as the IP injection procedure is reported to elicit a stress response 
in mice (Ryabinin et al., 1999). This will be discussed in the Part II (animal) discussion 
(chapter 13) as this issue is also relevant to chapters 10 and 11. Another potential 
contributing factor which will be addressed here is a potential temporal effect. Literature 
examining the behavioural effect of haloperidol or similar compounds (such as 
eticlopride), in combination with caffeine or similar compounds (such as MSX-3, MSX-
4, and theophylline) have reported observation periods of between 10- and 30 minutes for 
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lever pressing, open field locomotion and wheel running (Correa et al., 2016; Ishiwari et 
al., 2007; López-Cruz et al., 2018; Santerre et al., 2012). To test the hypothesis that 
haloperidol had a suppressive effect greater than that of the vehicle plus saline condition 
(control), which diminished over the course of the ():5SDUDGLJP¶Vcomparably long 
2-hour observation period, an analysis of the first 1-hour period was performed (following 
the same procedures that are described in section 12.2.4). The figure (12.S.) and full 
results from this analysis (12.S.1.) are available for reference in Appendix M. Notably, 
when examining the first 1-hour period only, EFWR distance is statistically significantly 
lower in haloperidol condition compared to the control condition. The other results are 
largely unchanged. This provides support for the interpretation, provided here, that 
caffeine reversed haloperidol-induced suppression. 
There was no difference between any of the experimental conditions (i.e., vehicle 
+ saline, Haloperidol + saline, or haloperidol + caffeine), in terms of SPA, during the 
remainder of the active phase. On the other hand, SPA was lower than at baseline for all 
conditions during the following inactive phase. A compensation argument (Lark et al., 
2018; Pontzer et al., 2016) would make partial sense for the lower activity in the 
haloperidol + caffeine condition as, although all other parameters were equal, sedentary 
time was lower in this condition compared to baseline. However, in the vehicle + saline 
and haloperidol + saline conditions all EFWR parameters where suppressed, so a 
theoretical compensatory response would increase subsequent SPA, which is not the case. 
Instead, it is possible that there are lasting effects of disruption or stress from the 
experimental procedures (Ryabinin et al., 1999) that have not yet been recovered during 
the subsequent phase of SPA observation. This explanation would also extend to explain 
the lower SPA in the following inactive phase as by this point caffeine¶V effects would 




12.4.1. Conclusion  
In conclusion, as expected, the dopamine D2 receptor antagonist haloperidol 
suppressed EFWR. Furthermore, 40 mgÂkg caffeine, reversed this suppressing effect. 
Importantly, by using a duration and time of day that is appropriate for translation to 
human exercise behaviour, this also serves to validate the use of haloperidol as a 
pharmacological intervention to induce human sedentary-like behaviour in mice. 
Additionally, we demonstrate for the first time that caffeine, which is a nonselective 
adenosine receptor antagonist that is readily available for human consumption can elicit 










13.1. A summary of outcomes 
The aim of Part II of this thesis was to develop a relevant and translatable pre-
clinical model to measure the behavioural effects of pharmacological interventions on 
physical activity behaviour. Together, the experimental work detailed in chapters 10, 11 
and 12 have worked towards achieving this aim.  
In chapter 10 we determined the most appropriate wheel access paradigm to be 
EFWR, which despite resulting in lower levels of wheel running activity when compared 
to OFWR it was chosen to minimise stress and maximise measurement specificity.  
In chapter 11 we provided partial support for the hypothesis that caffeine would 
increase EFWR activity during the inactive phase, with some evidence of increased wheel 
running distance as well as a clear reduction in sedentary time, which is the number of 
minutes during the EFWR observation period where mice did not complete any wheel 
revolutions. In this chapter we also demonstrated for the first time that caffeine does not 
elicit a significant increase in voluntary wheel-running activity during the active phase. 
Furthermore, despite testing two (human equivalent) doses, and administering 6 repeated 
intermittent doses there was no evidence of behavioural sensitisation to caffeine, which 
had been reported previously in the literature. 
Chapter 12 validated the use of haloperidol as a method of pharmacologically 
inducing human sedentary-like behaviours in mice and demonstrated the ability for 
caffeine to reverse wheel-running suppression. There was no difference between baseline 
and haloperidol plus caffeine for wheel running distance, average speed, or maximum 
speed, whilst sedentary time was actually lower in the haloperidol plus caffeine condition. 
Receiving two sham injections containing only the vehicle substances (i.e., control) and 
haloperidol plus saline (i.e., haloperidol) both resulted in reduced wheel running distance, 
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average speed, and maximum speed. A further analysis of the first hour of the EFWR 
observation period revealed that wheel running distance was lowest in the haloperidol 
plus saline condition, demonstrating that caffeine was serving to reverse the suppressive 
effects of haloperidol as well as (but not limited to) providing an analgesic effect against 
receiving two consecutive injections.  
The model, as presented in chapter 12 provides the first functional model to assess 
the effects of pharmacological intervention on physical activity behaviour by using a 
duration and time of day that is appropriate for translation to human exercise behaviour. 
However, despite achieving the aim of Part II of this thesis, there are several 
considerations for future work which are discussed in the following sections. 
 
13.2. General limitations and future directions 
13.2.1. Ad libitum? 
A limitation of this study is that haloperidol administration has been shown to 
impact on food intake and eating time duration (Correa et al., 2016). However, as our 
EFWR paradigm prevented mice from accessing food or water during the wheel-running 
observation period, it is not possible to determine the possible effect that appetite and lack 
of access to food and water may have had on their perceptual responses to running. To 
eliminate this confounding variable, future work could maintain access to food and water, 
however, this would complicate the behavioural paradigm significantly. Interestingly, we 
also know that caffeine can decrease appetite for highly fatty foods in humans (Schubert 
et al., 2014) and therefore, increase appetite induced by haloperidol may be reversed by 




13.1.2. Optimal dosing 
Although the findings presented in chapter 12 were in agreement with the main 
findings from the literature, it should be noted, that lower doses of haloperidol < 0.2 
mgÂkg have failed to elicit significant reductions in wheel-running (Pardo et al., 2013), or 
a shift in preference away from wheel-running (Correa et al., 2016; see also Figure 12.1.). 
The dose used in chapter 12 (0.2 mgÂkg) was selected, based on findings published in the 
literature, to elicit maximum effect. Similarly, studies administering theophylline, MSX-
3, MSX-4, or indeed caffeine, have found that lower doses are unable to effectively 
protect against (Ishiwari et al., 2007) or reverse the suppression of dopaminergic 
antagonism or depletions (Pardo et al., 2012, 2013; Santerre et al., 2012). In chapter 12 
we used the higher dose of 40 mgÂkg caffeine, which was shown to significantly increase 
EFWR activity at ZT06 in chapter 11. Future work should establish the optimal dose 
range for these two drugs. This has been done previously with regard to cataleptic 
behaviours (Trevitt, Vallance, Harris, & Goode, 2009) but not wheel-running. As the 
doses of both haloperidol and caffeine used in the present study are near the top of the 
effective dose range published in the literature, it is possible that our EFWR paradigm 
may be more, or less, sensitive to reveal the effects of haloperidol and/or caffeine. 
 
13.1.3. Minimising procedure related distress 
A study (Ryabinin et al., 1999) showed a strong induction of Fos and Fos-related 
antigens in discrete areas of hypothalamus, amygdala, neocortex, septum, and thalamus 
following handling and intraperitoneal injection of physiological saline in C57BL/6J 
inbred mice. As this is the same strain of mice that was used throughout Part II of this 
thesis, this is highly revealing. Furthermore, this study (Ryabinin et al., 1999) reported 
that to achieve complete habituation of the immediate early gene response to injection 
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stress in stress-responsive brain areas of C57BL/6J mice, the following procedure needed 
to be followed: 4 days of handling (picking up the animal by its tail, once per day), 3 days 
of sham injections (needle was penetrated into the peritoneum, but no fluid was injected, 
once per day), 3 days of intraperitoneal injections (IP) with 10 ml/kg of saline (once per 
day), 4 days of IP injections of 20 ml/kg saline (resulting in a final volume of 0.4±0.6 ml 
per mouse, once per day). In this thesis, such a rigorous familiarisation procedure was not 
followed. Our mice were handled daily and were familiarised to the EFWR (and OFWR 
in chapter 10) procedure. However, they were not restrained during these trials and they 
did not receive sham injections. We did have control groups in all three studies in chapter 
11, as well as control condition sessions in chapters 10 and 12 (which utilised a within-
subject design), which will have ensured that the stress associated with the procedure was 
equal, regardless of treatment. Nevertheless, it is possible, likely even, that the stress 
associated with the experimental procedures reduced wheel-running activity in all mice. 
In the case of chapter 12 specifically, where mice received two consecutive injections it 
is possible that the stress response was amplified, explaining the unforeseen suppression 
of EFWR in the control condition, which was equal to that in the Haloperidol condition. 
 Future work could use Fos to compare one, vs two consecutive IP injections to 
quantify the additional stress, however, a better solution would be to complete a more 
systematic familiarisation procedure to reduce, if not eliminate, stress induced by the 
injection procedure. Another strategy would be to use a higher gauge needle, such as a 
31G ultra-fine hub-less insulin syringes, which are becoming more popular with mouse 
models (e.g., Gai et al., 2018). Although the relative contribution of the injection itself 
and the restraining that is required to administer the injection is uncertain, one can assume 
that the local injury and associated discomfort during wheel-running, caused by the 
injections would be reduced with the use of a higher gauge needle. 
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13.1.4. Tolerance of chronic administration 
A pH range of 4.5-8.0 is considered 'satisfactory' for IP injections (Weiss & Burge, 
2012), so the tartaric solution used in chapter 12 (and previously by Correa et al., 2016), 
as a vehicle for haloperidol, with a pH of 4, was on the limit. Despite the vehicle being 
generally well tolerated, one mouse had to be terminated before the end of the study due 
to an open wound at the injection site. Otherwise, the vehicle was generally well tolerated, 
however, it was only administered a total of 6 times per mouse in chapter 12. With a 
longer experiment looking to apply this model, there may be issues with tolerance. 
Interestingly, for oral administration, a pH as low as 3 can be tolerated (Weiss & Burge, 
2012). It is also possible to dissolve haloperidol in drinking water of rodents (Schmitt et 
al., 1999), which has been used in rats (for a 23 day period), indicating that it is a suitable 
mode of non-invasive chronic treatment. This approach would allow repeated 
administration of caffeine, and other drugs without concern for tolerability of the 
substance which is used to induce the suppressed behavioural state. As the intention of 
this model is to test the chronic effects of pharmacological interventions on physical 
activity behaviour this may be a desirable option. 
 
13.3. Conclusion 
In Part II of this thesis, a relevant and translatable pre-clinical model to measure 
the behavioural effects of pharmacological interventions on physical activity behaviour 
was developed. This chapter has discussed some of the limitations of the model in its 
current form and made recommendations for progressing to the next stage, which would 
be to assess the chronic effects of pharmacological interventions on physical activity 
behaviour.   
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14. General Discussion  
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14.1. A synthesis of overall outcomes 
14.1.1. Experimental medicine approach to behaviour change 
In this thesis, an EM approach was taken to progress our understanding of physical 
activity behaviour change interventions. The EM approach ensures that investigations not 
only identify whether an intervention is effective, but also provides a framework to 
understand how interventions elicit their effect on behaviour, which is via putative target 
engagement. The two parts of this thesis have taken divergent routes. Part I tested Paths 
D, as well as C, B, to develop a deeper understanding of the impact that perceptual 
responses during exercise have on outcomes related to exercise behaviour, as well as the 
extent to which these perceptual responses can be manipulated with pharmacological 
intervention. Part II developed a pre-clinical model to test Path X, which is the direct 
effect of an intervention on physical activity behaviour. After all, you cannot ask a mouse 
how they are feeling. Instead, target engagement is inferred by direct behavioural 
observation.  
Caffeine was used as the pharmacological intervention, not only for its reported 
effects on perceptual responses in humans and locomotive effects on animals but also 
because it is relatively cheap and readily available, without prescription. It may seem 
trivial, or even unethical, to test the effect of a pharmacological intervention on mice 
when it is safe to do so in humans. However, that would be missing the point. The reason 
for developing the preclinical model with caffeine, rather than alternative drugs is 
precisely because it is safe to do so in humans. Working concurrently with human and 
animal models enables the application of distinct yet complimentary sets of tools. In 
human work detailed in Part I the intensity of physical activity was standardised, then 
psychological and perceptual putative targets, thought to be important for determining 
physical activity behaviour, were measured in addition to a self-reported behavioural 
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choice measure to indicate preference; however, clearly this work is limited by its reliance 
on self-reported measures and the fact that physical activity behaviour was not directly 
observed. In Part II, with mice, the intensity of exercise was not standardised. Instead, 
physical activity behaviour was directly observed following the equivalent 
pharmacological intervention. Together, Part I and Part II provide translational models, 
able to detect psychological and behavioural effects of pharmacological intervention. 
This provides a platform from which to test the effects of alternative drugs, for trials at a 
pre-clinical and human level, on physical activity behaviour in the future.  
The state of the art has changed as a result of this investigation, and as such, the 
following sections provide an integration of the original findings detailed hear in with 
respect to specific paths of the EM approach. Which were introduced in section 1.2. of 
the General Introduction. 
 
14.1.3 State of the art ± Path C 
The aim of Part I of this thesis was to conduct a full test (Path D of the EM 
approach). Full tests determine whether an intervention strategy or a set of strategies 
changes physical activity behaviour, or a related outcome, via their effects on specified 
targets (Figure 1.1., Path D). Therefore, in this case, we sought to determine whether 
caffeine was able to influence exercise preference via its effects on feelings during 
exercise. However, a component of Path D is Path C which is concerned with target 
engagement. Without target engagement mediators cannot be determined, instead one can 
only conclude whether an intervention was effective, whilst the question of how? 
Remains unanswered.  
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Although there is substantial published research showing caffeine eliciting 
engagement of perceptual and psychological putative targets, including effort, affect, and 
enjoyment, in recreationally active and athletic participants (see Human Introduction 
section 2.3.1. for further detail), there were previously only two articles demonstrating 
(partial) target engagement in previously sedentary participants. The first demonstrated 
an indirect effect of perception of effort, indicated by improved time trial performance 
despite no change in RPE (Laurence, Wallman, & Guelfi, 2012), whilst the second article 
revealed that µOLNLQJ¶RISK\VLFDO DFWLYLW\ZDVKLJKHU IROORZLQJFDIIHLQH LQJHVWLRQ, but 
only in sedentary women and not in men (Schrader et al., 2013). We extend these findings 
by demonstrating that caffeine elicited significant engagement of several specific putative 
WDUJHWVZLWKLQWKHEURDGHUFRQWH[WRI³IHHOLQJVGXULQJH[HUFLVH´LGHQWLILHGDVWKHJOREDO
putative target in the General Introduction, section 1.3.) notably perception of effort, 
affect, and enjoyment in both a single-subject (chapter 4) and a group trial (chapter 5). 
These findings provide the first strong evidence testing Path C in previously sedentary 
participants, which corroborates evidence of caffeine eliciting target engagement in 
recreationally active and athletic populations. 
 
14.1.3 State of the art ± Paths B and D 
Ivanova and colleagues (2015) provided the first indirect test of Path D of the EM 
approach (as discussed in section 1.8.), though unknowingly. The authors demonstrated 
that commitment and acceptance therapy was able to engage the putative target (reducing 
the perception of effort), resulting in improved exercise tolerance, which is an alternative 
physical activity related outcome. The present study progresses this work by testing Path 
D using a pharmacological intervention. We provide the first experimental evidence that 
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pharmacological intervention can influence physical activity choice behaviour by 
manipulating feelings during and around exercise. 
When you engage a putative target and you see a change in behaviour, that 
provides evidence to consider the target as a determinant of behaviour (Sheeran et al., 
2017). Therefore, our findings provide further evidence that feelings during exercise, 
specifically perception of effort and affect, are important correlates/determinants of 
physical activity behaviour. We also provide evidence to suggest a casual role of 
psychological variables such as mood states of fatigue and vigour, as well as liking, 
enjoyment, and session RPE, even though we did it in a minor way, through choice, which 
is a related outcome, rather than long-term exercise adherence.  
An aim of this investigation was to understand the mechanisms underlying choice 
behaviour because with replicated preference tests alone, such as in chapter 4 and 5, it is 
not possible to establish which specific putative target, or targets, are the primary 
determinants of changes in choice behaviour. As caffeine appears to elicit significant 
changes in several of these variables it was important to establish which of the variables 
was the determining factor. To achieve this aim a qualitative explanatory analysis was 
conducted. This qualitative content analysis revealed that the factor most frequently (84% 
of choice occasions) attributed to determining choice was perception of effort. Affect, 
Pain, Mood state, and time-related factors, in contrast, were each cited in less than one-
quarter of all preference explanations. This provides further validation of Path B, 
particularly in terms of the relationship between the perception of effort and physical 
activity behaviour (see the General Introduction section 1.5. for a review of literature 
relating to target validation). It can be argued that this is weak evidence, as the 
behavioural outcome measure is choice, rather than long term adherence to exercise, for 
example, and the link between the putative target (perception of effort) and the behaviour 
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is qualitative, but it should not be ignored. This provides a valuable contribution to the 
field as this is the first experimental evidence that perception of effort may be more 
influential in determining exercise-related choice behaviour compared to affect and other 
perceptual and psychological responses during and around exercise.  
 
14.1.6. State of the art ± Path X 
An aim of Part II of this thesis was to develop a relevant and translatable pre-
clinical model for conducting standard efficacy trials/testing Path X in mice. The purpose 
of this model is to measure the behavioural effects of pharmacological interventions on 
physical activity behaviour that will compliment and facilitate concurrent human 
research, as well as to provide a platform to launch future preclinical trials. In contrast to 
Part I, changes in physical activity behaviour following pharmacological intervention 
(caffeine injections) were directly observed, with dependent variables including wheel 
running distance and speed, in addition to SPA which was recorded using infrared motion 
detection.  
Overall, it was evident that appropriate human equivalent doses of caffeine only 
proved to be effective at increasing physical activity when physical activity was 
habitually low. Low habitual physical activity was either observed at times of day that 
are inappropriate for translation to humans (such as detailed in chapter 11, study i), or, 
more suitably for human translation, during the active phase following pre-treatment with 
the dopamine D2 receptor antagonist haloperidol (detailed in chapter 12). Haloperidol 
induced human sedentary-like behaviours which were reversed by receiving caffeine.  
Each of the experimental chapters (10, 11, and 12) provided a partial test of Path 
X, however, more importantly, together, they describe incremental stages of developing 
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this model that may inform future trials. Despite limitations (as discussed in chapter 13), 
the model presented in chapter 12 provides the first example of a method to assess the 
effects of pharmacological intervention on physical activity behaviour by using a duration 
and time of day that is appropriate for translation to human exercise behaviour.  
 
14.2. Future directions 
As was discussed in the Human Discussion (section 7.4.), caffeine is able to 
reduce perception of effort by ~1-point on the Borg (1970) 6 ± 20 RPE scale. However, 
the clinical relevance of this effect is unclear. It has been suggested that parallel to the 
evaluation of currently available stimulants, we should try to develop psychoactive drugs 
that can reduce perception of effort by more than one point on the RPE scale (Doherty & 
Smith, 2005; Marcora, 2016). Psychoactive drugs that could reduce perception of effort 
IURP³KDUG´WR³HDV\´IRUH[DPSOHFRXOGEHhighly effective. This is where the 
preclinical model developed in Part II can be employed, to identify drug candidates for 
human trials. Adenosine antagonists, particularly selective to A2A receptors, such MSX-
3, MSX-4, and theophylline may be suitable initial targets (J. F. Chen et al., 2013). 
Another alternative pharmacological treatment, which is currently available on 
prescription, is modafinil, which is a D2 agonist used by many healthy people to reduce 
the perception of fatigue and sleepiness (Wesensten, Belenky, Thorne, Kautz, & Balkin, 
2004) and enhance cognition (Battleday & Brem, 2015), and it has also been shown to 
improve exercise tolerance and improve time trial performance (Jacobs & Bell, 2004).  
Another consideration for the identification of future drug targets is their impact 
on sleep quality and other negative side effects. This is a particular limitation of caffeine 
as it is well known to cause sleep disturbance (Ali et al., 2015; Brezinova, 1974), so its 
use in the afternoon or evening could be particularly problematic (Drake, Roehrs, 
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Shambroom, & Roth, 2013). Additionally, at relatively high doses, or even at low doses 
among individuals who suffer from anxiety-related conditions, caffeine is known to elicit 
anxiogenic-like effects (Yacoubi, Ledent, Parmentier, Costentin, & Vaugeois, 2000). 
The premise of the work presented throughout this thesis was to address a 
psychobiological reason for physical inactivity. The two theories which have underpinned 
this are HT (Ekkekakis et al., 2011; Kahneman, 1999; P. T. Young, 1952), and MIT 
(Brehm & Self, 1989; Richter et al., 2016; Wright, 2008), which together suggest that 
reducing the perception of effort and discomfort related to exercise will influence 
decisions to engage in future exercise. Qualitative data from an explanatory analysis in 
chapter 5 suggested that perception of effort may be the primary determinant of exercise 
choice behaviour. However, affect and perception of effort are negatively associated 
(Hardy & Rejeski, 1989) and their independent and combined effects on physical activity 
behaviour will need to be determined by future experimental work. Research on health 
behaviour change has long relied on intuition or pilot studies to determine how to engage 
targets. This approach is insufficient. An underlying principle of the EM approach is that 
theory development and competitive empirical tests need to go hand in hand in order to 
forge a science of target engagement, and ultimately behaviour change (Sheeran et al., 
2017). It is therefore essential to give fair consideration to evidence threatening the 
explanatory capacity of the current theoretical framework, which in this case is provided 
by HT and MIT. 
A very recent review article (Inzlicht, Shenhav, & Olivola, 2018) made the case 
that effort can be two things. Indeed, it can act as an aversive stimulus, RUµEDUULHU¶DQG
therefore a potential target for intervention (i.e., something that you want to reduce) as it 
has been considered throughout this thesis, but it can also add perceived value to 
achievements. For a full review see Inzlicht and colleagues (2018). Briefly, while people 
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will exert substantial effort to obtain something of value, what has been overlooked is the 
notion that working hard can also increase the perceived value of outcomes. Effort can 
even be experienced as valuable or rewarding in its own right. While humans and other 
animals are willing to exert more effort for better outcomes, they sometimes view the 
same outcomes as more rewarding if more (not less) effort was used to attain them. As 
an example, Inzlicht and colleagues (2018) refer to reports that mountaineers value 
mountain climbing precisely because it is so arduous and effortful (Loewenstein, 1999). 
Current work demonstrates WKDWHIIRUW¶VSRVLWLYHLPSDFWRQYDOXHPDQLIHVWVELRORJLFDOO\
(Hernandez Lallement et al., 2014; Ma, Meng, Wang, & Shen, 2013) and is basic and 
early-developing, occurring in children and non-human animals (Alessandri, Darcheville, 
& Zentall, 2008; Benozio & Diesendruck, 2015; A. W. Johnson & Gallagher, 2011). 
&RQVLGHULQJWKLVµHIIRUWSDUDGR[¶WKHUHIRUHFDQDGYDQFHHIIRUWWKHRULsing and its 
widespread applications. Clearly, interventions targeting perception of effort (such as the 
pharmacological intervention that has been tested in this thesis) will not be effective for 
people who heed particular value to physical effort. Furthermore, understanding the effort 
paradox opens the door for potential psychological intervention. For example, rather than 
seeing effort as aversive, it may be possible to develop cognitive appraisal techniques 
with people to view effort as adding value to exercise. This may be even more effective 
than a drug. However, it will not be easy to achieve and may not be possible for all people. 
Even if this can be achieved and people perceive effort to add value, one obvious 
moderator is the amount of effort demanded by a task. People are only willing to exert 
effort up to a limit (Brehm & Self, 1989; Richter et al., 2016; Wright, 2008) which is set 
by potential motivation. When either the effort required by a task exceeds potential 
motivation (i.e., maximum effort someone is willing to exert to succeed in the exercise 
task) or, when an individual perceives the exercise to be impossible (i.e., said individual 
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feels as though they have already exerted a true maximal effort and therefore can no 
longer continue) the person will disengage from the task. Any effort that is required above 
potential motivation will certainly be devalued rather than being sought after. Thus, 
excessive effort demands can break the effort±value link. Although there are reports that 
some people enjoy the challenge if HIIT (Bartlett et al., 2011), in future work 
investigating appraisal of effort value it would be prudent to test a variety of exercise 
intensities, as there may be significant variability in individual value-effort thresholds.  
The EM approach also encourages researchers to look beyond their µIDYRXULWH¶ 
theory or the behaviour at issue and to view the science of behaviour change in terms of 
targets ± their identification, measurement, validation, and engagement (Sheeran et al., 
2017). It is worth considering additional targets related to health and health-related 
behaviours for future studies.  
Low insulin sensitivity, or high resistance, is a core metabolic abnormality in type 
2 diabetes (S. E. Kahn, Hull, & Utzschneider, 2006; Kashyap & Defronzo, 2007). Yet, 
fluctuations in insulin sensitivity occur during the normal life cycle, with insulin 
resistance being observed during puberty (Moran et al., 1999) and pregnancy (Buchanan, 
Metzger, Freinkel, & Bergman, 1990), and with ageing (Defronzo, 1979). Whilst an 
increase in physical activity (Goodyear & Kahn, 1998) is associated with enhanced 
insulin sensitivity. Caffeine (3 mgÂkg) can acutely decrease insulin sensitivity in healthy 
humans, possibly as a result of elevated plasma adrenaline levels (Keijzers, De Galan, 
Tack, & Smits, 2002), suggesting that habitual caffeine intake should be limited. 
However, more recent work, in rats, has shown that chronic caffeine intake decreases 
serum adrenaline and prevents diet-induced insulin resistance and hypertension (Conde 
et al., 2012). If the chronic effect of caffeine on insulin sensitivity observed in rats is true 
for humans, then it is possible that the chronic combined effect of caffeine (Conde et al., 
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2012) and exercise (Goodyear & Kahn, 1998) may be particularly beneficial for the 
treatment and prevention of insulin resistance in clinical and sub-clinical populations. 
Therefore, including measures of insulin sensitivity as a putative target in pre-clinical and 
human studies, investigating the long-term effects of caffeine on physical activity 
behaviour, would be worthwhile. 
 
14.3. Conclusion 
This thesis has served as the first investigation utilising the EM approach to study 
physical activity behaviour change. Complimentary humans and animal work presented 
in Part I and II progress our understanding of the role of perceptual responses to exercise 
and physical activity behaviour. Further, this study has validated the use of 
pharmacological intervention, as a form of pharmacotherapy, to engage (manipulate) 
important perceptual targets, and in turn, influence physical activity choice behaviour. 
We provide the first experimental evidence demonstrating the role of perception of effort, 
in particular, in explaining physical activity choice behaviour which, if substantiated by 
future work would qualify perception of effort as a determinant of physical activity 
behaviour, rather than a correlate (as it is currently classified). Additionally, we 
established the preliminary workings of a pre-clinical model to assess the effects of 
pharmacological intervention on physical activity behaviour in mice. In sum, this thesis 
offers translational models, able to detect psychological and behavioural effects of 
pharmacological intervention, providing a platform from which to test the effects of 
alternative drugs, for trials at a pre-clinical and human level, on physical activity 
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Appendices   
Appendix A ± Physical Activity Readiness ± Questionnaire + (PAR-Q+) 
2014 PAR-Q+ 
 
GENERAL HEALTH QUESTIONNAIRES 
 
Please read the 8 questions below carefully and answer each one honestly: check 
YES or NO. 
 
 YES NO 
1. Has your doctor ever said that you have a heart condition or high 
blood pressure? Ƒ Ƒ 
2. Do you feel pain in your chest at rest, during your daily activities 
of living, or when you do physical activity? Ƒ Ƒ 
3. Do you lose balance because of dizziness or have you lost 
consciousness in the last 12 months? (Please answer NO if your 
dizziness was associated with over-breathing (including vigorous 
exercise). 
Ƒ Ƒ 
4. Have you ever been diagnosed with another chronic medical 
condition (other than heart disease or high blood pressure)? Ƒ Ƒ 
If yes, please list condition(s) here: 
 
5. Are you currently taking prescribed medications for a chronic 
medical condition? Ƒ Ƒ 
If yes, please list condition(s) and medications here: 
 
6. Do you currently have (or have you had within the past 12 months) 
a bone, joint or soft tissue (muscle, ligament, or tendon) problem 
that could be made worse by becoming more physically active? 
Please answer NO if you had a problem in the past but it does not 




If yes, please list condition(s) here: 
 
7. Has your doctor ever said that you should only do medically 
supervised physical activity? Ƒ Ƒ 
8. Do you suffer from any allergies or food intolerances? Ƒ Ƒ 
If yes, please list condition(s) below: 
 
 
If you answered No to all of the questions above, you are ready to participate in the study.  
Go to Page 5 and sign the PARTICIPANT DECLARATION.  You do not need to 




FOLLOW UP QUESTIONS ABOUT YOUR MEDICAL CONDITION(S) 
 
  YES NO 
1. Do you have arthritis, osteoporosis, or back problems? 
If the above condition(s) is/are present, answer questions 1a-1c.  
If NO, go to Question 2. 
Ƒ Ƒ 
1a. Do you have difficulty controlling your condition with 
medications or other physician-prescribed therapies? (Answer NO 
if you are not currently taking any medications or other 
treatments). 
Ƒ Ƒ 
1b. Do you have joint problems causing pain, a recent fracture or 
fracture caused by osteoporosis or cancer, displaced vertebrae 
(e.g. spondylolisthesis), and/or spondyloysis/pars defect (a crack 
in the bony ring on the back of the spinal column)? 
Ƒ Ƒ 
1c. Have you had steroid injections or taken steroid tablets regularly 
for more than 3 months? Ƒ Ƒ 
2. Do you have cancer of any kind? 
If the above condition(s) is/are present, answer questions 2a-2b.  
If NO, go to Question 3. 
Ƒ Ƒ 
2a. Does your cancer diagnosis include any of the following types: 
lung/bronchogenic, multiple myeloma (cancer of plasma cells), 
head and neck? 
Ƒ Ƒ 
2b. Are you currently receiving cancer therapy (such as chemotherapy 
or radiotherapy)? Ƒ Ƒ 
3. Do you have a heart or cardiovascular condition? This 
includes coronary artery disease, heart failure, diagnosed 
abnormality or heart rhythm. 
If the above condition(s) is/are present, answer questions 3a-3d.  
If NO, go to Question 4. 
Ƒ Ƒ 
3a. Do you have difficulty controlling your condition with 




if you are not currently taking any medications or other 
treatments). 
3b. Do you have an irregular heartbeat that required medical 
management? 
(e.g. atrial fibrillation, premature ventricular contraction) 
Ƒ Ƒ 
3c. Do you have chronic heart failure? Ƒ Ƒ 
3d. Do you have diagnosed coronary artery (cardiovascular) disease 
and have not participated in regular physical activity in the last 2 
months? 
Ƒ Ƒ 
4. Do you have high blood pressure? 
If the above condition(s) is/are present, answer questions 4a-4b.  
If NO, go to Question 5. 
Ƒ Ƒ 
4a. Do you have difficulty controlling your condition with 
medications or other physician-prescribed therapies? (Answer NO 
if you are not currently taking any medications or other 
treatments). 
Ƒ Ƒ 
4b. Do you have a resting blood pressure equal to or greater than 
160/90mmHg with or without medication? Ƒ Ƒ 
5. Do you have metabolic conditions? This includes Type 1 
diabetes, Type 2 diabetes, and pre-diabetes. 
If the above condition(s) is/are present, answer questions 5a-5e.  
If NO, go to Question 6. 
Ƒ Ƒ 
  YES NO 
5a. Do you often have difficulty controlling your blood sugar levels 
with foods, medications, or other physician-prescribed therapies? Ƒ Ƒ 
5b. Do you often suffer from signs and symptoms of low blood sugar 
(hypoglycaemia) following exercise and/or during activities of 
daily living?  Signs of hypoglycaemia may include shakiness, 
nervousness, unusual irritability, abnormal sweating, dizziness or 





5c. Do you have any signs or symptoms of diabetes complications 
such as heart or vascular disease and/or complications affecting 
your eyes, kidneys, OR the sensation in your toes and feet? 
Ƒ Ƒ 
5d. Do you have other metabolic conditions (such as current 
pregnancy related diabetes, chronic kidney disease, or liver 
problems)? 
Ƒ Ƒ 
5e. Are you planning to engage in what for you is unusually high (or 
vigorous) intensity exercise in the near future? Ƒ Ƒ 
6. Do you have any mental health problems or learning 
difficulties? 7KLV LQFOXGHV $O]KHLPHU¶V GHPHQWLD GHSUHVVLRQ
anxiety disorder, eating disorder, psychotic disorder, intellectual 
disability, and down syndrome. 
If the above condition(s) is/are present, answer questions 6a-6b.  
If NO, go to Question 7. 
Ƒ Ƒ 
6a. Do you have difficulty controlling your condition with 
medications or other physician-prescribed therapies? (Answer NO 
if you are not currently taking any medications or other 
treatments). 
Ƒ Ƒ 
6b. Do you ALSO have back problems affecting nerves or muscles? Ƒ Ƒ 
7. Do you have a respiratory disease? This includes chronic 
obstructive pulmonary disease, asthma, pulmonary high blood 
pressure. 
If the above condition(s) is/are present, answer questions 7a-7d.  
If NO, go to Question 8. 
Ƒ Ƒ 
7a. Do you have difficulty controlling your condition with 
medications or other physician-prescribed therapies? (Answer NO 
if you are not currently taking any medications or other 
treatments). 
Ƒ Ƒ 
7b. Has your doctor ever said you blood oxygen level is low at rest or 
during exercise and/or that you require supplemental oxygen 
therapy? 
Ƒ Ƒ 
7c. If asthmatic, do you currently have symptoms of chest tightness, 




days/week), or have you used your rescue medication more than 
twice in the last week? 
7d. Has your doctor ever said you have high blood pressure in the 
blood vessels of your lungs? Ƒ Ƒ 
8. Do you have a spinal cord injury? 
If the above condition(s) is/are present, answer questions 8a-8c.  
If NO, go to Question 9. 
Ƒ Ƒ 
8a. Do you have difficulty controlling your condition with 
medications or other physician-prescribed therapies? (Answer NO 
if you are not currently taking any medications or other 
treatments). 
Ƒ Ƒ 
8b. Do you commonly exhibit low resting blood pressure significant 
enough to cause dizziness, light-headedness, and/or fainting? Ƒ Ƒ 
  YES NO 
8c. Has your physician indicated that you exhibit sudden bouts of 
high blood pressure (known as autonomic dysreflexia)? Ƒ Ƒ 
9. Have you had a stroke? This includes transient ischemic attack 
(TIA) or cerebrovascular event. 
If the above condition(s) is/are present, answer questions 9a-9c.  
If NO, go to Question 10. 
Ƒ Ƒ 
9a. Do you have difficulty controlling your condition with 
medications or other physician-prescribed therapies? (Answer NO 
if you are not currently taking any medications or other 
treatments). 
Ƒ Ƒ 
9b. Do you have any impairment in walking or mobility? Ƒ Ƒ 
9c. Have you experienced a stroke or impairment in nerves or muscles 
in the past 6 months? Ƒ Ƒ 
10. Do you have any other medical condition which is not listed 




If you have other medical conditions, answer questions 10a-10c.  
If NO, read the Page 4 recommendations. 
10a. Have you experienced a blackout, fainted, or lost consciousness 
as a result of a head injury within the last 12 months OR have you 
had a diagnosed concussion within the last 12 months? 
Ƒ Ƒ 
10b. Do you have a medical condition that is not listed (such as 
epilepsy, neurological conditions, and kidney problems)? Ƒ Ƒ 
10c. Do you currently live with two or more medical conditions? Ƒ Ƒ 
 Please list your medical condition(s) and any related medications here: 
 
 
If you answered NO to all of the follow-up questions about your medical condition, you 
are ready to participate in the study.  Please sign the PARTICIPANT DECLARATION 
below. 
 
If you answered YES to one or more of the follow up questions about your medical 
condition, you should seek advice from a member of the research team regarding your 
study participation. 
 
If your health changes over the course of this study, please talk to your doctor and inform 














All persons who have completed the PAR-Q+ please read and sign the declaration below. 
If you are less than 18 years old, or require the assent of a care provider, your parent, 
guardian or carer provider must also sign this form. 
 
I, the undersigned, have read, understood to my full satisfaction and completed this 
questionnaire.  I acknowledge that this physical activity clearance is valid for a maximum 
of 12 months from the date it is completed and becomes invalid if my condition changes.  
I also acknowledge that a Trustee (such as my employer/community fitness centre, health 
care provider or other designate) may retain a copy of this form for their records.  In these 
instances, the Trustee will be required to adhere to local, national, national and 
international guidelines regarding the storage of personal health information ensuring that 
the Trustee maintains the privacy of the information and does not misuse or wrongfully 
disclose such information. 
 
ID_______________________________  Date_________________________________ 
 
Signature__________________________ Witness ____________________________ 
 
















































































































Appendix L ± Contents analysis from chapter 5 
1st-order theme Higher order theme Occurrences 
Task difficulty (hard) 
1. Perception of 











3. Affective valence 22 ± 27% 
Enjoyment 
Exercise-induced pain 4. Pain 22 ± 36% 
Time 
5. Time-related 15 ± 20% 
Monotony 
Thirsty 











IT001 Experimental 2 Experimental 3 Experimental 4 Experimental 5 Experimental 6 
Choice 1 0 1 1 1 
 
Felt better, 
almost no leg 
pain. 
"Even though it 
was hard, it 
was not as hard 
as last time" 
No pain, really 
less hard, pain 
usually but 
today there was 
no pain - even 
at the start. 
Time went 
quicker. 
During - Today felt 
longer, waiting for 
the voice asking for 
RPE. Fuck you! 
Did you change the 
steepness? Today 
there was pain from 




short, but today 
was a better 
session. Today 
was really fine. 
No pain, time 
was faster, still 
hards but 
easier. 
IT002 Experimental 2 Experimental 3 Experimental 4 Experimental 5 Experimental 6 
Choice 1 1 1 1 1 
 
Not sure what 
you put in it 
today. It feels 




Tired. Not pain 
but tired. After 





harder. It didn't 
feel as good. It 
felt like it was 
longer. 
When I got out 
of the car today 
I felt like this 
one was the 
happy pill. It 
felt easier as it 
went on. I felt 
thirstier. Today 
felt better. 
Poor sleep again on 
Monday evening. I 
don't feel as out of 
breath, but it feels 
harder work. I 
would stop if I 
could right now 
(which I am feeling 
for the first time). 
Today I felt like a 
rat on a wheel. I 
tried hard but there 
was no pleasure. 
This pill makes 
me jabber on! 





days feel like 





like taking off a 
coat, it didn't 
feel boring or 
menotonous, 
no pain, it 
didn't feel the 
same... 
IT003 Experimental 2 Experimental 3 Experimental 4 Experimental 5 Experimental 6 






why it felt 
harder. Last 
session was a 
really good 
session. 
Easier than last 
time but still 
really hard. 
I feel like I was 
better able to 
recover and more 
alert. 
Last session 
was hard, but 
this session 
was harder. 
IT004 Experimental 2 Experimental 3 Experimental 4 Experimental 5 Experimental 6 




Felt dizzy last 
time 
Felt lethargic, 
pain in hip. 
Today didn't 
feel as difficult, 
I was tired in 




Mentally today felt 
easier, physically it 




IT005 Experimental 2 Experimental 3 Experimental 4 Experimental 5 Experimental 6 





Felt difficult, I 
was maxed out, 
less alert after 
doing it. I feel 
mentally 
fatigued. 
I felt better 
today. 
Today felt longer. Today ZDVQ¶W 
really that hard, 
I could have 
gone on, it was 
actually 
enjoyable. 
IT006 Experimental 2 Experimental 3 Experimental 4 Experimental 5 Experimental 6 
Choice 0 1 1 1 1 
 
Started well, 
found it harder 
at the end, 





main thing was 
the pain. 
Less pain 
today, I felt 
good, alert, and 
energetic. Less 
effort! The end 
of the test felt 
like half way 
through. 
Pain and stuff was 
worse than the last  
but better than the 
one before that. 
Today felt harder. 
Less pain and 
less effort, I 
felt more 
energetic. I'm 
in a good 
mood. 
IT007 Experimental 2 Experimental 3 Experimental 4 Experimental 5 Experimental 6 





lighter than in 
the previous 
session, still 
not that light 
but lighter. 











today despite pain 
being the same. 
It felt quite 
hard today 
IT008 Experimental 2 Experimental 3 Experimental 4 Experimental 5 Experimental 6 
Choice 1 1 1 1 1 
 
Today was very 
similar, I 
remember the 
last one feeling 
easy though. 
It was a lot 
easier today, it 









harder at the end 
but easier than the 
last session. 
Very similar 
but today was 
maybe a little 
harder. 
IT009 Experimental 2 Experimental 3 Experimental 4 Experimental 5 Experimental 6 




It felt so much 
more steep 
today. I feel 
light headed and 
exhausted 
today. There 
was also less 
pain last time. 
Not as hard 
today, time 





Very similar Today was easier, I 
don't feel as tired, 
less exertion. 
Easier ish - a 
little bit. I don't 
know why but 
it just felt a 
little bit easier. 
IT010 Experimental 2 Experimental 3 Experimental 4 Experimental 5 Experimental 6 




Today I felt 
better. Legs felt 
better too. 
The hills were 
slightly harder 
today. 
I had a sicky feeling 
toward the end. 
Legs felt fine 
though. 
Legs felt heavy 
today. Last 
session I was 







Appendix M ± Supplementary analyses for chapter 12 
12.S.1. EFWR (first hour only) parameters following drug administration at ZT12 
EFWR distance was statistically significantly different between conditions, 
F(2.067, 37.209) = 14.521, p İ 3RVWKRFDQDO\VLVZDVSHUIRUPHGZLWKD
Bonferroni adjustment. There was not a statistically significant difference in when 
running distance between baseline (57.773 ± 13.144 m) and caffeine (55.232 ± 9.627 m), 
with a mean difference of just 2.541 (95% CI, -15.606 to 20.688) m, p = .772; whilst all 
other conditions were statistically significant from one another. Mice ran statistically 
significantly further at baseline than they did in the control (26.328 ± 7.336 m), and 
haloperidol conditions (20.998 ± 6.661), with mean differences of 31.444 (95% CI, 
15.388 to 47.500) m, p = .001, and 36.775 (95% CI, 19.063 to 54.486) m, p < .001, 
respectively. Mice also ran statistically significantly further in the caffeine condition than 
they did in the control, and haloperidol conditions, with mean differences of 28.903 (95% 
CI, 14.435 to 43.371) m, p = .001, and 34.234 (95% CI, 20.289 to 48.178) m, p < .001, 
respectively. Finally, mice ran statistically significantly further in the control condition 
than in the haloperidol condition, with a mean difference of 5.331 (95% CI, 0.56 to 
10.605) m, p = .048. (Figure 12.S. A). 
EFWR sedentary time was statistically significantly different between conditions, 
F(3, 54) = 40.730, p < .001. Post hoc analysis was performed with a Bonferroni 
adjustment. During the 2-h EFWR activity, there was statistically significantly more 
sedentary time in the control (73.805 ± 3.004%) and haloperidol conditions (75.949 ± 
3.611%), compared to baseline (49.706 ± 4.455%). With mean differences of 24.099 
(95% CI, 15.645 to 32.554)%, p < .001, and 26.244 (95% CI, 16.648 to 35.840)%, p < 
.001, respectively. There was also statistically significantly less sedentary time in the 
caffeine condition (40.113 ± 4.304%), compared to the baseline, control, and haloperidol 
305 
 
conditions. With mean differences of -9.593 (95% CI, -18.420 to -0.765)%, p = .035, -
33.693 (95% CI, -42.816 to -24.570)%, p < .001, and -35.837 (95% CI, -42.932 to -
28.742)%, p < .001, respectively. No other differences between conditions were 
statistically significant. (Figure 12.S. B). 
EFWR average speed was statistically significantly different between conditions, 
F(2.303, 41.461) = 6.332, p    İ  3RVWKRFDQDO\VLVZDVSHUIRUPHGZLWKD
Bonferroni adjustment. During the 2-h EFWR activity average running speed was 
statistically significantly lower in the control (1.284 ± 0.187 m/min) and haloperidol 
(1.145 ± 0.179 m/min) conditions compared to baseline (1.666 ± 0.246 m/min). With 
mean differences of -.382 (95% CI, -.628 to -.135) m/min, p = .004, and -.521 (95% CI, 
-.837 to -.205) m/min, p = .003, respectively. No other differences between conditions 
were statistically significant. (Figure 12.S. C). 
EFWR maximum speed was statistically significantly different between 
conditions, F(3, 54) = 8.325, p < .001. Post hoc analysis was performed with a Bonferroni 
adjustment. During the 2-h EFWR maximum running speed was statistically significantly 
lower in the control (3.060 ± 0.410 m/min), haloperidol (2.716 ± 0.411 m/min), and 
caffeine (3.651 ± 0.405 m/min) conditions compared to baseline (4.283 ± 0.511 m/min). 
With mean differences of -1.223 (95% CI, -1.978 to -.467) m/min, p = .003, -1.567 (95% 
CI, -2.483 to -.650) m/min, p = .002, and -.632 (95% CI, -1.246 to -.019) m/min, p = .044, 
respectively. Whilst maximum speed in the caffeine condition was statistically 
significantly higher than maximum speed in the control and haloperidol conditions. With 
mean differences of .591 (95% CI, .068 to 1.113) m/min, p = .029, and .935 (95% CI, 
.185 to 1.684) m/min, p = .017, respectively. No other differences between conditions 





Figure 12.S. Enclosed free wheel-running activity, during the first 1-hour of a (total) 2-hour observation 
period, at baseline and following 3 treatment conditions. Treatments (received in a randomised order and 
administered via IP injection) were: haloperidol vehicle followed by saline (control); haloperidol, followed 
by saline; and haloperidol, followed by 40 mgÂkg caffeine. The time of day was ZT12 (start of the active 
phase). A) total distance covered B) percentage of sedentary time. C) average running speed. D) maximum 
running speed. All values are presented as means ± SEM. * Indicates a significant difference between 
conditions at P < 0.05, ** at P < 0.01, and *** at P < 0.001. 
 
